id	sid	tid	token	lemma	pos
iajs-17	1	1	conseguences	conseguence	NOUN
iajs-17	1	2	of	of	ADP
iajs-17	1	3	soil	soil	NOUN
iajs-17	1	4	crude	crude	ADJ
iajs-17	1	5	oil	oil	NOUN
iajs-17	1	6	pollution	pollution	NOUN
iajs-17	1	7	on	on	ADP
iajs-17	1	8	some	some	DET
iajs-17	1	9	wood	wood	NOUN
iajs-17	1	10	properties	property	NOUN
iajs-17	1	11	of	of	ADP
iajs-17	1	12	olive	olive	NOUN
iajs-17	1	13	trees	tree	NOUN
iajs-17	1	14	chemistry	chemistry	NOUN
iajs-17	1	15	|	|	ADV
iajs-17	1	16	132	132	NUM
iajs-17	1	17	2016	2016	NUM
iajs-17	1	18	(	(	PUNCT
iajs-17	1	19	عاً	عاً	PROPN
iajs-17	1	20	3اىعذد	3اىعذد	NUM
iajs-17	1	21	)	)	PUNCT
iajs-17	1	22	29ٍديت	29ٍديت	NUM
iajs-17	1	23	إبِ	إبِ	X
iajs-17	1	24	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	1	25	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	1	26	اىصشفت	اىصشفت	VERB
iajs-17	1	27	ٗ	ٗ	VERB
iajs-17	1	28	اىخطبٞقٞت	اىخطبٞقٞت	ADV
iajs-17	1	29	اىَديذ	اىَديذ	PROPN
iajs-17	2	1	ibn	ibn	PROPN
iajs-17	2	2	al	al	PROPN
iajs-17	2	3	-	-	PUNCT
iajs-17	2	4	haitham	haitham	PROPN
iajs-17	2	5	jour	jour	X
iajs-17	2	6	.	.	PROPN
iajs-17	2	7	for	for	ADP
iajs-17	2	8	pure	pure	ADJ
iajs-17	2	9	&	&	CCONJ
iajs-17	2	10	appl	appl	PROPN
iajs-17	2	11	.	.	PUNCT
iajs-17	3	1	sci	sci	PROPN
iajs-17	3	2	.	.	PUNCT
iajs-17	3	3	vol	vol	NOUN
iajs-17	3	4	.	.	PROPN
iajs-17	3	5	29	29	NUM
iajs-17	3	6	(	(	PUNCT
iajs-17	3	7	3	3	NUM
iajs-17	3	8	)	)	SYM
iajs-17	3	9	2016	2016	NUM
iajs-17	3	10	effect	effect	NOUN
iajs-17	3	11	of	of	ADP
iajs-17	3	12	type	type	NOUN
iajs-17	3	13	2	2	NUM
iajs-17	3	14	diabetes	diabetes	NOUN
iajs-17	3	15	mellitus	mellitus	NOUN
iajs-17	3	16	on	on	ADP
iajs-17	3	17	extracellular	extracellular	ADJ
iajs-17	3	18	superoxide	superoxide	NOUN
iajs-17	3	19	dismutase	dismutase	NOUN
iajs-17	3	20	:	:	PUNCT
iajs-17	3	21	without	without	ADP
iajs-17	3	22	complications	complication	NOUN
iajs-17	3	23	among	among	ADP
iajs-17	3	24	iraqi	iraqi	ADJ
iajs-17	3	25	patients	patient	NOUN
iajs-17	3	26	namir	namir	PROPN
iajs-17	3	27	i.	i.	PROPN
iajs-17	3	28	haddad	haddad	PROPN
iajs-17	3	29	dept	dept	PROPN
iajs-17	3	30	.	.	PROPN
iajs-17	4	1	of	of	ADP
iajs-17	4	2	chemistry/	chemistry/	NUM
iajs-17	4	3	college	college	NOUN
iajs-17	4	4	of	of	ADP
iajs-17	4	5	science/	science/	NUM
iajs-17	4	6	university	university	PROPN
iajs-17	4	7	of	of	ADP
iajs-17	4	8	baghdad	baghdad	PROPN
iajs-17	4	9	essam	essam	PROPN
iajs-17	4	10	nori	nori	PROPN
iajs-17	4	11	national	national	PROPN
iajs-17	4	12	diabetes	diabetes	PROPN
iajs-17	4	13	center	center	NOUN
iajs-17	4	14	for	for	ADP
iajs-17	4	15	treatment	treatment	NOUN
iajs-17	4	16	and	and	CCONJ
iajs-17	4	17	research	research	NOUN
iajs-17	4	18	/	/	SYM
iajs-17	4	19	al	al	PROPN
iajs-17	4	20	-	-	PUNCT
iajs-17	4	21	mustansiriya	mustansiriya	PROPN
iajs-17	4	22	university	university	PROPN
iajs-17	4	23	sana'a	sana'a	PROPN
iajs-17	4	24	h.	h.	PROPN
iajs-17	4	25	ali	ali	PROPN
iajs-17	4	26	dept	dept	PROPN
iajs-17	4	27	.	.	PROPN
iajs-17	5	1	of	of	ADP
iajs-17	5	2	chemistry/	chemistry/	NUM
iajs-17	5	3	college	college	NOUN
iajs-17	5	4	of	of	ADP
iajs-17	5	5	science/	science/	NUM
iajs-17	5	6	university	university	PROPN
iajs-17	5	7	of	of	ADP
iajs-17	5	8	baghdad	baghdad	PROPN
iajs-17	5	9	received	receive	VERB
iajs-17	5	10	in	in	ADP
iajs-17	5	11	:	:	PUNCT
iajs-17	5	12	22	22	NUM
iajs-17	5	13	/	/	SYM
iajs-17	5	14	march/2016,accepted	march/2016,accepte	VERB
iajs-17	5	15	in:5	in:5	PROPN
iajs-17	5	16	/	/	SYM
iajs-17	5	17	april/2016	april/2016	NOUN
iajs-17	5	18	abstract	abstract	NOUN
iajs-17	5	19	the	the	DET
iajs-17	5	20	current	current	ADJ
iajs-17	5	21	study	study	NOUN
iajs-17	5	22	includes	include	VERB
iajs-17	5	23	(	(	PUNCT
iajs-17	5	24	130	130	NUM
iajs-17	5	25	)	)	PUNCT
iajs-17	5	26	t2	t2	NOUN
iajs-17	5	27	dm	dm	NOUN
iajs-17	5	28	patients	patient	NOUN
iajs-17	5	29	(	(	PUNCT
iajs-17	5	30	group	group	NOUN
iajs-17	5	31	p	p	NOUN
iajs-17	5	32	)	)	PUNCT
iajs-17	6	1	[	[	X
iajs-17	6	2	51	51	NUM
iajs-17	6	3	males	male	NOUN
iajs-17	6	4	and	and	CCONJ
iajs-17	6	5	79	79	NUM
iajs-17	6	6	females	female	NOUN
iajs-17	6	7	with	with	ADP
iajs-17	6	8	an	an	DET
iajs-17	6	9	ages	age	NOUN
iajs-17	6	10	range	range	NOUN
iajs-17	6	11	(	(	PUNCT
iajs-17	6	12	35	35	NUM
iajs-17	6	13	to	to	ADP
iajs-17	6	14	55	55	NUM
iajs-17	6	15	)	)	PUNCT
iajs-17	6	16	and	and	CCONJ
iajs-17	6	17	ages	age	NOUN
iajs-17	6	18	mean	mean	VERB
iajs-17	6	19	49.89	49.89	NUM
iajs-17	6	20	years	year	NOUN
iajs-17	6	21	]	]	PUNCT
iajs-17	6	22	,	,	PUNCT
iajs-17	6	23	they	they	PRON
iajs-17	6	24	are	be	AUX
iajs-17	6	25	sub	sub	ADJ
iajs-17	6	26	-	-	VERB
iajs-17	6	27	grouped	group	VERB
iajs-17	6	28	into	into	ADP
iajs-17	6	29	three	three	NUM
iajs-17	6	30	categories	category	NOUN
iajs-17	6	31	according	accord	VERB
iajs-17	6	32	to	to	ADP
iajs-17	6	33	their	their	PRON
iajs-17	6	34	hba1c	hba1c	ADJ
iajs-17	6	35	value	value	NOUN
iajs-17	6	36	.	.	PUNCT
iajs-17	7	1	patients	patient	NOUN
iajs-17	7	2	with	with	ADP
iajs-17	7	3	hba1c	hba1c	PROPN
iajs-17	7	4	less	less	ADJ
iajs-17	7	5	than	than	ADP
iajs-17	7	6	7	7	NUM
iajs-17	7	7	are	be	AUX
iajs-17	7	8	considered	consider	VERB
iajs-17	7	9	as	as	ADP
iajs-17	7	10	good	good	ADJ
iajs-17	7	11	controlled	control	VERB
iajs-17	7	12	diabetic	diabetic	ADJ
iajs-17	7	13	patients	patient	NOUN
iajs-17	7	14	(	(	PUNCT
iajs-17	7	15	30	30	NUM
iajs-17	7	16	patients	patient	NOUN
iajs-17	7	17	)	)	PUNCT
iajs-17	7	18	(	(	PUNCT
iajs-17	7	19	group	group	NOUN
iajs-17	7	20	p1	p1	PROPN
iajs-17	7	21	)	)	PUNCT
iajs-17	7	22	,	,	PUNCT
iajs-17	7	23	while	while	SCONJ
iajs-17	7	24	patients	patient	NOUN
iajs-17	7	25	with	with	ADP
iajs-17	7	26	hba1c	hba1c	NOUN
iajs-17	7	27	between	between	ADP
iajs-17	7	28	7	7	NUM
iajs-17	7	29	and	and	CCONJ
iajs-17	7	30	8	8	NUM
iajs-17	7	31	are	be	AUX
iajs-17	7	32	considered	consider	VERB
iajs-17	7	33	as	as	ADP
iajs-17	7	34	medium	medium	NOUN
iajs-17	7	35	controlled	control	VERB
iajs-17	7	36	diabetic	diabetic	ADJ
iajs-17	7	37	patients	patient	NOUN
iajs-17	7	38	(	(	PUNCT
iajs-17	7	39	40	40	NUM
iajs-17	7	40	patients	patient	NOUN
iajs-17	7	41	)	)	PUNCT
iajs-17	7	42	(	(	PUNCT
iajs-17	7	43	group	group	NOUN
iajs-17	7	44	p2	p2	PROPN
iajs-17	7	45	)	)	PUNCT
iajs-17	7	46	,	,	PUNCT
iajs-17	7	47	and	and	CCONJ
iajs-17	7	48	the	the	DET
iajs-17	7	49	patient	patient	NOUN
iajs-17	7	50	whom	whom	PRON
iajs-17	7	51	their	their	PRON
iajs-17	7	52	hba1c	hba1c	NOUN
iajs-17	7	53	more	more	ADJ
iajs-17	7	54	than	than	ADP
iajs-17	7	55	8	8	NUM
iajs-17	7	56	are	be	AUX
iajs-17	7	57	considered	consider	VERB
iajs-17	7	58	as	as	ADP
iajs-17	7	59	uncontrolled	uncontrolled	ADJ
iajs-17	7	60	diabetic	diabetic	ADJ
iajs-17	7	61	patients	patient	NOUN
iajs-17	7	62	(	(	PUNCT
iajs-17	7	63	50	50	NUM
iajs-17	7	64	patients	patient	NOUN
iajs-17	7	65	)	)	PUNCT
iajs-17	7	66	(	(	PUNCT
iajs-17	7	67	group	group	NOUN
iajs-17	7	68	p3	p3	PROPN
iajs-17	7	69	)	)	PUNCT
iajs-17	7	70	.	.	PUNCT
iajs-17	8	1	the	the	DET
iajs-17	8	2	patients	patient	NOUN
iajs-17	8	3	group	group	NOUN
iajs-17	8	4	results	result	NOUN
iajs-17	8	5	are	be	AUX
iajs-17	8	6	compared	compare	VERB
iajs-17	8	7	to	to	PART
iajs-17	8	8	control	control	VERB
iajs-17	8	9	healthy	healthy	ADJ
iajs-17	8	10	subjects	subject	NOUN
iajs-17	8	11	(	(	PUNCT
iajs-17	8	12	35	35	NUM
iajs-17	8	13	subjects	subject	NOUN
iajs-17	8	14	)	)	PUNCT
iajs-17	8	15	(	(	PUNCT
iajs-17	8	16	group	group	NOUN
iajs-17	8	17	c	c	NOUN
iajs-17	8	18	)	)	PUNCT
iajs-17	9	1	[	[	X
iajs-17	9	2	14	14	NUM
iajs-17	9	3	males	male	NOUN
iajs-17	9	4	and	and	CCONJ
iajs-17	9	5	21	21	NUM
iajs-17	9	6	females	female	NOUN
iajs-17	9	7	with	with	ADP
iajs-17	9	8	age	age	NOUN
iajs-17	9	9	range	range	NOUN
iajs-17	9	10	45.51	45.51	NUM
iajs-17	9	11	years	year	NOUN
iajs-17	9	12	]	]	PUNCT
iajs-17	9	13	matched	match	VERB
iajs-17	9	14	for	for	ADP
iajs-17	9	15	age	age	NOUN
iajs-17	9	16	,	,	PUNCT
iajs-17	9	17	gender	gender	NOUN
iajs-17	9	18	and	and	CCONJ
iajs-17	9	19	bmi	bmi	NOUN
iajs-17	9	20	were	be	AUX
iajs-17	9	21	included	include	VERB
iajs-17	9	22	in	in	ADP
iajs-17	9	23	the	the	DET
iajs-17	9	24	study	study	NOUN
iajs-17	9	25	.	.	PUNCT
iajs-17	10	1	patients	patient	NOUN
iajs-17	10	2	and	and	CCONJ
iajs-17	10	3	controls	control	NOUN
iajs-17	10	4	groups	group	NOUN
iajs-17	10	5	were	be	AUX
iajs-17	10	6	characterized	characterize	VERB
iajs-17	10	7	in	in	ADP
iajs-17	10	8	terms	term	NOUN
iajs-17	10	9	of	of	ADP
iajs-17	10	10	age	age	NOUN
iajs-17	10	11	(	(	PUNCT
iajs-17	10	12	year	year	NOUN
iajs-17	10	13	)	)	PUNCT
iajs-17	10	14	,	,	PUNCT
iajs-17	10	15	duration	duration	NOUN
iajs-17	10	16	of	of	ADP
iajs-17	10	17	dm	dm	PROPN
iajs-17	10	18	(	(	PUNCT
iajs-17	10	19	year	year	NOUN
iajs-17	10	20	)	)	PUNCT
iajs-17	10	21	,	,	PUNCT
iajs-17	10	22	body	body	NOUN
iajs-17	10	23	mass	mass	NOUN
iajs-17	10	24	index	index	NOUN
iajs-17	10	25	(	(	PUNCT
iajs-17	10	26	bmi	bmi	PROPN
iajs-17	10	27	)	)	PUNCT
iajs-17	10	28	(	(	PUNCT
iajs-17	10	29	kg/	kg/	PROPN
iajs-17	10	30	m2	m2	PROPN
iajs-17	10	31	)	)	PUNCT
iajs-17	10	32	,	,	PUNCT
iajs-17	10	33	serum	serum	NOUN
iajs-17	10	34	insulin	insulin	NOUN
iajs-17	10	35	(	(	PUNCT
iajs-17	10	36	μiu	μiu	PROPN
iajs-17	10	37	/	/	SYM
iajs-17	10	38	ml	ml	NOUN
iajs-17	10	39	)	)	PUNCT
iajs-17	10	40	,	,	PUNCT
iajs-17	10	41	fasting	fast	VERB
iajs-17	10	42	serum	serum	NOUN
iajs-17	10	43	glucose	glucose	NOUN
iajs-17	10	44	(	(	PUNCT
iajs-17	10	45	fsg	fsg	NOUN
iajs-17	10	46	)	)	PUNCT
iajs-17	10	47	(	(	PUNCT
iajs-17	10	48	mg	mg	PROPN
iajs-17	10	49	/	/	SYM
iajs-17	10	50	dl	dl	PROPN
iajs-17	10	51	)	)	PUNCT
iajs-17	10	52	,	,	PUNCT
iajs-17	10	53	homeostatic	homeostatic	ADJ
iajs-17	10	54	model	model	NOUN
iajs-17	10	55	assessment	assessment	NOUN
iajs-17	10	56	(	(	PUNCT
iajs-17	10	57	homa	homa	NOUN
iajs-17	10	58	)	)	PUNCT
iajs-17	10	59	parameters	parameter	NOUN
iajs-17	10	60	using	use	VERB
iajs-17	10	61	homa2	homa2	NOUN
iajs-17	10	62	calculator	calculator	NOUN
iajs-17	10	63	,	,	PUNCT
iajs-17	10	64	mda	mda	PROPN
iajs-17	10	65	(	(	PUNCT
iajs-17	10	66	mmol	mmol	NOUN
iajs-17	10	67	/	/	SYM
iajs-17	10	68	l	l	NOUN
iajs-17	10	69	)	)	PUNCT
iajs-17	10	70	using	use	VERB
iajs-17	10	71	tba	tba	NOUN
iajs-17	10	72	reaction	reaction	NOUN
iajs-17	10	73	method	method	NOUN
iajs-17	10	74	,	,	PUNCT
iajs-17	10	75	\and	\and	PROPN
iajs-17	10	76	ec	ec	PROPN
iajs-17	10	77	-	-	PUNCT
iajs-17	10	78	sod	sod	NOUN
iajs-17	10	79	activity	activity	NOUN
iajs-17	10	80	(	(	PUNCT
iajs-17	10	81	u	u	NOUN
iajs-17	10	82	/	/	SYM
iajs-17	10	83	ml	ml	VERB
iajs-17	10	84	)	)	PUNCT
iajs-17	10	85	,	,	PUNCT
iajs-17	10	86	using	use	VERB
iajs-17	10	87	riboflavin	riboflavin	NOUN
iajs-17	10	88	/	/	SYM
iajs-17	10	89	nbt	nbt	NOUN
iajs-17	10	90	method	method	NOUN
iajs-17	10	91	.	.	PUNCT
iajs-17	11	1	were	be	AUX
iajs-17	11	2	measured	measure	VERB
iajs-17	11	3	for	for	ADP
iajs-17	11	4	patients	patient	NOUN
iajs-17	11	5	and	and	CCONJ
iajs-17	11	6	control	control	NOUN
iajs-17	11	7	subjects	subject	NOUN
iajs-17	11	8	.	.	PUNCT
iajs-17	12	1	the	the	DET
iajs-17	12	2	hba1c	hba1c	PROPN
iajs-17	12	3	,	,	PUNCT
iajs-17	12	4	fsg	fsg	PROPN
iajs-17	12	5	,	,	PUNCT
iajs-17	12	6	fsi	fsi	PROPN
iajs-17	12	7	and	and	CCONJ
iajs-17	12	8	i.r	i.r	PROPN
iajs-17	12	9	have	have	AUX
iajs-17	12	10	been	be	AUX
iajs-17	12	11	found	find	VERB
iajs-17	12	12	to	to	PART
iajs-17	12	13	be	be	AUX
iajs-17	12	14	significantly	significantly	ADV
iajs-17	12	15	higher	high	ADJ
iajs-17	12	16	in	in	ADP
iajs-17	12	17	diabetic	diabetic	ADJ
iajs-17	12	18	patients	patient	NOUN
iajs-17	12	19	group	group	NOUN
iajs-17	12	20	(	(	PUNCT
iajs-17	12	21	p	p	NOUN
iajs-17	12	22	)	)	PUNCT
iajs-17	12	23	in	in	ADP
iajs-17	12	24	comparison	comparison	NOUN
iajs-17	12	25	to	to	ADP
iajs-17	12	26	group	group	PROPN
iajs-17	12	27	c.	c.	PROPN
iajs-17	12	28	the	the	DET
iajs-17	12	29	homa	homa	PROPN
iajs-17	12	30	parameters	parameter	NOUN
iajs-17	12	31	(	(	PUNCT
iajs-17	12	32	s%	s%	NOUN
iajs-17	12	33	and	and	CCONJ
iajs-17	12	34	β%	β%	VERB
iajs-17	12	35	)	)	PUNCT
iajs-17	12	36	have	have	AUX
iajs-17	12	37	been	be	AUX
iajs-17	12	38	found	find	VERB
iajs-17	12	39	to	to	PART
iajs-17	12	40	be	be	AUX
iajs-17	12	41	significantly	significantly	ADV
iajs-17	12	42	higher	high	ADJ
iajs-17	12	43	in	in	ADP
iajs-17	12	44	group	group	NOUN
iajs-17	12	45	c	c	PROPN
iajs-17	12	46	as	as	SCONJ
iajs-17	12	47	compared	compare	VERB
iajs-17	12	48	to	to	ADP
iajs-17	12	49	diabetic	diabetic	ADJ
iajs-17	12	50	patients	patient	NOUN
iajs-17	12	51	group	group	NOUN
iajs-17	12	52	(	(	PUNCT
iajs-17	12	53	group	group	NOUN
iajs-17	12	54	p	p	NOUN
iajs-17	12	55	)	)	PUNCT
iajs-17	12	56	,	,	PUNCT
iajs-17	12	57	serum	serum	VERB
iajs-17	12	58	specific	specific	ADJ
iajs-17	12	59	sod	sod	NOUN
iajs-17	12	60	activity	activity	NOUN
iajs-17	12	61	,	,	PUNCT
iajs-17	12	62	ec	ec	PROPN
iajs-17	12	63	-	-	PUNCT
iajs-17	12	64	sod	sod	NOUN
iajs-17	12	65	activity	activity	NOUN
iajs-17	12	66	found	find	VERB
iajs-17	12	67	to	to	PART
iajs-17	12	68	be	be	AUX
iajs-17	12	69	significantly	significantly	ADV
iajs-17	12	70	higher	high	ADJ
iajs-17	12	71	in	in	ADP
iajs-17	12	72	control	control	NOUN
iajs-17	12	73	group	group	PROPN
iajs-17	12	74	c	c	PROPN
iajs-17	12	75	in	in	ADP
iajs-17	12	76	comparison	comparison	NOUN
iajs-17	12	77	to	to	ADP
iajs-17	12	78	patients	patient	NOUN
iajs-17	12	79	group	group	NOUN
iajs-17	12	80	p.	p.	PROPN
iajs-17	12	81	serum	serum	PROPN
iajs-17	12	82	mda	mda	PROPN
iajs-17	12	83	level	level	NOUN
iajs-17	12	84	showed	show	VERB
iajs-17	12	85	a	a	DET
iajs-17	12	86	significantly	significantly	ADV
iajs-17	12	87	higher	high	ADJ
iajs-17	12	88	value	value	NOUN
iajs-17	12	89	in	in	ADP
iajs-17	12	90	diabetic	diabetic	ADJ
iajs-17	12	91	patients	patient	NOUN
iajs-17	12	92	group	group	NOUN
iajs-17	13	1	p	p	NOUN
iajs-17	13	2	in	in	ADP
iajs-17	13	3	comparison	comparison	NOUN
iajs-17	13	4	to	to	ADP
iajs-17	13	5	control	control	PROPN
iajs-17	13	6	group	group	PROPN
iajs-17	13	7	c.	c.	PROPN
iajs-17	13	8	the	the	DET
iajs-17	13	9	fsg	fsg	PROPN
iajs-17	13	10	,	,	PUNCT
iajs-17	13	11	fsi	fsi	PROPN
iajs-17	13	12	and	and	CCONJ
iajs-17	13	13	i.r	i.r	PROPN
iajs-17	13	14	have	have	AUX
iajs-17	13	15	been	be	AUX
iajs-17	13	16	showed	show	VERB
iajs-17	13	17	that	that	SCONJ
iajs-17	13	18	they	they	PRON
iajs-17	13	19	are	be	AUX
iajs-17	13	20	increased	increase	VERB
iajs-17	13	21	as	as	ADP
iajs-17	13	22	hba1c	hba1c	NOUN
iajs-17	13	23	increase	increase	NOUN
iajs-17	13	24	,	,	PUNCT
iajs-17	13	25	i.e.	i.e.	X
iajs-17	13	26	these	these	DET
iajs-17	13	27	parameter	parameter	NOUN
iajs-17	13	28	were	be	AUX
iajs-17	13	29	higher	high	ADJ
iajs-17	13	30	in	in	ADP
iajs-17	13	31	group	group	NOUN
iajs-17	13	32	p3	p3	PROPN
iajs-17	13	33	compared	compare	VERB
iajs-17	13	34	with	with	ADP
iajs-17	13	35	group	group	NOUN
iajs-17	13	36	p2	p2	NOUN
iajs-17	13	37	,	,	PUNCT
iajs-17	13	38	group	group	NOUN
iajs-17	13	39	p1	p1	NOUN
iajs-17	13	40	and	and	CCONJ
iajs-17	13	41	group	group	NOUN
iajs-17	13	42	c.	c.	PROPN
iajs-17	13	43	homa	homa	PROPN
iajs-17	13	44	parameters	parameter	NOUN
iajs-17	13	45	(	(	PUNCT
iajs-17	13	46	s%	s%	NOUN
iajs-17	13	47	and	and	CCONJ
iajs-17	13	48	β%	β%	VERB
iajs-17	13	49	)	)	PUNCT
iajs-17	13	50	have	have	AUX
iajs-17	13	51	shown	show	VERB
iajs-17	13	52	a	a	DET
iajs-17	13	53	significant	significant	ADJ
iajs-17	13	54	decrease	decrease	NOUN
iajs-17	13	55	as	as	ADP
iajs-17	13	56	hba1c	hba1c	NOUN
iajs-17	13	57	increase	increase	NOUN
iajs-17	13	58	,	,	PUNCT
iajs-17	13	59	i.e.	i.e.	X
iajs-17	13	60	these	these	DET
iajs-17	13	61	parameter	parameter	NOUN
iajs-17	13	62	were	be	AUX
iajs-17	13	63	lesser	less	ADJ
iajs-17	13	64	in	in	ADP
iajs-17	13	65	group	group	NOUN
iajs-17	13	66	p3	p3	PROPN
iajs-17	13	67	than	than	ADP
iajs-17	13	68	group	group	NOUN
iajs-17	13	69	p2	p2	NOUN
iajs-17	13	70	,	,	PUNCT
iajs-17	13	71	and	and	CCONJ
iajs-17	13	72	were	be	AUX
iajs-17	13	73	higher	high	ADJ
iajs-17	13	74	in	in	ADP
iajs-17	13	75	group	group	NOUN
iajs-17	13	76	p2	p2	PROPN
iajs-17	13	77	than	than	ADP
iajs-17	13	78	group	group	NOUN
iajs-17	13	79	p1	p1	NOUN
iajs-17	13	80	,	,	PUNCT
iajs-17	13	81	although	although	SCONJ
iajs-17	13	82	these	these	DET
iajs-17	13	83	parameters	parameter	NOUN
iajs-17	13	84	were	be	AUX
iajs-17	13	85	lower	low	ADJ
iajs-17	13	86	in	in	ADP
iajs-17	13	87	patients	patient	NOUN
iajs-17	13	88	group	group	NOUN
iajs-17	13	89	p	p	PROPN
iajs-17	13	90	than	than	ADP
iajs-17	13	91	control	control	PROPN
iajs-17	13	92	group	group	PROPN
iajs-17	13	93	c.	c.	PROPN
iajs-17	13	94	and	and	CCONJ
iajs-17	13	95	serum	serum	PROPN
iajs-17	13	96	ec	ec	PROPN
iajs-17	13	97	-	-	PUNCT
iajs-17	13	98	sod	sod	NOUN
iajs-17	13	99	activity	activity	NOUN
iajs-17	13	100	were	be	AUX
iajs-17	13	101	decreased	decrease	VERB
iajs-17	13	102	as	as	ADP
iajs-17	13	103	hba1c	hba1c	NOUN
iajs-17	13	104	increase	increase	NOUN
iajs-17	13	105	,	,	PUNCT
iajs-17	13	106	i.e.	i.e.	X
iajs-17	13	107	sod	sod	NOUN
iajs-17	13	108	activity	activity	NOUN
iajs-17	13	109	,	,	PUNCT
iajs-17	13	110	specific	specific	ADJ
iajs-17	13	111	sod	sod	NOUN
iajs-17	13	112	activity	activity	NOUN
iajs-17	13	113	and	and	CCONJ
iajs-17	13	114	serum	serum	NOUN
iajs-17	13	115	ec	ec	PROPN
iajs-17	13	116	-	-	PUNCT
iajs-17	13	117	sod	sod	NOUN
iajs-17	13	118	activity	activity	NOUN
iajs-17	13	119	were	be	AUX
iajs-17	13	120	found	find	VERB
iajs-17	13	121	to	to	PART
iajs-17	13	122	be	be	AUX
iajs-17	13	123	significantly	significantly	ADV
iajs-17	13	124	higher	high	ADJ
iajs-17	13	125	in	in	ADP
iajs-17	13	126	group	group	NOUN
iajs-17	13	127	p1	p1	NOUN
iajs-17	13	128	comparing	compare	VERB
iajs-17	13	129	with	with	ADP
iajs-17	13	130	group	group	NOUN
iajs-17	13	131	p2	p2	PROPN
iajs-17	13	132	and	and	CCONJ
iajs-17	13	133	p3	p3	PROPN
iajs-17	13	134	,	,	PUNCT
iajs-17	13	135	while	while	SCONJ
iajs-17	13	136	serum	serum	NOUN
iajs-17	13	137	mda	mda	PROPN
iajs-17	13	138	level	level	NOUN
iajs-17	13	139	in	in	ADP
iajs-17	13	140	group	group	NOUN
iajs-17	13	141	p3	p3	PROPN
iajs-17	13	142	was	be	AUX
iajs-17	13	143	significantly	significantly	ADV
iajs-17	13	144	higher	high	ADJ
iajs-17	13	145	than	than	ADP
iajs-17	13	146	group	group	NOUN
iajs-17	13	147	p2	p2	NOUN
iajs-17	13	148	,	,	PUNCT
iajs-17	13	149	and	and	CCONJ
iajs-17	13	150	p1	p1	NOUN
iajs-17	13	151	.	.	PUNCT
iajs-17	14	1	the	the	DET
iajs-17	14	2	serum	serum	PROPN
iajs-17	14	3	mda	mda	PROPN
iajs-17	14	4	level	level	NOUN
iajs-17	14	5	in	in	ADP
iajs-17	14	6	group	group	NOUN
iajs-17	14	7	p1	p1	NOUN
iajs-17	14	8	and	and	CCONJ
iajs-17	14	9	group	group	NOUN
iajs-17	14	10	p2	p2	PROPN
iajs-17	14	11	showed	show	VERB
iajs-17	14	12	a	a	DET
iajs-17	14	13	significant	significant	ADJ
iajs-17	14	14	positive	positive	ADJ
iajs-17	14	15	correlation	correlation	NOUN
iajs-17	14	16	with	with	ADP
iajs-17	14	17	age	age	NOUN
iajs-17	14	18	.	.	PUNCT
iajs-17	15	1	in	in	ADP
iajs-17	15	2	group	group	PROPN
iajs-17	15	3	p3	p3	PROPN
iajs-17	15	4	,	,	PUNCT
iajs-17	15	5	mda	mda	PROPN
iajs-17	15	6	showed	show	VERB
iajs-17	15	7	a	a	DET
iajs-17	15	8	significant	significant	ADJ
iajs-17	15	9	negative	negative	ADJ
iajs-17	15	10	correlation	correlation	NOUN
iajs-17	15	11	with	with	ADP
iajs-17	15	12	serum	serum	NOUN
iajs-17	15	13	cr	cr	PROPN
iajs-17	15	14	level	level	NOUN
iajs-17	15	15	,	,	PUNCT
iajs-17	15	16	while	while	SCONJ
iajs-17	15	17	,	,	PUNCT
iajs-17	15	18	a	a	DET
iajs-17	15	19	significant	significant	ADJ
iajs-17	15	20	positive	positive	ADJ
iajs-17	15	21	correlation	correlation	NOUN
iajs-17	15	22	was	be	AUX
iajs-17	15	23	observed	observe	VERB
iajs-17	15	24	with	with	ADP
iajs-17	15	25	age	age	NOUN
iajs-17	15	26	,	,	PUNCT
iajs-17	15	27	duration	duration	NOUN
iajs-17	15	28	of	of	ADP
iajs-17	15	29	dm	dm	PROPN
iajs-17	15	30	,	,	PUNCT
iajs-17	15	31	and	and	CCONJ
iajs-17	15	32	hba1c	hba1c	PROPN
iajs-17	15	33	.	.	PUNCT
iajs-17	16	1	chemistry	chemistry	NOUN
iajs-17	16	2	|	|	ADV
iajs-17	16	3	133	133	NUM
iajs-17	16	4	2016	2016	NUM
iajs-17	16	5	(	(	PUNCT
iajs-17	16	6	عاً	عاً	PROPN
iajs-17	16	7	3اىعذد	3اىعذد	NUM
iajs-17	16	8	)	)	PUNCT
iajs-17	16	9	29ٍديت	29ٍديت	NUM
iajs-17	16	10	إبِ	إبِ	X
iajs-17	16	11	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	16	12	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	16	13	اىصشفت	اىصشفت	VERB
iajs-17	16	14	ٗ	ٗ	VERB
iajs-17	16	15	اىخطبٞقٞت	اىخطبٞقٞت	ADV
iajs-17	16	16	اىَديذ	اىَديذ	PROPN
iajs-17	17	1	ibn	ibn	PROPN
iajs-17	17	2	al	al	PROPN
iajs-17	17	3	-	-	PUNCT
iajs-17	17	4	haitham	haitham	PROPN
iajs-17	17	5	jour	jour	X
iajs-17	17	6	.	.	PROPN
iajs-17	17	7	for	for	ADP
iajs-17	17	8	pure	pure	ADJ
iajs-17	17	9	&	&	CCONJ
iajs-17	17	10	appl	appl	PROPN
iajs-17	17	11	.	.	PUNCT
iajs-17	18	1	sci	sci	PROPN
iajs-17	18	2	.	.	PUNCT
iajs-17	18	3	vol	vol	NOUN
iajs-17	18	4	.	.	PROPN
iajs-17	18	5	29	29	NUM
iajs-17	18	6	(	(	PUNCT
iajs-17	18	7	3	3	NUM
iajs-17	18	8	)	)	PUNCT
iajs-17	18	9	2016	2016	NUM
iajs-17	18	10	we	we	PRON
iajs-17	18	11	can	can	AUX
iajs-17	18	12	conclude	conclude	VERB
iajs-17	18	13	that	that	SCONJ
iajs-17	18	14	the	the	DET
iajs-17	18	15	t2	t2	NOUN
iajs-17	18	16	dm	dm	NOUN
iajs-17	18	17	patients	patient	NOUN
iajs-17	18	18	have	have	VERB
iajs-17	18	19	a	a	DET
iajs-17	18	20	risk	risk	NOUN
iajs-17	18	21	of	of	ADP
iajs-17	18	22	oxidative	oxidative	ADJ
iajs-17	18	23	stress	stress	NOUN
iajs-17	18	24	due	due	ADP
iajs-17	18	25	to	to	ADP
iajs-17	18	26	increasing	increase	VERB
iajs-17	18	27	the	the	DET
iajs-17	18	28	level	level	NOUN
iajs-17	18	29	of	of	ADP
iajs-17	18	30	serum	serum	NOUN
iajs-17	18	31	mda	mda	PROPN
iajs-17	18	32	and	and	CCONJ
iajs-17	18	33	decreasing	decrease	VERB
iajs-17	18	34	ec	ec	PROPN
iajs-17	18	35	-	-	PUNCT
iajs-17	18	36	sod	sod	NOUN
iajs-17	18	37	activity	activity	NOUN
iajs-17	18	38	.	.	PUNCT
iajs-17	19	1	the	the	DET
iajs-17	19	2	hba1c	hba1c	PROPN
iajs-17	19	3	value	value	NOUN
iajs-17	19	4	between	between	ADP
iajs-17	19	5	7	7	NUM
iajs-17	19	6	to	to	PART
iajs-17	19	7	8	8	NUM
iajs-17	19	8	%	%	NOUN
iajs-17	19	9	can	can	AUX
iajs-17	19	10	not	not	PART
iajs-17	19	11	be	be	AUX
iajs-17	19	12	considered	consider	VERB
iajs-17	19	13	as	as	ADP
iajs-17	19	14	an	an	DET
iajs-17	19	15	acceptable	acceptable	ADJ
iajs-17	19	16	hba1c	hba1c	NOUN
iajs-17	19	17	value	value	NOUN
iajs-17	19	18	,	,	PUNCT
iajs-17	19	19	due	due	ADJ
iajs-17	19	20	the	the	DET
iajs-17	19	21	severing	severing	NOUN
iajs-17	19	22	of	of	ADP
iajs-17	19	23	oxidative	oxidative	ADJ
iajs-17	19	24	stress	stress	NOUN
iajs-17	19	25	rising	rise	VERB
iajs-17	19	26	manifested	manifest	VERB
iajs-17	19	27	clearly	clearly	ADV
iajs-17	19	28	in	in	ADP
iajs-17	19	29	this	this	DET
iajs-17	19	30	patients	patient	NOUN
iajs-17	19	31	group	group	NOUN
iajs-17	19	32	.	.	PUNCT
iajs-17	20	1	keywords	keyword	NOUN
iajs-17	20	2	:	:	PUNCT
iajs-17	20	3	t2	t2	PROPN
iajs-17	20	4	dm	dm	NOUN
iajs-17	20	5	;	;	PUNCT
iajs-17	20	6	sod	sod	NOUN
iajs-17	20	7	:	:	PUNCT
iajs-17	20	8	ec	ec	NOUN
iajs-17	20	9	-	-	PUNCT
iajs-17	20	10	sod	sod	NOUN
iajs-17	20	11	;	;	PUNCT
iajs-17	20	12	mda	mda	PROPN
iajs-17	20	13	;	;	PUNCT
iajs-17	20	14	hyperglycemia	hyperglycemia	NOUN
iajs-17	20	15	.	.	PUNCT
iajs-17	21	1	chemistry	chemistry	NOUN
iajs-17	21	2	|	|	ADV
iajs-17	21	3	134	134	NUM
iajs-17	21	4	2016	2016	NUM
iajs-17	21	5	(	(	PUNCT
iajs-17	21	6	عاً	عاً	PROPN
iajs-17	21	7	3اىعذد	3اىعذد	NUM
iajs-17	21	8	)	)	PUNCT
iajs-17	21	9	29ٍديت	29ٍديت	NUM
iajs-17	21	10	إبِ	إبِ	X
iajs-17	21	11	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	21	12	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	21	13	اىصشفت	اىصشفت	VERB
iajs-17	21	14	ٗ	ٗ	VERB
iajs-17	21	15	اىخطبٞقٞت	اىخطبٞقٞت	ADV
iajs-17	21	16	اىَديذ	اىَديذ	PROPN
iajs-17	22	1	ibn	ibn	PROPN
iajs-17	22	2	al	al	PROPN
iajs-17	22	3	-	-	PUNCT
iajs-17	22	4	haitham	haitham	PROPN
iajs-17	22	5	jour	jour	X
iajs-17	22	6	.	.	PROPN
iajs-17	22	7	for	for	ADP
iajs-17	22	8	pure	pure	ADJ
iajs-17	22	9	&	&	CCONJ
iajs-17	22	10	appl	appl	PROPN
iajs-17	22	11	.	.	PUNCT
iajs-17	23	1	sci	sci	PROPN
iajs-17	23	2	.	.	PUNCT
iajs-17	23	3	vol	vol	NOUN
iajs-17	23	4	.	.	PROPN
iajs-17	23	5	29	29	NUM
iajs-17	23	6	(	(	PUNCT
iajs-17	23	7	3	3	NUM
iajs-17	23	8	)	)	PUNCT
iajs-17	23	9	2016	2016	NUM
iajs-17	23	10	1	1	NUM
iajs-17	23	11	.	.	PUNCT
iajs-17	24	1	introduction	introduction	NOUN
iajs-17	24	2	diabetes	diabetes	NOUN
iajs-17	24	3	mellitus	mellitus	NOUN
iajs-17	24	4	(	(	PUNCT
iajs-17	24	5	dm	dm	PROPN
iajs-17	24	6	)	)	PUNCT
iajs-17	24	7	is	be	AUX
iajs-17	24	8	a	a	DET
iajs-17	24	9	metabolic	metabolic	NOUN
iajs-17	24	10	disorder	disorder	NOUN
iajs-17	24	11	;	;	PUNCT
iajs-17	24	12	the	the	DET
iajs-17	24	13	patients	patient	NOUN
iajs-17	24	14	with	with	ADP
iajs-17	24	15	dm	dm	PROPN
iajs-17	24	16	are	be	AUX
iajs-17	24	17	suffer	suffer	VERB
iajs-17	24	18	from	from	ADP
iajs-17	24	19	abnormally	abnormally	ADV
iajs-17	24	20	hyperglycemia	hyperglycemia	NOUN
iajs-17	24	21	.	.	PUNCT
iajs-17	25	1	the	the	DET
iajs-17	25	2	cause	cause	NOUN
iajs-17	25	3	of	of	ADP
iajs-17	25	4	dm	dm	PROPN
iajs-17	25	5	is	be	AUX
iajs-17	25	6	either	either	CCONJ
iajs-17	25	7	the	the	DET
iajs-17	25	8	pancreas	pancrea	NOUN
iajs-17	25	9	dose	dose	VERB
iajs-17	25	10	not	not	PART
iajs-17	25	11	produces	produce	VERB
iajs-17	25	12	insulin	insulin	NOUN
iajs-17	25	13	or	or	CCONJ
iajs-17	25	14	the	the	DET
iajs-17	25	15	cells	cell	NOUN
iajs-17	25	16	do	do	AUX
iajs-17	25	17	not	not	PART
iajs-17	25	18	response	response	VERB
iajs-17	25	19	to	to	ADP
iajs-17	25	20	the	the	DET
iajs-17	25	21	insulin	insulin	NOUN
iajs-17	25	22	secreted	secrete	VERB
iajs-17	25	23	or	or	CCONJ
iajs-17	25	24	both	both	PRON
iajs-17	25	25	[	[	X
iajs-17	25	26	1	1	NUM
iajs-17	25	27	]	]	PUNCT
iajs-17	25	28	.	.	PUNCT
iajs-17	26	1	as	as	SCONJ
iajs-17	26	2	these	these	DET
iajs-17	26	3	disorders	disorder	NOUN
iajs-17	26	4	are	be	AUX
iajs-17	26	5	progresses	progress	NOUN
iajs-17	26	6	that	that	PRON
iajs-17	26	7	can	can	AUX
iajs-17	26	8	be	be	AUX
iajs-17	26	9	lead	lead	ADJ
iajs-17	26	10	to	to	ADP
iajs-17	26	11	many	many	ADJ
iajs-17	26	12	complications	complication	NOUN
iajs-17	26	13	like	like	ADP
iajs-17	26	14	cardiovascular	cardiovascular	ADJ
iajs-17	26	15	disease	disease	NOUN
iajs-17	26	16	,	,	PUNCT
iajs-17	26	17	retinopathy	retinopathy	ADJ
iajs-17	26	18	,	,	PUNCT
iajs-17	26	19	nephropathy	nephropathy	NOUN
iajs-17	26	20	and	and	CCONJ
iajs-17	26	21	ulceration	ulceration	NOUN
iajs-17	26	22	[	[	X
iajs-17	26	23	2	2	NUM
iajs-17	26	24	]	]	PUNCT
iajs-17	26	25	.	.	PUNCT
iajs-17	27	1	symptoms	symptom	NOUN
iajs-17	27	2	hyperglycemia	hyperglycemia	NOUN
iajs-17	27	3	include	include	VERB
iajs-17	27	4	thirst	thirst	NOUN
iajs-17	27	5	,	,	PUNCT
iajs-17	27	6	polyuria	polyuria	NOUN
iajs-17	27	7	,	,	PUNCT
iajs-17	27	8	polydipsia	polydipsia	NOUN
iajs-17	27	9	,	,	PUNCT
iajs-17	27	10	unexplained	unexplained	ADJ
iajs-17	27	11	weight	weight	NOUN
iajs-17	27	12	loss	loss	NOUN
iajs-17	27	13	,	,	PUNCT
iajs-17	27	14	sometimes	sometimes	ADV
iajs-17	27	15	with	with	ADP
iajs-17	27	16	polyphagia	polyphagia	NOUN
iajs-17	27	17	,	,	PUNCT
iajs-17	27	18	and	and	CCONJ
iajs-17	27	19	blurred	blurred	ADJ
iajs-17	27	20	vision	vision	NOUN
iajs-17	27	21	[	[	X
iajs-17	27	22	3	3	NUM
iajs-17	27	23	]	]	PUNCT
iajs-17	27	24	.	.	PUNCT
iajs-17	28	1	dm	dm	PROPN
iajs-17	28	2	is	be	AUX
iajs-17	28	3	likely	likely	ADJ
iajs-17	28	4	to	to	PART
iajs-17	28	5	be	be	AUX
iajs-17	28	6	underreported	underreported	ADJ
iajs-17	28	7	as	as	ADP
iajs-17	28	8	a	a	DET
iajs-17	28	9	cause	cause	NOUN
iajs-17	28	10	of	of	ADP
iajs-17	28	11	death	death	NOUN
iajs-17	28	12	simply	simply	ADV
iajs-17	28	13	because	because	SCONJ
iajs-17	28	14	diabetes	diabete	NOUN
iajs-17	28	15	leads	lead	VERB
iajs-17	28	16	to	to	ADP
iajs-17	28	17	many	many	ADJ
iajs-17	28	18	complications	complication	NOUN
iajs-17	28	19	that	that	PRON
iajs-17	28	20	ultimately	ultimately	ADV
iajs-17	28	21	cause	cause	VERB
iajs-17	28	22	death	death	NOUN
iajs-17	28	23	.	.	PUNCT
iajs-17	29	1	dm	dm	NOUN
iajs-17	29	2	can	can	AUX
iajs-17	29	3	be	be	AUX
iajs-17	29	4	classified	classify	VERB
iajs-17	29	5	into	into	ADP
iajs-17	29	6	four	four	NUM
iajs-17	29	7	types	type	NOUN
iajs-17	29	8	[	[	X
iajs-17	29	9	3	3	NUM
iajs-17	29	10	]	]	X
iajs-17	29	11	:	:	PUNCT
iajs-17	29	12	i.	i.	PROPN
iajs-17	29	13	insulin	insulin	PROPN
iajs-17	29	14	-	-	PUNCT
iajs-17	29	15	dependent	dependent	ADJ
iajs-17	29	16	diabetes	diabetes	NOUN
iajs-17	29	17	mellitus	mellitus	NOUN
iajs-17	29	18	(	(	PUNCT
iajs-17	29	19	iddm	iddm	PROPN
iajs-17	29	20	)	)	PUNCT
iajs-17	29	21	or	or	CCONJ
iajs-17	29	22	type	type	NOUN
iajs-17	29	23	i	i	PRON
iajs-17	29	24	diabetes	diabete	VERB
iajs-17	29	25	mellitus	mellitus	NOUN
iajs-17	29	26	(	(	PUNCT
iajs-17	29	27	t1	t1	NOUN
iajs-17	29	28	dm	dm	PROPN
iajs-17	29	29	):	):	PUNCT
iajs-17	29	30	in	in	ADP
iajs-17	29	31	t1	t1	PROPN
iajs-17	29	32	dm	dm	PROPN
iajs-17	29	33	patients	patient	NOUN
iajs-17	29	34	there	there	PRON
iajs-17	29	35	is	be	VERB
iajs-17	29	36	no	no	DET
iajs-17	29	37	endogenous	endogenous	ADJ
iajs-17	29	38	insulin	insulin	NOUN
iajs-17	29	39	secretory	secretory	NOUN
iajs-17	29	40	capacity	capacity	NOUN
iajs-17	29	41	and	and	CCONJ
iajs-17	29	42	they	they	PRON
iajs-17	29	43	depend	depend	VERB
iajs-17	29	44	on	on	ADP
iajs-17	29	45	injected	inject	VERB
iajs-17	29	46	insulin	insulin	NOUN
iajs-17	29	47	to	to	PART
iajs-17	29	48	prevent	prevent	VERB
iajs-17	29	49	ketosis	ketosis	NOUN
iajs-17	29	50	and	and	CCONJ
iajs-17	29	51	sustain	sustain	VERB
iajs-17	29	52	life	life	NOUN
iajs-17	29	53	.	.	PUNCT
iajs-17	30	1	ii	ii	PROPN
iajs-17	30	2	.	.	PUNCT
iajs-17	31	1	non	non	ADJ
iajs-17	31	2	-	-	ADJ
iajs-17	31	3	insulin	insulin	ADJ
iajs-17	31	4	-	-	PUNCT
iajs-17	31	5	dependent	dependent	ADJ
iajs-17	31	6	diabetes	diabetes	NOUN
iajs-17	31	7	mellitus	mellitus	NOUN
iajs-17	31	8	(	(	PUNCT
iajs-17	31	9	niddm	niddm	PROPN
iajs-17	31	10	)	)	PUNCT
iajs-17	31	11	or	or	CCONJ
iajs-17	31	12	type	type	NOUN
iajs-17	31	13	ii	ii	NOUN
iajs-17	31	14	diabetes	diabetes	NOUN
iajs-17	31	15	mellitus	mellitus	NOUN
iajs-17	31	16	(	(	PUNCT
iajs-17	31	17	t2	t2	PROPN
iajs-17	31	18	dm	dm	PROPN
iajs-17	31	19	):	):	PUNCT
iajs-17	31	20	in	in	ADP
iajs-17	31	21	this	this	DET
iajs-17	31	22	type	type	NOUN
iajs-17	31	23	insulin	insulin	NOUN
iajs-17	31	24	levels	level	NOUN
iajs-17	31	25	may	may	AUX
iajs-17	31	26	be	be	AUX
iajs-17	31	27	normal	normal	ADJ
iajs-17	31	28	,	,	PUNCT
iajs-17	31	29	elevated	elevated	ADJ
iajs-17	31	30	,	,	PUNCT
iajs-17	31	31	or	or	CCONJ
iajs-17	31	32	depressed	depressed	ADJ
iajs-17	31	33	;	;	PUNCT
iajs-17	31	34	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-17	31	35	and	and	CCONJ
iajs-17	31	36	insulin	insulin	NOUN
iajs-17	31	37	resistance	resistance	NOUN
iajs-17	31	38	characterize	characterize	VERB
iajs-17	31	39	most	most	ADJ
iajs-17	31	40	patients	patient	NOUN
iajs-17	31	41	.	.	PUNCT
iajs-17	32	1	these	these	DET
iajs-17	32	2	patients	patient	NOUN
iajs-17	32	3	do	do	AUX
iajs-17	32	4	not	not	PART
iajs-17	32	5	need	need	VERB
iajs-17	32	6	insulin	insulin	NOUN
iajs-17	32	7	treatment	treatment	NOUN
iajs-17	32	8	to	to	PART
iajs-17	32	9	survive	survive	VERB
iajs-17	32	10	.	.	PUNCT
iajs-17	33	1	most	most	ADJ
iajs-17	33	2	patients	patient	NOUN
iajs-17	33	3	with	with	ADP
iajs-17	33	4	this	this	DET
iajs-17	33	5	form	form	NOUN
iajs-17	33	6	of	of	ADP
iajs-17	33	7	dm	dm	PROPN
iajs-17	33	8	are	be	AUX
iajs-17	33	9	obese	obese	ADJ
iajs-17	33	10	,	,	PUNCT
iajs-17	33	11	and	and	CCONJ
iajs-17	33	12	obesity	obesity	NOUN
iajs-17	33	13	itself	itself	PRON
iajs-17	33	14	causes	cause	VERB
iajs-17	33	15	some	some	DET
iajs-17	33	16	degree	degree	NOUN
iajs-17	33	17	of	of	ADP
iajs-17	33	18	insulin	insulin	NOUN
iajs-17	33	19	resistance	resistance	NOUN
iajs-17	33	20	.	.	PUNCT
iajs-17	34	1	iii	iii	X
iajs-17	34	2	.	.	PUNCT
iajs-17	35	1	gestational	gestational	ADJ
iajs-17	35	2	diabetes	diabetes	NOUN
iajs-17	35	3	mellitus	mellitus	NOUN
iajs-17	35	4	(	(	PUNCT
iajs-17	35	5	gdm	gdm	NOUN
iajs-17	35	6	):	):	PUNCT
iajs-17	35	7	is	be	AUX
iajs-17	35	8	a	a	DET
iajs-17	35	9	carbohydrate	carbohydrate	ADJ
iajs-17	35	10	intolerance	intolerance	NOUN
iajs-17	35	11	of	of	ADP
iajs-17	35	12	variable	variable	ADJ
iajs-17	35	13	severity	severity	NOUN
iajs-17	35	14	with	with	ADP
iajs-17	35	15	onset	onset	NOUN
iajs-17	35	16	or	or	CCONJ
iajs-17	35	17	first	first	ADJ
iajs-17	35	18	recognition	recognition	NOUN
iajs-17	35	19	during	during	ADP
iajs-17	35	20	the	the	DET
iajs-17	35	21	pregnancy	pregnancy	NOUN
iajs-17	35	22	.	.	PUNCT
iajs-17	36	1	free	free	ADJ
iajs-17	36	2	radicals	radical	NOUN
iajs-17	36	3	are	be	AUX
iajs-17	36	4	atoms	atom	NOUN
iajs-17	36	5	or	or	CCONJ
iajs-17	36	6	molecules	molecule	NOUN
iajs-17	36	7	with	with	ADP
iajs-17	36	8	an	an	DET
iajs-17	36	9	unpaired	unpaired	ADJ
iajs-17	36	10	electron	electron	NOUN
iajs-17	36	11	and	and	CCONJ
iajs-17	36	12	they	they	PRON
iajs-17	36	13	are	be	AUX
iajs-17	36	14	produced	produce	VERB
iajs-17	36	15	by	by	ADP
iajs-17	36	16	living	live	VERB
iajs-17	36	17	organisms	organism	NOUN
iajs-17	36	18	as	as	ADP
iajs-17	36	19	a	a	DET
iajs-17	36	20	result	result	NOUN
iajs-17	36	21	of	of	ADP
iajs-17	36	22	normal	normal	ADJ
iajs-17	36	23	cellular	cellular	ADJ
iajs-17	36	24	metabolism	metabolism	NOUN
iajs-17	36	25	pathways	pathway	NOUN
iajs-17	36	26	and	and	CCONJ
iajs-17	36	27	environmental	environmental	ADJ
iajs-17	36	28	factors	factor	NOUN
iajs-17	36	29	,	,	PUNCT
iajs-17	36	30	such	such	ADJ
iajs-17	36	31	as	as	ADP
iajs-17	36	32	cigarette	cigarette	NOUN
iajs-17	36	33	smoke	smoke	NOUN
iajs-17	36	34	or	or	CCONJ
iajs-17	36	35	air	air	NOUN
iajs-17	36	36	pollutants	pollutant	NOUN
iajs-17	36	37	[	[	X
iajs-17	36	38	4	4	NUM
iajs-17	36	39	&	&	CCONJ
iajs-17	36	40	5	5	NUM
iajs-17	36	41	]	]	PUNCT
iajs-17	36	42	.	.	PUNCT
iajs-17	37	1	the	the	DET
iajs-17	37	2	most	most	ADV
iajs-17	37	3	common	common	ADJ
iajs-17	37	4	free	free	ADJ
iajs-17	37	5	radicals	radical	NOUN
iajs-17	37	6	are	be	AUX
iajs-17	37	7	superoxide	superoxide	NOUN
iajs-17	37	8	(	(	PUNCT
iajs-17	37	9	o2	o2	PROPN
iajs-17	37	10	.	.	PUNCT
iajs-17	37	11	)	)	PUNCT
iajs-17	37	12	,	,	PUNCT
iajs-17	37	13	hydroxyl	hydroxyl	NOUN
iajs-17	37	14	(	(	PUNCT
iajs-17	37	15	.	.	PUNCT
iajs-17	38	1	oh	oh	INTJ
iajs-17	38	2	)	)	PUNCT
iajs-17	39	1	and	and	CCONJ
iajs-17	39	2	peroxynitrite	peroxynitrite	ADJ
iajs-17	39	3	(	(	PUNCT
iajs-17	39	4	onoo	onoo	ADJ
iajs-17	39	5	.−	.−	PUNCT
iajs-17	39	6	)	)	PUNCT
iajs-17	39	7	.	.	PUNCT
iajs-17	40	1	free	free	ADJ
iajs-17	40	2	radicals	radical	NOUN
iajs-17	40	3	are	be	AUX
iajs-17	40	4	important	important	ADJ
iajs-17	40	5	intermediates	intermediate	NOUN
iajs-17	40	6	in	in	ADP
iajs-17	40	7	many	many	ADJ
iajs-17	40	8	natural	natural	ADJ
iajs-17	40	9	processes	process	NOUN
iajs-17	40	10	such	such	ADJ
iajs-17	40	11	as	as	ADP
iajs-17	40	12	cytotoxicity	cytotoxicity	NOUN
iajs-17	40	13	,	,	PUNCT
iajs-17	40	14	neurotransmission	neurotransmission	NOUN
iajs-17	40	15	and	and	CCONJ
iajs-17	40	16	phagocytosis	phagocytosis	NOUN
iajs-17	40	17	[	[	X
iajs-17	40	18	6	6	NUM
iajs-17	40	19	]	]	PUNCT
iajs-17	40	20	.	.	PUNCT
iajs-17	41	1	due	due	ADP
iajs-17	41	2	to	to	ADP
iajs-17	41	3	their	their	PRON
iajs-17	41	4	electron	electron	NOUN
iajs-17	41	5	pair	pair	NOUN
iajs-17	41	6	,	,	PUNCT
iajs-17	41	7	free	free	ADJ
iajs-17	41	8	radicals	radical	NOUN
iajs-17	41	9	are	be	AUX
iajs-17	41	10	highly	highly	ADV
iajs-17	41	11	reactive	reactive	ADJ
iajs-17	41	12	and	and	CCONJ
iajs-17	41	13	can	can	AUX
iajs-17	41	14	react	react	VERB
iajs-17	41	15	fastly	fastly	ADV
iajs-17	41	16	with	with	ADP
iajs-17	41	17	other	other	ADJ
iajs-17	41	18	molecules	molecule	NOUN
iajs-17	41	19	to	to	PART
iajs-17	41	20	capture	capture	VERB
iajs-17	41	21	the	the	DET
iajs-17	41	22	needed	need	VERB
iajs-17	41	23	electron	electron	NOUN
iajs-17	41	24	and	and	CCONJ
iajs-17	41	25	thus	thus	ADV
iajs-17	41	26	gain	gain	VERB
iajs-17	41	27	stability	stability	NOUN
iajs-17	41	28	.	.	PUNCT
iajs-17	42	1	that	that	PRON
iajs-17	42	2	leads	lead	VERB
iajs-17	42	3	to	to	ADP
iajs-17	42	4	chain	chain	NOUN
iajs-17	42	5	reaction	reaction	NOUN
iajs-17	42	6	,	,	PUNCT
iajs-17	42	7	once	once	ADV
iajs-17	42	8	when	when	SCONJ
iajs-17	42	9	it	it	PRON
iajs-17	42	10	is	be	AUX
iajs-17	42	11	started	start	VERB
iajs-17	42	12	it	it	PRON
iajs-17	42	13	can	can	AUX
iajs-17	42	14	cascade	cascade	VERB
iajs-17	42	15	and	and	CCONJ
iajs-17	42	16	finally	finally	ADV
iajs-17	42	17	leads	lead	VERB
iajs-17	42	18	to	to	ADP
iajs-17	42	19	a	a	DET
iajs-17	42	20	disruption	disruption	NOUN
iajs-17	42	21	of	of	ADP
iajs-17	42	22	the	the	DET
iajs-17	42	23	living	live	VERB
iajs-17	42	24	cells	cell	NOUN
iajs-17	42	25	[	[	X
iajs-17	42	26	7	7	NUM
iajs-17	42	27	]	]	PUNCT
iajs-17	42	28	.	.	PUNCT
iajs-17	43	1	antioxidants	antioxidant	NOUN
iajs-17	43	2	are	be	AUX
iajs-17	43	3	the	the	DET
iajs-17	43	4	molecules	molecule	NOUN
iajs-17	43	5	capable	capable	ADJ
iajs-17	43	6	of	of	ADP
iajs-17	43	7	stabilize	stabilize	NOUN
iajs-17	43	8	or	or	CCONJ
iajs-17	43	9	deactivate	deactivate	VERB
iajs-17	43	10	free	free	ADJ
iajs-17	43	11	radicals	radical	NOUN
iajs-17	43	12	before	before	SCONJ
iajs-17	43	13	they	they	PRON
iajs-17	43	14	attack	attack	VERB
iajs-17	43	15	living	living	NOUN
iajs-17	43	16	cells	cell	NOUN
iajs-17	43	17	.	.	PUNCT
iajs-17	44	1	antioxidants	antioxidant	NOUN
iajs-17	44	2	can	can	AUX
iajs-17	44	3	be	be	AUX
iajs-17	44	4	considered	consider	VERB
iajs-17	44	5	a	a	DET
iajs-17	44	6	critical	critical	ADJ
iajs-17	44	7	molecules	molecule	NOUN
iajs-17	44	8	for	for	ADP
iajs-17	44	9	maintaining	maintain	VERB
iajs-17	44	10	optimum	optimum	ADJ
iajs-17	44	11	health	health	NOUN
iajs-17	44	12	and	and	CCONJ
iajs-17	44	13	wellbeing	wellbeing	NOUN
iajs-17	44	14	.	.	PUNCT
iajs-17	45	1	the	the	DET
iajs-17	45	2	most	most	ADV
iajs-17	45	3	common	common	ADJ
iajs-17	45	4	antioxidant	antioxidant	ADJ
iajs-17	45	5	systems	system	NOUN
iajs-17	45	6	are	be	AUX
iajs-17	45	7	enzymatic	enzymatic	ADJ
iajs-17	45	8	antioxidant	antioxidant	ADJ
iajs-17	45	9	system	system	NOUN
iajs-17	45	10	like	like	ADP
iajs-17	45	11	superoxide	superoxide	NOUN
iajs-17	45	12	dismutase	dismutase	NOUN
iajs-17	45	13	and	and	CCONJ
iajs-17	45	14	glutathione	glutathione	NOUN
iajs-17	45	15	reductase	reductase	NOUN
iajs-17	45	16	,	,	PUNCT
iajs-17	45	17	and	and	CCONJ
iajs-17	45	18	nonenzymatic	nonenzymatic	ADJ
iajs-17	45	19	antioxidants	antioxidant	NOUN
iajs-17	45	20	system	system	NOUN
iajs-17	45	21	such	such	ADJ
iajs-17	45	22	as	as	ADP
iajs-17	45	23	c	c	PROPN
iajs-17	45	24	and	and	CCONJ
iajs-17	45	25	e	e	NOUN
iajs-17	45	26	vitamins	vitamin	NOUN
iajs-17	45	27	[	[	X
iajs-17	45	28	8	8	NUM
iajs-17	45	29	]	]	PUNCT
iajs-17	45	30	.	.	PUNCT
iajs-17	46	1	from	from	ADP
iajs-17	46	2	the	the	DET
iajs-17	46	3	above	above	NOUN
iajs-17	46	4	we	we	PRON
iajs-17	46	5	can	can	AUX
iajs-17	46	6	say	say	VERB
iajs-17	46	7	free	free	ADJ
iajs-17	46	8	radicals	radical	NOUN
iajs-17	46	9	are	be	AUX
iajs-17	46	10	normally	normally	ADV
iajs-17	46	11	formed	form	VERB
iajs-17	46	12	in	in	ADP
iajs-17	46	13	the	the	DET
iajs-17	46	14	living	live	VERB
iajs-17	46	15	cells	cell	NOUN
iajs-17	46	16	and	and	CCONJ
iajs-17	46	17	the	the	DET
iajs-17	46	18	body	body	NOUN
iajs-17	46	19	response	response	NOUN
iajs-17	46	20	to	to	ADP
iajs-17	46	21	the	the	DET
iajs-17	46	22	harmful	harmful	ADJ
iajs-17	46	23	effect	effect	NOUN
iajs-17	46	24	of	of	ADP
iajs-17	46	25	these	these	DET
iajs-17	46	26	radicals	radical	NOUN
iajs-17	46	27	by	by	ADP
iajs-17	46	28	its	its	PRON
iajs-17	46	29	antioxidant	antioxidant	ADJ
iajs-17	46	30	systems	system	NOUN
iajs-17	46	31	,	,	PUNCT
iajs-17	46	32	so	so	SCONJ
iajs-17	46	33	in	in	ADP
iajs-17	46	34	the	the	DET
iajs-17	46	35	ordinary	ordinary	ADJ
iajs-17	46	36	state	state	NOUN
iajs-17	46	37	there	there	PRON
iajs-17	46	38	is	be	VERB
iajs-17	46	39	a	a	DET
iajs-17	46	40	balance	balance	NOUN
iajs-17	46	41	between	between	ADP
iajs-17	46	42	oxidants	oxidant	NOUN
iajs-17	46	43	and	and	CCONJ
iajs-17	46	44	antioxidants	antioxidant	NOUN
iajs-17	46	45	,	,	PUNCT
iajs-17	46	46	any	any	DET
iajs-17	46	47	shift	shift	NOUN
iajs-17	46	48	from	from	ADP
iajs-17	46	49	this	this	DET
iajs-17	46	50	equilibrium	equilibrium	NOUN
iajs-17	46	51	regardless	regardless	ADV
iajs-17	46	52	increasing	increase	VERB
iajs-17	46	53	production	production	NOUN
iajs-17	46	54	of	of	ADP
iajs-17	46	55	radicals	radical	NOUN
iajs-17	46	56	or	or	CCONJ
iajs-17	46	57	any	any	DET
iajs-17	46	58	defect	defect	NOUN
iajs-17	46	59	in	in	ADP
iajs-17	46	60	the	the	DET
iajs-17	46	61	ao	ao	PROPN
iajs-17	46	62	systems	system	NOUN
iajs-17	46	63	may	may	AUX
iajs-17	46	64	be	be	AUX
iajs-17	46	65	present	present	ADJ
iajs-17	46	66	,	,	PUNCT
iajs-17	46	67	that	that	PRON
iajs-17	46	68	leads	lead	VERB
iajs-17	46	69	to	to	PART
iajs-17	46	70	produce	produce	VERB
iajs-17	46	71	a	a	DET
iajs-17	46	72	condition	condition	NOUN
iajs-17	46	73	known	know	VERB
iajs-17	46	74	as	as	ADP
iajs-17	46	75	‗‗oxidative	‗‗oxidative	ADJ
iajs-17	46	76	stress	stress	NOUN
iajs-17	46	77	‘	'	PUNCT
iajs-17	46	78	‘	'	PUNCT
iajs-17	46	79	[	[	X
iajs-17	46	80	9	9	NUM
iajs-17	46	81	]	]	PUNCT
iajs-17	46	82	.	.	PUNCT
iajs-17	47	1	that	that	PRON
iajs-17	47	2	plays	play	VERB
iajs-17	47	3	important	important	ADJ
iajs-17	47	4	role	role	NOUN
iajs-17	47	5	in	in	ADP
iajs-17	47	6	the	the	DET
iajs-17	47	7	development	development	NOUN
iajs-17	47	8	of	of	ADP
iajs-17	47	9	vascular	vascular	ADJ
iajs-17	47	10	complications	complication	NOUN
iajs-17	47	11	in	in	ADP
iajs-17	47	12	dm	dm	PROPN
iajs-17	47	13	particularly	particularly	ADV
iajs-17	47	14	t2	t2	NOUN
iajs-17	47	15	dm	dm	NUM
iajs-17	48	1	[	[	X
iajs-17	48	2	10	10	NUM
iajs-17	48	3	]	]	PUNCT
iajs-17	48	4	.	.	PUNCT
iajs-17	49	1	free	free	ADJ
iajs-17	49	2	radical	radical	ADJ
iajs-17	49	3	formation	formation	NOUN
iajs-17	49	4	in	in	ADP
iajs-17	49	5	dm	dm	PROPN
iajs-17	49	6	by	by	ADP
iajs-17	49	7	non	non	ADJ
iajs-17	49	8	-	-	ADJ
iajs-17	49	9	enzymatic	enzymatic	ADJ
iajs-17	49	10	glycation	glycation	NOUN
iajs-17	49	11	of	of	ADP
iajs-17	49	12	proteins	protein	NOUN
iajs-17	49	13	,	,	PUNCT
iajs-17	49	14	glucose	glucose	NOUN
iajs-17	49	15	oxidation	oxidation	NOUN
iajs-17	49	16	and	and	CCONJ
iajs-17	49	17	increased	increase	VERB
iajs-17	49	18	lipid	lipid	NOUN
iajs-17	49	19	peroxidation	peroxidation	NOUN
iajs-17	49	20	lead	lead	NOUN
iajs-17	49	21	to	to	ADP
iajs-17	49	22	damage	damage	NOUN
iajs-17	49	23	of	of	ADP
iajs-17	49	24	ao	ao	PROPN
iajs-17	49	25	enzymes	enzyme	NOUN
iajs-17	50	1	[	[	X
iajs-17	50	2	11	11	NUM
iajs-17	50	3	]	]	PUNCT
iajs-17	50	4	.	.	PUNCT
iajs-17	50	5	extracellular	extracellular	ADJ
iajs-17	50	6	-	-	PUNCT
iajs-17	50	7	superoxide	superoxide	NOUN
iajs-17	50	8	dismutase	dismutase	NOUN
iajs-17	50	9	(	(	PUNCT
iajs-17	50	10	ec	ec	NOUN
iajs-17	50	11	-	-	PUNCT
iajs-17	50	12	sod	sod	NOUN
iajs-17	50	13	)	)	PUNCT
iajs-17	50	14	is	be	AUX
iajs-17	50	15	a	a	DET
iajs-17	50	16	secretory	secretory	ADJ
iajs-17	50	17	glycoprotein	glycoprotein	NOUN
iajs-17	50	18	located	locate	VERB
iajs-17	50	19	in	in	ADP
iajs-17	50	20	blood	blood	NOUN
iajs-17	50	21	vessel	vessel	NOUN
iajs-17	50	22	walls	wall	NOUN
iajs-17	50	23	at	at	ADP
iajs-17	50	24	high	high	ADJ
iajs-17	50	25	levels	level	NOUN
iajs-17	50	26	and	and	CCONJ
iajs-17	50	27	may	may	AUX
iajs-17	50	28	be	be	AUX
iajs-17	50	29	important	important	ADJ
iajs-17	50	30	in	in	ADP
iajs-17	50	31	the	the	DET
iajs-17	50	32	antioxidant	antioxidant	ADJ
iajs-17	50	33	ability	ability	NOUN
iajs-17	50	34	of	of	ADP
iajs-17	50	35	vascular	vascular	ADJ
iajs-17	50	36	walls	wall	NOUN
iajs-17	50	37	[	[	X
iajs-17	50	38	12	12	NUM
iajs-17	50	39	]	]	PUNCT
iajs-17	50	40	.	.	PUNCT
iajs-17	51	1	ec	ec	PROPN
iajs-17	51	2	-	-	PUNCT
iajs-17	51	3	sod	sod	NOUN
iajs-17	51	4	has	have	AUX
iajs-17	51	5	been	be	AUX
iajs-17	51	6	studied	study	VERB
iajs-17	51	7	in	in	ADP
iajs-17	51	8	low	low	ADJ
iajs-17	51	9	extent	extent	NOUN
iajs-17	51	10	in	in	ADP
iajs-17	51	11	dm	dm	PROPN
iajs-17	51	12	,	,	PUNCT
iajs-17	51	13	some	some	DET
iajs-17	51	14	studies	study	NOUN
iajs-17	51	15	have	have	AUX
iajs-17	51	16	been	be	AUX
iajs-17	51	17	reviewed	review	VERB
iajs-17	51	18	:	:	PUNCT
iajs-17	51	19	chemistry	chemistry	NOUN
iajs-17	51	20	|	|	ADV
iajs-17	51	21	135	135	NUM
iajs-17	51	22	2016	2016	NUM
iajs-17	51	23	(	(	PUNCT
iajs-17	51	24	عاً	عاً	PROPN
iajs-17	51	25	3اىعذد	3اىعذد	NUM
iajs-17	51	26	)	)	PUNCT
iajs-17	51	27	29ٍديت	29ٍديت	NUM
iajs-17	51	28	إبِ	إبِ	X
iajs-17	51	29	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	51	30	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	51	31	اىصشفت	اىصشفت	VERB
iajs-17	51	32	ٗ	ٗ	VERB
iajs-17	51	33	اىخطبٞقٞت	اىخطبٞقٞت	ADV
iajs-17	51	34	اىَديذ	اىَديذ	PROPN
iajs-17	52	1	ibn	ibn	PROPN
iajs-17	52	2	al	al	PROPN
iajs-17	52	3	-	-	PUNCT
iajs-17	52	4	haitham	haitham	PROPN
iajs-17	52	5	jour	jour	X
iajs-17	52	6	.	.	PROPN
iajs-17	52	7	for	for	ADP
iajs-17	52	8	pure	pure	ADJ
iajs-17	52	9	&	&	CCONJ
iajs-17	52	10	appl	appl	PROPN
iajs-17	52	11	.	.	PUNCT
iajs-17	53	1	sci	sci	PROPN
iajs-17	53	2	.	.	PUNCT
iajs-17	53	3	vol	vol	NOUN
iajs-17	53	4	.	.	PROPN
iajs-17	53	5	29	29	NUM
iajs-17	53	6	(	(	PUNCT
iajs-17	53	7	3	3	NUM
iajs-17	53	8	)	)	PUNCT
iajs-17	53	9	2016	2016	NUM
iajs-17	53	10	in	in	ADP
iajs-17	53	11	a	a	DET
iajs-17	53	12	genetic	genetic	ADJ
iajs-17	53	13	study	study	NOUN
iajs-17	53	14	presented	present	VERB
iajs-17	53	15	by	by	ADP
iajs-17	53	16	fumiaki	fumiaki	PROPN
iajs-17	53	17	kimura	kimura	PROPN
iajs-17	53	18	et	et	PROPN
iajs-17	53	19	al	al	PROPN
iajs-17	53	20	,	,	PUNCT
iajs-17	53	21	2003	2003	NUM
iajs-17	53	22	,	,	PUNCT
iajs-17	53	23	serum	serum	PROPN
iajs-17	53	24	ec	ec	PROPN
iajs-17	53	25	-	-	PUNCT
iajs-17	53	26	sod	sod	NOUN
iajs-17	53	27	has	have	AUX
iajs-17	53	28	been	be	AUX
iajs-17	53	29	evaluated	evaluate	VERB
iajs-17	53	30	in	in	ADP
iajs-17	53	31	t2	t2	NOUN
iajs-17	53	32	dm	dm	PROPN
iajs-17	53	33	patients	patient	NOUN
iajs-17	53	34	to	to	PART
iajs-17	53	35	assess	assess	VERB
iajs-17	53	36	whether	whether	SCONJ
iajs-17	53	37	increased	increase	VERB
iajs-17	53	38	ec	ec	PROPN
iajs-17	53	39	-	-	PUNCT
iajs-17	53	40	sod	sod	NOUN
iajs-17	53	41	concentration	concentration	NOUN
iajs-17	53	42	is	be	AUX
iajs-17	53	43	associated	associate	VERB
iajs-17	53	44	with	with	ADP
iajs-17	53	45	the	the	DET
iajs-17	53	46	development	development	NOUN
iajs-17	53	47	of	of	ADP
iajs-17	53	48	diabetic	diabetic	ADJ
iajs-17	53	49	vascular	vascular	ADJ
iajs-17	53	50	complications	complication	NOUN
iajs-17	53	51	,	,	PUNCT
iajs-17	53	52	they	they	PRON
iajs-17	53	53	found	find	VERB
iajs-17	53	54	a	a	DET
iajs-17	53	55	strong	strong	ADJ
iajs-17	53	56	relationship	relationship	NOUN
iajs-17	53	57	between	between	ADP
iajs-17	53	58	the	the	DET
iajs-17	53	59	serum	serum	NOUN
iajs-17	53	60	level	level	NOUN
iajs-17	53	61	of	of	ADP
iajs-17	53	62	ec	ec	PROPN
iajs-17	53	63	-	-	PUNCT
iajs-17	53	64	sod	sod	NOUN
iajs-17	53	65	and	and	CCONJ
iajs-17	53	66	the	the	DET
iajs-17	53	67	severity	severity	NOUN
iajs-17	53	68	of	of	ADP
iajs-17	53	69	both	both	CCONJ
iajs-17	53	70	microvascular	microvascular	ADJ
iajs-17	53	71	and	and	CCONJ
iajs-17	53	72	macrovascular	macrovascular	ADJ
iajs-17	53	73	diabetic	diabetic	ADJ
iajs-17	53	74	complications	complication	NOUN
iajs-17	53	75	[	[	X
iajs-17	53	76	13	13	NUM
iajs-17	53	77	]	]	PUNCT
iajs-17	53	78	.	.	PUNCT
iajs-17	54	1	ec	ec	PROPN
iajs-17	54	2	-	-	PUNCT
iajs-17	54	3	sod	sod	NOUN
iajs-17	54	4	has	have	AUX
iajs-17	54	5	been	be	AUX
iajs-17	54	6	studied	study	VERB
iajs-17	54	7	in	in	ADP
iajs-17	54	8	t2	t2	NOUN
iajs-17	54	9	dm	dm	NOUN
iajs-17	54	10	with	with	ADP
iajs-17	54	11	a	a	DET
iajs-17	54	12	correlation	correlation	NOUN
iajs-17	54	13	to	to	ADP
iajs-17	54	14	insulin	insulin	NOUN
iajs-17	54	15	resistance	resistance	NOUN
iajs-17	54	16	,	,	PUNCT
iajs-17	54	17	by	by	ADP
iajs-17	54	18	t	t	PROPN
iajs-17	54	19	adachi	adachi	PROPN
iajs-17	54	20	et	et	PROPN
iajs-17	54	21	al	al	PROPN
iajs-17	54	22	,	,	PUNCT
iajs-17	54	23	2004	2004	NUM
iajs-17	54	24	,	,	PUNCT
iajs-17	54	25	they	they	PRON
iajs-17	54	26	found	find	VERB
iajs-17	54	27	the	the	DET
iajs-17	54	28	ec	ec	PROPN
iajs-17	54	29	-	-	PUNCT
iajs-17	54	30	sod	sod	NOUN
iajs-17	54	31	level	level	NOUN
iajs-17	54	32	was	be	AUX
iajs-17	54	33	strongly	strongly	ADV
iajs-17	54	34	and	and	CCONJ
iajs-17	54	35	positively	positively	ADV
iajs-17	54	36	associated	associate	VERB
iajs-17	54	37	to	to	ADP
iajs-17	54	38	homeostasis	homeostasis	NOUN
iajs-17	54	39	model	model	NOUN
iajs-17	54	40	assessment	assessment	NOUN
iajs-17	54	41	-	-	PUNCT
iajs-17	54	42	insulin	insulin	NOUN
iajs-17	54	43	resistance	resistance	NOUN
iajs-17	54	44	(	(	PUNCT
iajs-17	54	45	homa.ir	homa.ir	NOUN
iajs-17	54	46	)	)	PUNCT
iajs-17	55	1	[	[	X
iajs-17	55	2	12	12	NUM
iajs-17	55	3	]	]	PUNCT
iajs-17	55	4	.	.	PUNCT
iajs-17	56	1	w.	w.	PROPN
iajs-17	56	2	ajam	ajam	PROPN
iajs-17	56	3	et	et	PROPN
iajs-17	56	4	al	al	PROPN
iajs-17	56	5	,	,	PUNCT
iajs-17	56	6	2012	2012	NUM
iajs-17	56	7	,	,	PUNCT
iajs-17	56	8	introduced	introduce	VERB
iajs-17	56	9	a	a	DET
iajs-17	56	10	work	work	NOUN
iajs-17	56	11	involves	involve	VERB
iajs-17	56	12	estimating	estimate	VERB
iajs-17	56	13	the	the	DET
iajs-17	56	14	oxidative	oxidative	ADJ
iajs-17	56	15	status	status	NOUN
iajs-17	56	16	in	in	ADP
iajs-17	56	17	post	post	ADJ
iajs-17	56	18	-	-	ADJ
iajs-17	56	19	menopausal	menopausal	ADJ
iajs-17	56	20	women	woman	NOUN
iajs-17	56	21	with	with	ADP
iajs-17	56	22	t2	t2	PROPN
iajs-17	56	23	dm	dm	PROPN
iajs-17	56	24	and	and	CCONJ
iajs-17	56	25	the	the	DET
iajs-17	56	26	ec	ec	PROPN
iajs-17	56	27	-	-	PUNCT
iajs-17	56	28	sod	sod	NOUN
iajs-17	56	29	was	be	AUX
iajs-17	56	30	one	one	NUM
iajs-17	56	31	of	of	ADP
iajs-17	56	32	the	the	DET
iajs-17	56	33	oxidative	oxidative	ADJ
iajs-17	56	34	stress	stress	NOUN
iajs-17	56	35	markers	marker	NOUN
iajs-17	56	36	,	,	PUNCT
iajs-17	56	37	they	they	PRON
iajs-17	56	38	found	find	VERB
iajs-17	56	39	an	an	DET
iajs-17	56	40	elevation	elevation	NOUN
iajs-17	56	41	of	of	ADP
iajs-17	56	42	(	(	PUNCT
iajs-17	56	43	ec	ec	NOUN
iajs-17	56	44	-	-	PUNCT
iajs-17	56	45	sod	sod	NOUN
iajs-17	56	46	)	)	PUNCT
iajs-17	56	47	concentrations	concentration	NOUN
iajs-17	56	48	[	[	X
iajs-17	56	49	14	14	NUM
iajs-17	56	50	]	]	PUNCT
iajs-17	56	51	.	.	PUNCT
iajs-17	57	1	according	accord	VERB
iajs-17	57	2	to	to	ADP
iajs-17	57	3	proteinuria	proteinuria	NOUN
iajs-17	57	4	the	the	DET
iajs-17	57	5	patients	patient	NOUN
iajs-17	57	6	in	in	ADP
iajs-17	57	7	study	study	NOUN
iajs-17	57	8	of	of	ADP
iajs-17	57	9	armin	armin	PROPN
iajs-17	57	10	rashidi	rashidi	PROPN
iajs-17	57	11	,	,	PUNCT
iajs-17	57	12	et	et	PROPN
iajs-17	57	13	al	al	PROPN
iajs-17	57	14	,	,	PUNCT
iajs-17	57	15	2009	2009	NUM
iajs-17	57	16	,	,	PUNCT
iajs-17	57	17	has	have	AUX
iajs-17	57	18	been	be	AUX
iajs-17	57	19	classified	classify	VERB
iajs-17	57	20	into	into	ADP
iajs-17	57	21	groups	group	NOUN
iajs-17	57	22	,	,	PUNCT
iajs-17	57	23	to	to	PART
iajs-17	57	24	evaluate	evaluate	VERB
iajs-17	57	25	the	the	DET
iajs-17	57	26	oxidative	oxidative	ADJ
iajs-17	57	27	status	status	NOUN
iajs-17	57	28	in	in	ADP
iajs-17	57	29	t2	t2	PROPN
iajs-17	57	30	dm	dm	PROPN
iajs-17	57	31	,	,	PUNCT
iajs-17	57	32	ec	ec	PROPN
iajs-17	57	33	-	-	PUNCT
iajs-17	57	34	sod	sod	NOUN
iajs-17	57	35	levels	level	NOUN
iajs-17	57	36	was	be	AUX
iajs-17	57	37	both	both	PRON
iajs-17	57	38	significantly	significantly	ADV
iajs-17	57	39	associated	associate	VERB
iajs-17	57	40	with	with	ADP
iajs-17	57	41	proteinuria	proteinuria	NOUN
iajs-17	57	42	[	[	X
iajs-17	57	43	15	15	NUM
iajs-17	57	44	]	]	PUNCT
iajs-17	57	45	.	.	PUNCT
iajs-17	58	1	ec	ec	PROPN
iajs-17	58	2	-	-	PUNCT
iajs-17	58	3	sod	sod	NOUN
iajs-17	58	4	levels	level	NOUN
iajs-17	58	5	were	be	AUX
iajs-17	58	6	in	in	ADP
iajs-17	58	7	gdm	gdm	NOUN
iajs-17	58	8	by	by	ADP
iajs-17	58	9	s.	s.	PROPN
iajs-17	58	10	kharab	kharab	PROPN
iajs-17	58	11	,	,	PUNCT
iajs-17	58	12	2010	2010	NUM
iajs-17	58	13	,	,	PUNCT
iajs-17	58	14	and	and	CCONJ
iajs-17	58	15	it	it	PRON
iajs-17	58	16	was	be	AUX
iajs-17	58	17	significantly	significantly	ADV
iajs-17	58	18	decrees	decree	NOUN
iajs-17	58	19	in	in	ADP
iajs-17	58	20	those	those	DET
iajs-17	58	21	women	woman	NOUN
iajs-17	58	22	[	[	X
iajs-17	58	23	16	16	NUM
iajs-17	58	24	]	]	PUNCT
iajs-17	58	25	.	.	PUNCT
iajs-17	59	1	so	so	ADV
iajs-17	59	2	our	our	PRON
iajs-17	59	3	study	study	NOUN
iajs-17	59	4	was	be	AUX
iajs-17	59	5	aimed	aim	VERB
iajs-17	59	6	:	:	PUNCT
iajs-17	59	7	studying	study	VERB
iajs-17	59	8	the	the	DET
iajs-17	59	9	effect	effect	NOUN
iajs-17	59	10	of	of	ADP
iajs-17	59	11	t2	t2	NOUN
iajs-17	59	12	dm	dm	NOUN
iajs-17	59	13	on	on	ADP
iajs-17	59	14	the	the	DET
iajs-17	59	15	oxidative	oxidative	ADJ
iajs-17	59	16	stress	stress	NOUN
iajs-17	59	17	by	by	ADP
iajs-17	59	18	measuring	measure	VERB
iajs-17	59	19	:	:	PUNCT
iajs-17	59	20	serum	serum	NOUN
iajs-17	59	21	mda	mda	PROPN
iajs-17	59	22	level	level	NOUN
iajs-17	59	23	as	as	ADP
iajs-17	59	24	an	an	DET
iajs-17	59	25	oxidants	oxidant	NOUN
iajs-17	59	26	marker	marker	NOUN
iajs-17	59	27	and	and	CCONJ
iajs-17	59	28	ec	ec	PROPN
iajs-17	59	29	-	-	PUNCT
iajs-17	59	30	sod	sod	NOUN
iajs-17	59	31	as	as	ADP
iajs-17	59	32	an	an	DET
iajs-17	59	33	antioxidants	antioxidant	NOUN
iajs-17	59	34	in	in	ADP
iajs-17	59	35	patients	patient	NOUN
iajs-17	59	36	of	of	ADP
iajs-17	59	37	t2	t2	PROPN
iajs-17	59	38	dm	dm	PROPN
iajs-17	59	39	iraqi	iraqi	ADJ
iajs-17	59	40	patients	patient	NOUN
iajs-17	59	41	(	(	PUNCT
iajs-17	59	42	without	without	ADP
iajs-17	59	43	any	any	DET
iajs-17	59	44	complications	complication	NOUN
iajs-17	59	45	)	)	PUNCT
iajs-17	59	46	.	.	PUNCT
iajs-17	60	1	2	2	X
iajs-17	60	2	.	.	X
iajs-17	60	3	subjects	subject	NOUN
iajs-17	60	4	,	,	PUNCT
iajs-17	60	5	materials	material	NOUN
iajs-17	60	6	and	and	CCONJ
iajs-17	60	7	methods	method	NOUN
iajs-17	60	8	2.1	2.1	NUM
iajs-17	60	9	study	study	NOUN
iajs-17	60	10	population	population	NOUN
iajs-17	60	11	patients	patient	NOUN
iajs-17	60	12	enrolled	enrol	VERB
iajs-17	60	13	in	in	ADP
iajs-17	60	14	the	the	DET
iajs-17	60	15	present	present	ADJ
iajs-17	60	16	study	study	NOUN
iajs-17	60	17	were	be	AUX
iajs-17	60	18	subdivided	subdivide	VERB
iajs-17	60	19	into	into	ADP
iajs-17	60	20	iraqi	iraqi	ADJ
iajs-17	60	21	t2	t2	NOUN
iajs-17	60	22	dm	dm	PROPN
iajs-17	60	23	(	(	PUNCT
iajs-17	60	24	130	130	NUM
iajs-17	60	25	)	)	PUNCT
iajs-17	60	26	subjects	subject	NOUN
iajs-17	60	27	,	,	PUNCT
iajs-17	60	28	they	they	PRON
iajs-17	60	29	clinically	clinically	ADV
iajs-17	60	30	diagnosed	diagnose	VERB
iajs-17	60	31	with	with	ADP
iajs-17	60	32	t2	t2	PROPN
iajs-17	60	33	dm	dm	PROPN
iajs-17	60	34	,	,	PUNCT
iajs-17	60	35	all	all	PRON
iajs-17	60	36	of	of	ADP
iajs-17	60	37	them	they	PRON
iajs-17	60	38	were	be	AUX
iajs-17	60	39	diagnosed	diagnose	VERB
iajs-17	60	40	proven	prove	VERB
iajs-17	60	41	under	under	ADP
iajs-17	60	42	the	the	DET
iajs-17	60	43	supervision	supervision	NOUN
iajs-17	60	44	of	of	ADP
iajs-17	60	45	specialists	specialist	NOUN
iajs-17	60	46	,	,	PUNCT
iajs-17	60	47	and	and	CCONJ
iajs-17	60	48	(	(	PUNCT
iajs-17	60	49	35	35	NUM
iajs-17	60	50	)	)	PUNCT
iajs-17	60	51	healthy	healthy	ADJ
iajs-17	60	52	subjects	subject	NOUN
iajs-17	60	53	as	as	ADP
iajs-17	60	54	a	a	DET
iajs-17	60	55	control	control	NOUN
iajs-17	60	56	.	.	PUNCT
iajs-17	61	1	all	all	DET
iajs-17	61	2	subjects	subject	NOUN
iajs-17	61	3	were	be	AUX
iajs-17	61	4	selected	select	VERB
iajs-17	61	5	from	from	ADP
iajs-17	61	6	the	the	DET
iajs-17	61	7	national	national	ADJ
iajs-17	61	8	diabetes	diabetes	NOUN
iajs-17	61	9	center	center	NOUN
iajs-17	61	10	for	for	ADP
iajs-17	61	11	treatment	treatment	NOUN
iajs-17	61	12	and	and	CCONJ
iajs-17	61	13	research	research	NOUN
iajs-17	61	14	,	,	PUNCT
iajs-17	61	15	al	al	PROPN
iajs-17	61	16	-	-	PUNCT
iajs-17	61	17	mustassryia	mustassryia	PROPN
iajs-17	61	18	university	university	PROPN
iajs-17	61	19	,	,	PUNCT
iajs-17	61	20	baghdad	baghdad	PROPN
iajs-17	61	21	,	,	PUNCT
iajs-17	61	22	iraq	iraq	PROPN
iajs-17	61	23	during	during	ADP
iajs-17	61	24	the	the	DET
iajs-17	61	25	period	period	NOUN
iajs-17	61	26	from	from	ADP
iajs-17	61	27	november	november	PROPN
iajs-17	61	28	,	,	PUNCT
iajs-17	61	29	2014	2014	NUM
iajs-17	61	30	to	to	ADP
iajs-17	61	31	may	may	AUX
iajs-17	61	32	,	,	PUNCT
iajs-17	61	33	2015	2015	NUM
iajs-17	61	34	.	.	PUNCT
iajs-17	62	1	2.2	2.2	NUM
iajs-17	62	2	.	.	PUNCT
iajs-17	62	3	sampling	sample	VERB
iajs-17	62	4	after	after	ADP
iajs-17	62	5	an	an	DET
iajs-17	62	6	overnight	overnight	ADJ
iajs-17	62	7	,	,	PUNCT
iajs-17	62	8	fasting	fast	VERB
iajs-17	62	9	venous	venous	ADJ
iajs-17	62	10	blood	blood	NOUN
iajs-17	62	11	samples	sample	NOUN
iajs-17	62	12	were	be	AUX
iajs-17	62	13	collected	collect	VERB
iajs-17	62	14	aseptically	aseptically	ADV
iajs-17	62	15	from	from	ADP
iajs-17	62	16	the	the	DET
iajs-17	62	17	subjects	subject	NOUN
iajs-17	62	18	via	via	ADP
iajs-17	62	19	venipuncture	venipuncture	NOUN
iajs-17	62	20	,	,	PUNCT
iajs-17	62	21	(	(	PUNCT
iajs-17	62	22	5ml	5ml	NOUN
iajs-17	62	23	)	)	PUNCT
iajs-17	62	24	was	be	AUX
iajs-17	62	25	collected	collect	VERB
iajs-17	62	26	and	and	CCONJ
iajs-17	62	27	divided	divide	VERB
iajs-17	62	28	into	into	ADP
iajs-17	62	29	two	two	NUM
iajs-17	62	30	parts	part	NOUN
iajs-17	62	31	,	,	PUNCT
iajs-17	62	32	(	(	PUNCT
iajs-17	62	33	4ml	4ml	NOUN
iajs-17	62	34	)	)	PUNCT
iajs-17	62	35	was	be	AUX
iajs-17	62	36	kept	keep	VERB
iajs-17	62	37	in	in	ADP
iajs-17	62	38	plain	plain	ADJ
iajs-17	62	39	tubes	tube	NOUN
iajs-17	62	40	without	without	ADP
iajs-17	62	41	any	any	DET
iajs-17	62	42	anticoagulant	anticoagulant	NOUN
iajs-17	62	43	at	at	ADP
iajs-17	62	44	room	room	NOUN
iajs-17	62	45	temperature	temperature	NOUN
iajs-17	62	46	for	for	ADP
iajs-17	62	47	half	half	NOUN
iajs-17	62	48	hour	hour	NOUN
iajs-17	62	49	.	.	PUNCT
iajs-17	63	1	the	the	DET
iajs-17	63	2	tube	tube	NOUN
iajs-17	63	3	then	then	ADV
iajs-17	63	4	was	be	AUX
iajs-17	63	5	centrifuged	centrifuge	VERB
iajs-17	63	6	(	(	PUNCT
iajs-17	63	7	3000	3000	NUM
iajs-17	63	8	×	×	NOUN
iajs-17	63	9	g	g	NOUN
iajs-17	63	10	)	)	PUNCT
iajs-17	63	11	for	for	ADP
iajs-17	63	12	15min	15min	NUM
iajs-17	63	13	.	.	PUNCT
iajs-17	64	1	the	the	DET
iajs-17	64	2	clear	clear	ADJ
iajs-17	64	3	serum	serum	NOUN
iajs-17	64	4	was	be	AUX
iajs-17	64	5	pipetted	pipette	VERB
iajs-17	64	6	into	into	ADP
iajs-17	64	7	clear	clear	ADJ
iajs-17	64	8	dry	dry	ADJ
iajs-17	64	9	eppendorfs	eppendorf	NOUN
iajs-17	64	10	and	and	CCONJ
iajs-17	64	11	stored	store	VERB
iajs-17	64	12	at	at	ADP
iajs-17	64	13	(	(	PUNCT
iajs-17	64	14	-20	-20	PROPN
iajs-17	64	15	c	c	PROPN
iajs-17	64	16	ο	ο	NOUN
iajs-17	64	17	)	)	PUNCT
iajs-17	64	18	until	until	SCONJ
iajs-17	64	19	used	use	VERB
iajs-17	64	20	for	for	ADP
iajs-17	64	21	different	different	ADJ
iajs-17	64	22	investigations	investigation	NOUN
iajs-17	64	23	,	,	PUNCT
iajs-17	64	24	while	while	SCONJ
iajs-17	64	25	(	(	PUNCT
iajs-17	64	26	1ml	1ml	NOUN
iajs-17	64	27	)	)	PUNCT
iajs-17	64	28	of	of	ADP
iajs-17	64	29	the	the	DET
iajs-17	64	30	whole	whole	ADJ
iajs-17	64	31	blood	blood	NOUN
iajs-17	64	32	was	be	AUX
iajs-17	64	33	kept	keep	VERB
iajs-17	64	34	in	in	ADP
iajs-17	64	35	tube	tube	NOUN
iajs-17	64	36	with	with	ADP
iajs-17	64	37	edta	edta	NOUN
iajs-17	64	38	anticoagulant	anticoagulant	NOUN
iajs-17	64	39	and	and	CCONJ
iajs-17	64	40	used	use	VERB
iajs-17	64	41	in	in	ADP
iajs-17	64	42	the	the	DET
iajs-17	64	43	estimation	estimation	NOUN
iajs-17	64	44	of	of	ADP
iajs-17	64	45	hba1c	hba1c	PROPN
iajs-17	64	46	.	.	PUNCT
iajs-17	65	1	2.3	2.3	NUM
iajs-17	65	2	.	.	PUNCT
iajs-17	65	3	exclusion	exclusion	NOUN
iajs-17	65	4	criteria	criterion	NOUN
iajs-17	65	5	any	any	DET
iajs-17	65	6	known	know	VERB
iajs-17	65	7	disease	disease	NOUN
iajs-17	65	8	except	except	SCONJ
iajs-17	65	9	dm	dm	NUM
iajs-17	65	10	including	include	VERB
iajs-17	65	11	t1	t1	PROPN
iajs-17	65	12	dm	dm	NOUN
iajs-17	65	13	and	and	CCONJ
iajs-17	65	14	gdm	gdm	NOUN
iajs-17	65	15	,	,	PUNCT
iajs-17	65	16	also	also	ADV
iajs-17	65	17	patients	patient	VERB
iajs-17	65	18	t2	t2	NOUN
iajs-17	65	19	dm	dm	PROPN
iajs-17	65	20	and	and	CCONJ
iajs-17	65	21	treat	treat	VERB
iajs-17	65	22	with	with	ADP
iajs-17	65	23	insulin	insulin	NOUN
iajs-17	65	24	are	be	AUX
iajs-17	65	25	excluded	exclude	VERB
iajs-17	65	26	.	.	PUNCT
iajs-17	66	1	the	the	DET
iajs-17	66	2	patients	patient	NOUN
iajs-17	66	3	who	who	PRON
iajs-17	66	4	take	take	VERB
iajs-17	66	5	any	any	DET
iajs-17	66	6	supplement	supplement	NOUN
iajs-17	66	7	are	be	AUX
iajs-17	66	8	excluded	exclude	VERB
iajs-17	66	9	.	.	PUNCT
iajs-17	67	1	2.4	2.4	NUM
iajs-17	67	2	.	.	PUNCT
iajs-17	68	1	inclusion	inclusion	NOUN
iajs-17	68	2	criteria	criterion	NOUN
iajs-17	68	3	any	any	DET
iajs-17	68	4	known	know	VERB
iajs-17	68	5	disease	disease	NOUN
iajs-17	68	6	other	other	ADJ
iajs-17	68	7	than	than	ADP
iajs-17	68	8	t2	t2	NOUN
iajs-17	68	9	dm	dm	NOUN
iajs-17	68	10	including	include	VERB
iajs-17	68	11	t1	t1	PROPN
iajs-17	68	12	dm	dm	NOUN
iajs-17	68	13	and	and	CCONJ
iajs-17	68	14	gdm	gdm	NOUN
iajs-17	68	15	,	,	PUNCT
iajs-17	68	16	also	also	ADV
iajs-17	68	17	t2	t2	NOUN
iajs-17	68	18	dm	dm	PROPN
iajs-17	68	19	patient	patient	NOUN
iajs-17	68	20	and	and	CCONJ
iajs-17	68	21	treated	treat	VERB
iajs-17	68	22	with	with	ADP
iajs-17	68	23	insulin	insulin	NOUN
iajs-17	68	24	are	be	AUX
iajs-17	68	25	excluded	exclude	VERB
iajs-17	68	26	.	.	PUNCT
iajs-17	69	1	the	the	DET
iajs-17	69	2	patients	patient	NOUN
iajs-17	69	3	who	who	PRON
iajs-17	69	4	take	take	VERB
iajs-17	69	5	any	any	DET
iajs-17	69	6	supplements	supplement	NOUN
iajs-17	69	7	are	be	AUX
iajs-17	69	8	excluded	exclude	VERB
iajs-17	69	9	.	.	PUNCT
iajs-17	70	1	chemistry	chemistry	NOUN
iajs-17	70	2	|	|	ADV
iajs-17	70	3	136	136	NUM
iajs-17	70	4	2016	2016	NUM
iajs-17	70	5	(	(	PUNCT
iajs-17	70	6	عاً	عاً	PROPN
iajs-17	70	7	3اىعذد	3اىعذد	NUM
iajs-17	70	8	)	)	PUNCT
iajs-17	70	9	29ٍديت	29ٍديت	NUM
iajs-17	70	10	إبِ	إبِ	X
iajs-17	70	11	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	70	12	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	70	13	اىصشفت	اىصشفت	VERB
iajs-17	70	14	ٗ	ٗ	VERB
iajs-17	70	15	اىخطبٞقٞت	اىخطبٞقٞت	ADV
iajs-17	70	16	اىَديذ	اىَديذ	PROPN
iajs-17	71	1	ibn	ibn	PROPN
iajs-17	71	2	al	al	PROPN
iajs-17	71	3	-	-	PUNCT
iajs-17	71	4	haitham	haitham	PROPN
iajs-17	71	5	jour	jour	X
iajs-17	71	6	.	.	PROPN
iajs-17	71	7	for	for	ADP
iajs-17	71	8	pure	pure	ADJ
iajs-17	71	9	&	&	CCONJ
iajs-17	71	10	appl	appl	PROPN
iajs-17	71	11	.	.	PUNCT
iajs-17	72	1	sci	sci	PROPN
iajs-17	72	2	.	.	PUNCT
iajs-17	72	3	vol	vol	NOUN
iajs-17	72	4	.	.	PROPN
iajs-17	72	5	29	29	NUM
iajs-17	72	6	(	(	PUNCT
iajs-17	72	7	3	3	NUM
iajs-17	72	8	)	)	PUNCT
iajs-17	72	9	2016	2016	NUM
iajs-17	72	10	2.5	2.5	NUM
iajs-17	72	11	.	.	PUNCT
iajs-17	73	1	design	design	VERB
iajs-17	73	2	the	the	DET
iajs-17	73	3	patients	patient	NOUN
iajs-17	73	4	were	be	AUX
iajs-17	73	5	subdivided	subdivide	VERB
iajs-17	73	6	into	into	ADP
iajs-17	73	7	three	three	NUM
iajs-17	73	8	groups	group	NOUN
iajs-17	73	9	according	accord	VERB
iajs-17	73	10	to	to	ADP
iajs-17	73	11	their	their	PRON
iajs-17	73	12	hba1c	hba1c	ADJ
iajs-17	73	13	test	test	NOUN
iajs-17	73	14	value	value	NOUN
iajs-17	73	15	.	.	PUNCT
iajs-17	74	1	patients	patient	NOUN
iajs-17	74	2	with	with	ADP
iajs-17	74	3	(	(	PUNCT
iajs-17	74	4	hba1c	hba1c	X
iajs-17	74	5	value	value	NOUN
iajs-17	74	6	less	less	ADJ
iajs-17	74	7	than	than	ADP
iajs-17	74	8	7	7	NUM
iajs-17	74	9	)	)	PUNCT
iajs-17	74	10	were	be	AUX
iajs-17	74	11	considered	consider	VERB
iajs-17	74	12	good	good	ADJ
iajs-17	74	13	controlled	control	VERB
iajs-17	74	14	t2	t2	PROPN
iajs-17	74	15	dm	dm	NUM
iajs-17	74	16	according	accord	VERB
iajs-17	74	17	to	to	ADP
iajs-17	74	18	universal	universal	ADJ
iajs-17	74	19	guide	guide	NOUN
iajs-17	74	20	,	,	PUNCT
iajs-17	74	21	while	while	SCONJ
iajs-17	74	22	,	,	PUNCT
iajs-17	74	23	patients	patient	NOUN
iajs-17	74	24	with	with	ADP
iajs-17	74	25	(	(	PUNCT
iajs-17	74	26	hba1c	hba1c	NOUN
iajs-17	74	27	value	value	NOUN
iajs-17	74	28	from	from	ADP
iajs-17	74	29	7	7	NUM
iajs-17	74	30	-	-	SYM
iajs-17	74	31	8)	8)	NUM
iajs-17	74	32	were	be	AUX
iajs-17	74	33	involved	involve	VERB
iajs-17	74	34	within	within	ADP
iajs-17	74	35	middle	middle	PROPN
iajs-17	74	36	controlled	control	VERB
iajs-17	74	37	t2	t2	PROPN
iajs-17	74	38	dm	dm	PROPN
iajs-17	74	39	.	.	PUNCT
iajs-17	75	1	patients	patient	NOUN
iajs-17	75	2	with	with	ADP
iajs-17	75	3	(	(	PUNCT
iajs-17	75	4	hba1c	hba1c	X
iajs-17	75	5	value	value	NOUN
iajs-17	75	6	more	more	ADJ
iajs-17	75	7	than	than	ADP
iajs-17	75	8	8)	8)	NUM
iajs-17	75	9	were	be	AUX
iajs-17	75	10	included	include	VERB
iajs-17	75	11	within	within	ADP
iajs-17	75	12	uncontrolled	uncontrolled	ADJ
iajs-17	75	13	t2	t2	NOUN
iajs-17	75	14	dm	dm	NOUN
iajs-17	75	15	.	.	PROPN
iajs-17	75	16	2.6	2.6	NUM
iajs-17	75	17	.	.	PUNCT
iajs-17	76	1	methods	method	NOUN
iajs-17	76	2	the	the	DET
iajs-17	76	3	medical	medical	ADJ
iajs-17	76	4	history	history	NOUN
iajs-17	76	5	of	of	ADP
iajs-17	76	6	each	each	DET
iajs-17	76	7	patient	patient	NOUN
iajs-17	76	8	was	be	AUX
iajs-17	76	9	taken	take	VERB
iajs-17	76	10	regarding	regard	VERB
iajs-17	76	11	,	,	PUNCT
iajs-17	76	12	age	age	NOUN
iajs-17	76	13	,	,	PUNCT
iajs-17	76	14	duration	duration	NOUN
iajs-17	76	15	of	of	ADP
iajs-17	76	16	dm	dm	NOUN
iajs-17	76	17	and	and	CCONJ
iajs-17	76	18	body	body	NOUN
iajs-17	76	19	mass	mass	NOUN
iajs-17	76	20	index	index	NOUN
iajs-17	76	21	(	(	PUNCT
iajs-17	76	22	bmi	bmi	PROPN
iajs-17	76	23	)	)	PUNCT
iajs-17	76	24	,	,	PUNCT
iajs-17	76	25	and	and	CCONJ
iajs-17	76	26	if	if	SCONJ
iajs-17	76	27	the	the	DET
iajs-17	76	28	patient	patient	NOUN
iajs-17	76	29	was	be	AUX
iajs-17	76	30	smoker	smoker	ADJ
iajs-17	76	31	or	or	CCONJ
iajs-17	76	32	alcoholic	alcoholic	ADJ
iajs-17	76	33	was	be	AUX
iajs-17	76	34	reported	report	VERB
iajs-17	76	35	.	.	PUNCT
iajs-17	77	1	glycated	glycate	VERB
iajs-17	77	2	hemoglobin	hemoglobin	NOUN
iajs-17	77	3	(	(	PUNCT
iajs-17	77	4	hba1c	hba1c	PROPN
iajs-17	77	5	)	)	PUNCT
iajs-17	77	6	was	be	AUX
iajs-17	77	7	determined	determine	VERB
iajs-17	77	8	by	by	ADP
iajs-17	77	9	using	use	VERB
iajs-17	77	10	stanbiom	stanbiom	PROPN
iajs-17	77	11	glycohemoglobin	glycohemoglobin	PROPN
iajs-17	77	12	kit	kit	PROPN
iajs-17	77	13	,	,	PUNCT
iajs-17	77	14	germany	germany	PROPN
iajs-17	77	15	.	.	PUNCT
iajs-17	78	1	fasting	fast	VERB
iajs-17	78	2	serum	serum	NOUN
iajs-17	78	3	glucose	glucose	NOUN
iajs-17	78	4	level	level	NOUN
iajs-17	78	5	was	be	AUX
iajs-17	78	6	measured	measure	VERB
iajs-17	78	7	using	use	VERB
iajs-17	78	8	an	an	DET
iajs-17	78	9	enzymatic	enzymatic	ADJ
iajs-17	78	10	colorimetric	colorimetric	ADJ
iajs-17	78	11	method	method	NOUN
iajs-17	78	12	,	,	PUNCT
iajs-17	78	13	using	use	VERB
iajs-17	78	14	spinreact	spinreact	NOUN
iajs-17	78	15	kit	kit	PROPN
iajs-17	78	16	,	,	PUNCT
iajs-17	78	17	espain	espain	NOUN
iajs-17	78	18	.	.	PUNCT
iajs-17	79	1	fasting	fast	VERB
iajs-17	79	2	serum	serum	NOUN
iajs-17	79	3	insulin	insulin	NOUN
iajs-17	79	4	level	level	NOUN
iajs-17	79	5	(	(	PUNCT
iajs-17	79	6	fsi	fsi	PROPN
iajs-17	79	7	)	)	PUNCT
iajs-17	79	8	was	be	AUX
iajs-17	79	9	measured	measure	VERB
iajs-17	79	10	spectrophotometrically	spectrophotometrically	ADV
iajs-17	79	11	.	.	PUNCT
iajs-17	80	1	homa	homa	NOUN
iajs-17	80	2	index	index	NOUN
iajs-17	80	3	were	be	AUX
iajs-17	80	4	measured	measure	VERB
iajs-17	80	5	by	by	ADP
iajs-17	80	6	homa-2	homa-2	PROPN
iajs-17	80	7	program	program	NOUN
iajs-17	80	8	.	.	PUNCT
iajs-17	81	1	ec	ec	PROPN
iajs-17	81	2	-	-	PUNCT
iajs-17	81	3	sod	sod	NOUN
iajs-17	81	4	activity	activity	NOUN
iajs-17	81	5	was	be	AUX
iajs-17	81	6	assayed	assayed	ADJ
iajs-17	81	7	in	in	ADP
iajs-17	81	8	serum	serum	NOUN
iajs-17	81	9	by	by	ADP
iajs-17	81	10	quantifying	quantify	VERB
iajs-17	81	11	the	the	DET
iajs-17	81	12	inhibition	inhibition	NOUN
iajs-17	81	13	of	of	ADP
iajs-17	81	14	nbt	nbt	VERB
iajs-17	81	15	transformation	transformation	NOUN
iajs-17	81	16	to	to	ADP
iajs-17	81	17	formazan	formazan	ADJ
iajs-17	81	18	,	,	PUNCT
iajs-17	81	19	after	after	ADP
iajs-17	81	20	pooling	pool	VERB
iajs-17	81	21	the	the	DET
iajs-17	81	22	collecting	collecting	NOUN
iajs-17	81	23	serum	serum	NOUN
iajs-17	81	24	.	.	PUNCT
iajs-17	82	1	the	the	DET
iajs-17	82	2	ec	ec	PROPN
iajs-17	82	3	-	-	PUNCT
iajs-17	82	4	sod	sod	NOUN
iajs-17	82	5	activity	activity	NOUN
iajs-17	82	6	was	be	AUX
iajs-17	82	7	calculated	calculate	VERB
iajs-17	82	8	by	by	ADP
iajs-17	82	9	estimating	estimate	VERB
iajs-17	82	10	the	the	DET
iajs-17	82	11	amount	amount	NOUN
iajs-17	82	12	of	of	ADP
iajs-17	82	13	generated	generate	VERB
iajs-17	82	14	superoxide	superoxide	NOUN
iajs-17	82	15	anions	anion	NOUN
iajs-17	82	16	which	which	PRON
iajs-17	82	17	scavenged	scavenge	VERB
iajs-17	82	18	by	by	ADP
iajs-17	82	19	sod	sod	NOUN
iajs-17	82	20	(	(	PUNCT
iajs-17	82	21	the	the	DET
iajs-17	82	22	inhibitory	inhibitory	ADJ
iajs-17	82	23	level	level	NOUN
iajs-17	82	24	of	of	ADP
iajs-17	82	25	formazan	formazan	ADJ
iajs-17	82	26	color	color	NOUN
iajs-17	82	27	development	development	NOUN
iajs-17	82	28	)	)	PUNCT
iajs-17	83	1	[	[	X
iajs-17	83	2	17	17	NUM
iajs-17	83	3	]	]	PUNCT
iajs-17	83	4	.	.	PUNCT
iajs-17	84	1	the	the	DET
iajs-17	84	2	results	result	NOUN
iajs-17	84	3	were	be	AUX
iajs-17	84	4	expressed	express	VERB
iajs-17	84	5	as	as	ADP
iajs-17	84	6	u	u	NOUN
iajs-17	84	7	/	/	SYM
iajs-17	84	8	ml	ml	NOUN
iajs-17	84	9	.	.	PUNCT
iajs-17	85	1	serum	serum	PROPN
iajs-17	85	2	mda	mda	PROPN
iajs-17	85	3	was	be	AUX
iajs-17	85	4	estimated	estimate	VERB
iajs-17	85	5	using	use	VERB
iajs-17	85	6	the	the	DET
iajs-17	85	7	thiobarbituric	thiobarbituric	ADJ
iajs-17	85	8	acid	acid	NOUN
iajs-17	85	9	(	(	PUNCT
iajs-17	85	10	tba	tba	NOUN
iajs-17	85	11	)	)	PUNCT
iajs-17	85	12	reaction	reaction	NOUN
iajs-17	86	1	[	[	X
iajs-17	86	2	18	18	NUM
iajs-17	86	3	]	]	PUNCT
iajs-17	86	4	.	.	PUNCT
iajs-17	87	1	determination	determination	NOUN
iajs-17	87	2	of	of	ADP
iajs-17	87	3	chromium	chromium	NOUN
iajs-17	87	4	has	have	AUX
iajs-17	87	5	been	be	AUX
iajs-17	87	6	done	do	VERB
iajs-17	87	7	using	use	VERB
iajs-17	87	8	atomic	atomic	ADJ
iajs-17	87	9	absorption	absorption	NOUN
iajs-17	87	10	spectrophotometry	spectrophotometry	NOUN
iajs-17	88	1	[	[	X
iajs-17	88	2	gbc	gbc	PROPN
iajs-17	88	3	933	933	NUM
iajs-17	88	4	plus	plus	NOUN
iajs-17	88	5	,	,	PUNCT
iajs-17	88	6	japan	japan	PROPN
iajs-17	88	7	]	]	PUNCT
iajs-17	88	8	.	.	PUNCT
iajs-17	89	1	2.7	2.7	NUM
iajs-17	89	2	.	.	PUNCT
iajs-17	90	1	statistical	statistical	ADJ
iajs-17	90	2	analysis	analysis	NOUN
iajs-17	90	3	"	"	PUNCT
iajs-17	90	4	ibm	ibm	PROPN
iajs-17	90	5	spss	spss	PROPN
iajs-17	90	6	(	(	PUNCT
iajs-17	90	7	version	version	NOUN
iajs-17	90	8	20	20	NUM
iajs-17	90	9	)	)	PUNCT
iajs-17	90	10	has	have	AUX
iajs-17	90	11	been	be	AUX
iajs-17	90	12	used	use	VERB
iajs-17	90	13	for	for	ADP
iajs-17	90	14	the	the	DET
iajs-17	90	15	analysis	analysis	NOUN
iajs-17	90	16	and	and	CCONJ
iajs-17	90	17	presentations	presentation	NOUN
iajs-17	90	18	of	of	ADP
iajs-17	90	19	data	datum	NOUN
iajs-17	90	20	.	.	PUNCT
iajs-17	91	1	quantitative	quantitative	ADJ
iajs-17	91	2	data	datum	NOUN
iajs-17	91	3	were	be	AUX
iajs-17	91	4	presented	present	VERB
iajs-17	91	5	as	as	ADP
iajs-17	91	6	form	form	NOUN
iajs-17	91	7	of	of	ADP
iajs-17	91	8	mean	mean	ADJ
iajs-17	91	9	and	and	CCONJ
iajs-17	91	10	standard	standard	ADJ
iajs-17	91	11	deviation	deviation	NOUN
iajs-17	91	12	(	(	PUNCT
iajs-17	91	13	sd	sd	NOUN
iajs-17	91	14	)	)	PUNCT
iajs-17	91	15	.	.	PUNCT
iajs-17	92	1	differences	difference	NOUN
iajs-17	92	2	in	in	ADP
iajs-17	92	3	means	mean	NOUN
iajs-17	92	4	between	between	ADP
iajs-17	92	5	study	study	NOUN
iajs-17	92	6	groups	group	NOUN
iajs-17	92	7	were	be	AUX
iajs-17	92	8	tested	test	VERB
iajs-17	92	9	for	for	ADP
iajs-17	92	10	statistical	statistical	ADJ
iajs-17	92	11	significance	significance	NOUN
iajs-17	92	12	with	with	ADP
iajs-17	92	13	independent	independent	ADJ
iajs-17	92	14	samples	sample	NOUN
iajs-17	92	15	t	t	NOUN
iajs-17	92	16	-	-	PUNCT
iajs-17	92	17	test	test	NOUN
iajs-17	92	18	.	.	PUNCT
iajs-17	93	1	one	one	NUM
iajs-17	93	2	-	-	PUNCT
iajs-17	93	3	way	way	NOUN
iajs-17	93	4	analysis	analysis	NOUN
iajs-17	93	5	of	of	ADP
iajs-17	93	6	variance	variance	NOUN
iajs-17	93	7	(	(	PUNCT
iajs-17	93	8	anova	anova	PROPN
iajs-17	93	9	)	)	PUNCT
iajs-17	93	10	was	be	AUX
iajs-17	93	11	used	use	VERB
iajs-17	93	12	to	to	PART
iajs-17	93	13	compare	compare	VERB
iajs-17	93	14	the	the	DET
iajs-17	93	15	parameters	parameter	NOUN
iajs-17	93	16	among	among	ADP
iajs-17	93	17	groups	group	NOUN
iajs-17	93	18	followed	follow	VERB
iajs-17	93	19	by	by	ADP
iajs-17	93	20	post	post	X
iajs-17	93	21	hoc	hoc	X
iajs-17	93	22	test	test	NOUN
iajs-17	93	23	.	.	PUNCT
iajs-17	94	1	chemistry	chemistry	NOUN
iajs-17	94	2	|	|	ADV
iajs-17	94	3	137	137	NUM
iajs-17	94	4	2016	2016	NUM
iajs-17	94	5	(	(	PUNCT
iajs-17	94	6	عاً	عاً	PROPN
iajs-17	94	7	3اىعذد	3اىعذد	NUM
iajs-17	94	8	)	)	PUNCT
iajs-17	94	9	29اىَديذ	29اىَديذ	NUM
iajs-17	95	1	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	95	2	ٍديت	ٍديت	VERB
iajs-17	95	3	إبِ	إبِ	X
iajs-17	95	4	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	95	5	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	95	6	اىصشفت	اىصشفت	VERB
iajs-17	95	7	ibn	ibn	PROPN
iajs-17	95	8	al	al	PROPN
iajs-17	95	9	-	-	PUNCT
iajs-17	95	10	haitham	haitham	PROPN
iajs-17	95	11	jour	jour	X
iajs-17	95	12	.	.	PROPN
iajs-17	96	1	for	for	ADP
iajs-17	96	2	pure	pure	ADJ
iajs-17	96	3	&	&	CCONJ
iajs-17	96	4	appl	appl	PROPN
iajs-17	96	5	.	.	PUNCT
iajs-17	97	1	sci	sci	PROPN
iajs-17	97	2	.	.	PUNCT
iajs-17	97	3	vol	vol	NOUN
iajs-17	97	4	.	.	PROPN
iajs-17	97	5	29	29	NUM
iajs-17	97	6	(	(	PUNCT
iajs-17	97	7	3	3	NUM
iajs-17	97	8	)	)	PUNCT
iajs-17	97	9	2016	2016	NUM
iajs-17	97	10	3	3	NUM
iajs-17	97	11	.	.	PUNCT
iajs-17	97	12	results	result	VERB
iajs-17	97	13	the	the	DET
iajs-17	97	14	patients	patient	NOUN
iajs-17	97	15	group	group	NOUN
iajs-17	97	16	(	(	PUNCT
iajs-17	97	17	p	p	NOUN
iajs-17	97	18	)	)	PUNCT
iajs-17	97	19	has	have	AUX
iajs-17	97	20	shown	show	VERB
iajs-17	97	21	a	a	DET
iajs-17	97	22	highly	highly	ADV
iajs-17	97	23	significant	significant	ADJ
iajs-17	97	24	increase	increase	NOUN
iajs-17	97	25	in	in	ADP
iajs-17	97	26	fsg	fsg	PROPN
iajs-17	97	27	,	,	PUNCT
iajs-17	97	28	hba1c	hba1c	PROPN
iajs-17	97	29	,	,	PUNCT
iajs-17	97	30	(	(	PUNCT
iajs-17	97	31	fsi	fsi	NOUN
iajs-17	97	32	)	)	PUNCT
iajs-17	97	33	level	level	NOUN
iajs-17	97	34	,	,	PUNCT
iajs-17	97	35	homa2	homa2	NOUN
iajs-17	97	36	-	-	PUNCT
iajs-17	97	37	ir	ir	PROPN
iajs-17	97	38	,	,	PUNCT
iajs-17	97	39	and	and	CCONJ
iajs-17	97	40	serum	serum	PROPN
iajs-17	97	41	mda	mda	PROPN
iajs-17	97	42	when	when	SCONJ
iajs-17	97	43	comparing	compare	VERB
iajs-17	97	44	to	to	AUX
iajs-17	97	45	control	control	NOUN
iajs-17	97	46	group	group	NOUN
iajs-17	97	47	(	(	PUNCT
iajs-17	97	48	c	c	NOUN
iajs-17	97	49	)	)	PUNCT
iajs-17	97	50	,	,	PUNCT
iajs-17	97	51	while	while	SCONJ
iajs-17	97	52	no	no	DET
iajs-17	97	53	significant	significant	ADJ
iajs-17	97	54	increase	increase	NOUN
iajs-17	97	55	in	in	ADP
iajs-17	97	56	bmi	bmi	NOUN
iajs-17	97	57	between	between	ADP
iajs-17	97	58	p	p	PROPN
iajs-17	97	59	and	and	CCONJ
iajs-17	97	60	c	c	NOUN
iajs-17	97	61	groups	group	NOUN
iajs-17	97	62	(	(	PUNCT
iajs-17	97	63	table	table	NOUN
iajs-17	97	64	1	1	NUM
iajs-17	97	65	)	)	PUNCT
iajs-17	97	66	.	.	PUNCT
iajs-17	98	1	group	group	PROPN
iajs-17	98	2	p	p	PROPN
iajs-17	98	3	has	have	AUX
iajs-17	98	4	been	be	AUX
iajs-17	98	5	shown	show	VERB
iajs-17	98	6	a	a	DET
iajs-17	98	7	significant	significant	ADJ
iajs-17	98	8	decrease	decrease	NOUN
iajs-17	98	9	in	in	ADP
iajs-17	98	10	homa	homa	NOUN
iajs-17	98	11	-	-	PUNCT
iajs-17	98	12	β%	β%	NOUN
iajs-17	98	13	,	,	PUNCT
iajs-17	98	14	homa_s%	homa_s%	PRON
iajs-17	98	15	,	,	PUNCT
iajs-17	98	16	serum	serum	NOUN
iajs-17	98	17	cr	cr	PROPN
iajs-17	98	18	level	level	NOUN
iajs-17	98	19	and	and	CCONJ
iajs-17	98	20	ec_sod	ec_sod	PROPN
iajs-17	98	21	in	in	ADP
iajs-17	98	22	comparison	comparison	NOUN
iajs-17	98	23	to	to	ADP
iajs-17	98	24	group	group	PROPN
iajs-17	98	25	c	c	PROPN
iajs-17	98	26	(	(	PUNCT
iajs-17	98	27	table	table	NOUN
iajs-17	98	28	1	1	NUM
iajs-17	98	29	)	)	PUNCT
iajs-17	98	30	.	.	PUNCT
iajs-17	99	1	fsg	fsg	PROPN
iajs-17	99	2	,	,	PUNCT
iajs-17	99	3	fsi	fsi	PROPN
iajs-17	99	4	,	,	PUNCT
iajs-17	99	5	homa2	homa2	NOUN
iajs-17	99	6	-	-	PUNCT
iajs-17	99	7	ir	ir	PROPN
iajs-17	99	8	,	,	PUNCT
iajs-17	99	9	and	and	CCONJ
iajs-17	99	10	serum	serum	PROPN
iajs-17	99	11	mda	mda	PROPN
iajs-17	99	12	were	be	AUX
iajs-17	99	13	increased	increase	VERB
iajs-17	99	14	as	as	SCONJ
iajs-17	99	15	the	the	DET
iajs-17	99	16	hba1c	hba1c	NOUN
iajs-17	99	17	increased	increase	VERB
iajs-17	99	18	,	,	PUNCT
iajs-17	99	19	i.e.	i.e.	X
iajs-17	99	20	these	these	DET
iajs-17	99	21	parameters	parameter	NOUN
iajs-17	99	22	were	be	AUX
iajs-17	99	23	higher	high	ADJ
iajs-17	99	24	in	in	ADP
iajs-17	99	25	group	group	NOUN
iajs-17	99	26	p3	p3	PROPN
iajs-17	99	27	than	than	ADP
iajs-17	99	28	group	group	NOUN
iajs-17	99	29	p2	p2	NOUN
iajs-17	99	30	,	,	PUNCT
iajs-17	99	31	in	in	ADP
iajs-17	99	32	group	group	NOUN
iajs-17	99	33	p2	p2	PROPN
iajs-17	99	34	and	and	CCONJ
iajs-17	99	35	were	be	AUX
iajs-17	99	36	higher	high	ADJ
iajs-17	99	37	than	than	ADP
iajs-17	99	38	group	group	NOUN
iajs-17	99	39	p1	p1	NOUN
iajs-17	99	40	,	,	PUNCT
iajs-17	99	41	although	although	SCONJ
iajs-17	99	42	these	these	DET
iajs-17	99	43	parameters	parameter	NOUN
iajs-17	99	44	were	be	AUX
iajs-17	99	45	higher	high	ADJ
iajs-17	99	46	in	in	ADP
iajs-17	99	47	patients	patient	NOUN
iajs-17	99	48	group	group	NOUN
iajs-17	99	49	p	p	PROPN
iajs-17	99	50	than	than	ADP
iajs-17	99	51	control	control	PROPN
iajs-17	99	52	group	group	PROPN
iajs-17	99	53	c.	c.	PROPN
iajs-17	99	54	homa	homa	PROPN
iajs-17	99	55	-	-	PUNCT
iajs-17	99	56	β%	β%	NOUN
iajs-17	99	57	,	,	PUNCT
iajs-17	99	58	homa_s%	homa_s%	PRON
iajs-17	99	59	,	,	PUNCT
iajs-17	99	60	serum	serum	NOUN
iajs-17	99	61	cr	cr	PROPN
iajs-17	99	62	level	level	PROPN
iajs-17	99	63	and	and	CCONJ
iajs-17	99	64	ec_sod	ec_sod	PROPN
iajs-17	99	65	were	be	AUX
iajs-17	99	66	decreased	decrease	VERB
iajs-17	99	67	as	as	SCONJ
iajs-17	99	68	the	the	DET
iajs-17	99	69	hba1c	hba1c	NOUN
iajs-17	99	70	increased	increase	VERB
iajs-17	99	71	,	,	PUNCT
iajs-17	99	72	i.e.	i.e.	X
iajs-17	99	73	these	these	DET
iajs-17	99	74	parameters	parameter	NOUN
iajs-17	99	75	were	be	AUX
iajs-17	99	76	lesser	less	ADJ
iajs-17	99	77	in	in	ADP
iajs-17	99	78	group	group	NOUN
iajs-17	99	79	p3	p3	PROPN
iajs-17	99	80	than	than	ADP
iajs-17	99	81	group	group	NOUN
iajs-17	99	82	p2	p2	NOUN
iajs-17	99	83	,	,	PUNCT
iajs-17	99	84	and	and	CCONJ
iajs-17	99	85	were	be	AUX
iajs-17	99	86	higher	high	ADJ
iajs-17	99	87	in	in	ADP
iajs-17	99	88	group	group	NOUN
iajs-17	99	89	p2	p2	PROPN
iajs-17	99	90	than	than	ADP
iajs-17	99	91	group	group	NOUN
iajs-17	99	92	p1	p1	NOUN
iajs-17	99	93	,	,	PUNCT
iajs-17	99	94	although	although	SCONJ
iajs-17	99	95	these	these	DET
iajs-17	99	96	parameters	parameter	NOUN
iajs-17	99	97	were	be	AUX
iajs-17	99	98	lower	low	ADJ
iajs-17	99	99	in	in	ADP
iajs-17	99	100	patients	patient	NOUN
iajs-17	99	101	group	group	NOUN
iajs-17	99	102	p	p	PROPN
iajs-17	99	103	than	than	ADP
iajs-17	99	104	control	control	PROPN
iajs-17	99	105	group	group	PROPN
iajs-17	99	106	c.	c.	PROPN
iajs-17	99	107	ec	ec	PROPN
iajs-17	99	108	-	-	PUNCT
iajs-17	99	109	sod	sod	NOUN
iajs-17	99	110	was	be	AUX
iajs-17	99	111	assayed	assayed	ADJ
iajs-17	99	112	in	in	ADP
iajs-17	99	113	serum	serum	NOUN
iajs-17	99	114	of	of	ADP
iajs-17	99	115	patients	patient	NOUN
iajs-17	99	116	and	and	CCONJ
iajs-17	99	117	control	control	VERB
iajs-17	99	118	subjects	subject	NOUN
iajs-17	99	119	using	use	VERB
iajs-17	99	120	pooling	pool	VERB
iajs-17	99	121	method	method	NOUN
iajs-17	99	122	and	and	CCONJ
iajs-17	99	123	the	the	DET
iajs-17	99	124	results	result	NOUN
iajs-17	99	125	revealed	reveal	VERB
iajs-17	99	126	that	that	SCONJ
iajs-17	99	127	the	the	DET
iajs-17	99	128	ec	ec	PROPN
iajs-17	99	129	-	-	PUNCT
iajs-17	99	130	sod	sod	NOUN
iajs-17	99	131	activity	activity	NOUN
iajs-17	99	132	in	in	ADP
iajs-17	99	133	control	control	NOUN
iajs-17	99	134	group	group	NOUN
iajs-17	99	135	was	be	AUX
iajs-17	99	136	higher	high	ADJ
iajs-17	99	137	than	than	ADP
iajs-17	99	138	patients	patient	NOUN
iajs-17	99	139	group	group	NOUN
iajs-17	99	140	(	(	PUNCT
iajs-17	99	141	12.43	12.43	NUM
iajs-17	99	142	vs.	vs.	ADP
iajs-17	99	143	10.05	10.05	NUM
iajs-17	99	144	u	u	NOUN
iajs-17	99	145	/	/	SYM
iajs-17	99	146	ml	ml	NOUN
iajs-17	99	147	)	)	PUNCT
iajs-17	99	148	(	(	PUNCT
iajs-17	99	149	table	table	NOUN
iajs-17	99	150	3	3	NUM
iajs-17	99	151	)	)	PUNCT
iajs-17	99	152	.	.	PUNCT
iajs-17	100	1	also	also	ADV
iajs-17	100	2	,	,	PUNCT
iajs-17	100	3	ec	ec	PROPN
iajs-17	100	4	-	-	PUNCT
iajs-17	100	5	sod	sod	NOUN
iajs-17	100	6	activity	activity	NOUN
iajs-17	100	7	was	be	AUX
iajs-17	100	8	decreased	decrease	VERB
iajs-17	100	9	as	as	ADP
iajs-17	100	10	hba1c	hba1c	PROPN
iajs-17	100	11	increase	increase	NOUN
iajs-17	100	12	in	in	ADP
iajs-17	100	13	the	the	DET
iajs-17	100	14	groups	group	NOUN
iajs-17	100	15	,	,	PUNCT
iajs-17	100	16	i.e.	i.e.	X
iajs-17	100	17	ec	ec	PROPN
iajs-17	100	18	-	-	PUNCT
iajs-17	100	19	sod	sod	NOUN
iajs-17	100	20	activity	activity	NOUN
iajs-17	100	21	in	in	ADP
iajs-17	100	22	controlled	control	VERB
iajs-17	100	23	patients	patient	NOUN
iajs-17	100	24	group	group	NOUN
iajs-17	100	25	was	be	AUX
iajs-17	100	26	higher	high	ADJ
iajs-17	100	27	than	than	ADP
iajs-17	100	28	medium	medium	NOUN
iajs-17	100	29	controlled	control	VERB
iajs-17	100	30	group	group	NOUN
iajs-17	100	31	and	and	CCONJ
iajs-17	100	32	both	both	PRON
iajs-17	100	33	were	be	AUX
iajs-17	100	34	higher	high	ADJ
iajs-17	100	35	than	than	ADP
iajs-17	100	36	uncontrolled	uncontrolled	ADJ
iajs-17	100	37	group	group	NOUN
iajs-17	100	38	(	(	PUNCT
iajs-17	100	39	11.78	11.78	NUM
iajs-17	100	40	,	,	PUNCT
iajs-17	100	41	10.5	10.5	NUM
iajs-17	100	42	and	and	CCONJ
iajs-17	100	43	7.86	7.86	NUM
iajs-17	100	44	u	u	NOUN
iajs-17	100	45	/	/	SYM
iajs-17	100	46	ml	ml	VERB
iajs-17	100	47	)	)	PUNCT
iajs-17	100	48	,	,	PUNCT
iajs-17	100	49	table	table	NOUN
iajs-17	100	50	(	(	PUNCT
iajs-17	100	51	3	3	NUM
iajs-17	100	52	)	)	PUNCT
iajs-17	100	53	.	.	PUNCT
iajs-17	101	1	t2	t2	NOUN
iajs-17	101	2	dm	dm	PROPN
iajs-17	101	3	is	be	AUX
iajs-17	101	4	a	a	DET
iajs-17	101	5	chronic	chronic	ADJ
iajs-17	101	6	disease	disease	NOUN
iajs-17	101	7	characterized	characterize	VERB
iajs-17	101	8	mainly	mainly	ADV
iajs-17	101	9	by	by	ADP
iajs-17	101	10	a	a	DET
iajs-17	101	11	disorder	disorder	NOUN
iajs-17	101	12	in	in	ADP
iajs-17	101	13	the	the	DET
iajs-17	101	14	metabolism	metabolism	NOUN
iajs-17	101	15	of	of	ADP
iajs-17	101	16	glucose	glucose	NOUN
iajs-17	101	17	associated	associate	VERB
iajs-17	101	18	with	with	ADP
iajs-17	101	19	a	a	DET
iajs-17	101	20	lowering	lowering	NOUN
iajs-17	101	21	of	of	ADP
iajs-17	101	22	the	the	DET
iajs-17	101	23	ability	ability	NOUN
iajs-17	101	24	of	of	ADP
iajs-17	101	25	tissues	tissue	NOUN
iajs-17	101	26	to	to	PART
iajs-17	101	27	respond	respond	VERB
iajs-17	101	28	to	to	ADP
iajs-17	101	29	insulin	insulin	NOUN
iajs-17	101	30	secerted	secerte	VERB
iajs-17	101	31	(	(	PUNCT
iajs-17	101	32	insulin	insulin	NOUN
iajs-17	101	33	resistance	resistance	NOUN
iajs-17	101	34	)	)	PUNCT
iajs-17	101	35	.	.	PUNCT
iajs-17	102	1	the	the	DET
iajs-17	102	2	resulting	result	VERB
iajs-17	102	3	hyperglycemia	hyperglycemia	NOUN
iajs-17	102	4	damages	damage	NOUN
iajs-17	102	5	nerve	nerve	NOUN
iajs-17	102	6	cells	cell	NOUN
iajs-17	102	7	and	and	CCONJ
iajs-17	102	8	blood	blood	NOUN
iajs-17	102	9	vessels	vessel	NOUN
iajs-17	102	10	through	through	ADP
iajs-17	102	11	the	the	DET
iajs-17	102	12	body	body	NOUN
iajs-17	102	13	,	,	PUNCT
iajs-17	102	14	leading	lead	VERB
iajs-17	102	15	to	to	ADP
iajs-17	102	16	micro	micro	ADJ
iajs-17	102	17	-	-	ADJ
iajs-17	102	18	vascular	vascular	ADJ
iajs-17	102	19	diseases	disease	NOUN
iajs-17	102	20	such	such	ADJ
iajs-17	102	21	as	as	ADP
iajs-17	102	22	nephropathy	nephropathy	ADJ
iajs-17	102	23	,	,	PUNCT
iajs-17	102	24	neuropathy	neuropathy	ADJ
iajs-17	102	25	and	and	CCONJ
iajs-17	102	26	retinopathy	retinopathy	ADJ
iajs-17	102	27	.	.	PUNCT
iajs-17	103	1	furthermore	furthermore	ADV
iajs-17	103	2	,	,	PUNCT
iajs-17	103	3	the	the	DET
iajs-17	103	4	risk	risk	NOUN
iajs-17	103	5	for	for	ADP
iajs-17	103	6	cardiovascular	cardiovascular	ADJ
iajs-17	103	7	disease	disease	NOUN
iajs-17	103	8	(	(	PUNCT
iajs-17	103	9	cvd	cvd	PROPN
iajs-17	103	10	)	)	PUNCT
iajs-17	103	11	is	be	AUX
iajs-17	103	12	considerably	considerably	ADV
iajs-17	103	13	elevated	elevate	VERB
iajs-17	103	14	in	in	ADP
iajs-17	103	15	patients	patient	NOUN
iajs-17	103	16	with	with	ADP
iajs-17	103	17	t2	t2	PROPN
iajs-17	103	18	dm	dm	PROPN
iajs-17	103	19	compared	compare	VERB
iajs-17	103	20	to	to	ADP
iajs-17	103	21	the	the	DET
iajs-17	103	22	general	general	ADJ
iajs-17	103	23	population	population	NOUN
iajs-17	103	24	.	.	PUNCT
iajs-17	104	1	as	as	ADP
iajs-17	104	2	a	a	DET
iajs-17	104	3	consequence	consequence	NOUN
iajs-17	104	4	,	,	PUNCT
iajs-17	104	5	t2	t2	NOUN
iajs-17	104	6	dm	dm	PROPN
iajs-17	104	7	represents	represent	VERB
iajs-17	104	8	a	a	DET
iajs-17	104	9	major	major	ADJ
iajs-17	104	10	public	public	ADJ
iajs-17	104	11	health	health	NOUN
iajs-17	104	12	problem	problem	NOUN
iajs-17	104	13	[	[	X
iajs-17	104	14	19	19	NUM
iajs-17	104	15	]	]	PUNCT
iajs-17	104	16	.	.	PUNCT
iajs-17	105	1	dm	dm	PROPN
iajs-17	105	2	is	be	AUX
iajs-17	105	3	an	an	DET
iajs-17	105	4	endocrinological	endocrinological	ADJ
iajs-17	105	5	disease	disease	NOUN
iajs-17	105	6	associated	associate	VERB
iajs-17	105	7	with	with	ADP
iajs-17	105	8	a	a	DET
iajs-17	105	9	severe	severe	ADJ
iajs-17	105	10	metabolic	metabolic	NOUN
iajs-17	105	11	and	and	CCONJ
iajs-17	105	12	oxidative	oxidative	ADJ
iajs-17	105	13	stress	stress	NOUN
iajs-17	105	14	problem	problem	NOUN
iajs-17	105	15	.	.	PUNCT
iajs-17	106	1	in	in	ADP
iajs-17	106	2	the	the	DET
iajs-17	106	3	presence	presence	NOUN
iajs-17	106	4	of	of	ADP
iajs-17	106	5	free	free	ADJ
iajs-17	106	6	radicals	radical	NOUN
iajs-17	106	7	,	,	PUNCT
iajs-17	106	8	glucose	glucose	NOUN
iajs-17	106	9	can	can	AUX
iajs-17	106	10	undergo	undergo	VERB
iajs-17	106	11	a	a	DET
iajs-17	106	12	process	process	NOUN
iajs-17	106	13	called	call	VERB
iajs-17	106	14	autooxidation	autooxidation	NOUN
iajs-17	106	15	.	.	PUNCT
iajs-17	107	1	studies	study	NOUN
iajs-17	107	2	show	show	VERB
iajs-17	107	3	that	that	SCONJ
iajs-17	107	4	oxidative	oxidative	ADJ
iajs-17	107	5	stress	stress	NOUN
iajs-17	107	6	has	have	VERB
iajs-17	107	7	the	the	DET
iajs-17	107	8	greatest	great	ADJ
iajs-17	107	9	role	role	NOUN
iajs-17	107	10	in	in	ADP
iajs-17	107	11	developing	develop	VERB
iajs-17	107	12	complications	complication	NOUN
iajs-17	107	13	[	[	X
iajs-17	107	14	20	20	NUM
iajs-17	107	15	]	]	PUNCT
iajs-17	107	16	.	.	PUNCT
iajs-17	108	1	results	result	NOUN
iajs-17	108	2	showed	show	VERB
iajs-17	108	3	in	in	ADP
iajs-17	108	4	table	table	NOUN
iajs-17	108	5	(	(	PUNCT
iajs-17	108	6	1	1	NUM
iajs-17	108	7	)	)	PUNCT
iajs-17	108	8	,	,	PUNCT
iajs-17	108	9	indicated	indicate	VERB
iajs-17	108	10	significant	significant	ADJ
iajs-17	108	11	increase	increase	NOUN
iajs-17	108	12	in	in	ADP
iajs-17	108	13	hba1c	hba1c	PROPN
iajs-17	108	14	,	,	PUNCT
iajs-17	108	15	fsg	fsg	PROPN
iajs-17	108	16	,	,	PUNCT
iajs-17	108	17	fsi	fsi	PROPN
iajs-17	108	18	,	,	PUNCT
iajs-17	108	19	and	and	CCONJ
iajs-17	108	20	homa2	homa2	NOUN
iajs-17	108	21	-	-	PUNCT
iajs-17	108	22	ir	ir	PROPN
iajs-17	108	23	in	in	ADP
iajs-17	108	24	group	group	NOUN
iajs-17	108	25	(	(	PUNCT
iajs-17	108	26	p	p	NOUN
iajs-17	108	27	)	)	PUNCT
iajs-17	108	28	in	in	ADP
iajs-17	108	29	comparison	comparison	NOUN
iajs-17	108	30	with	with	ADP
iajs-17	108	31	group	group	NOUN
iajs-17	108	32	(	(	PUNCT
iajs-17	108	33	c	c	NOUN
iajs-17	108	34	)	)	PUNCT
iajs-17	108	35	.	.	PUNCT
iajs-17	109	1	these	these	DET
iajs-17	109	2	findings	finding	NOUN
iajs-17	109	3	are	be	AUX
iajs-17	109	4	in	in	ADP
iajs-17	109	5	agreement	agreement	NOUN
iajs-17	109	6	with	with	ADP
iajs-17	109	7	previous	previous	ADJ
iajs-17	109	8	study	study	NOUN
iajs-17	109	9	of	of	ADP
iajs-17	109	10	arie	arie	PROPN
iajs-17	109	11	srihardyastutie	srihardyastutie	PROPN
iajs-17	109	12	et	et	PROPN
iajs-17	109	13	al	al	PROPN
iajs-17	109	14	,	,	PUNCT
iajs-17	109	15	2015	2015	NUM
iajs-17	109	16	[	[	X
iajs-17	109	17	21	21	NUM
iajs-17	109	18	]	]	PUNCT
iajs-17	109	19	.	.	PUNCT
iajs-17	110	1	there	there	PRON
iajs-17	110	2	are	be	VERB
iajs-17	110	3	many	many	ADJ
iajs-17	110	4	studies	study	NOUN
iajs-17	110	5	also	also	ADV
iajs-17	110	6	has	have	AUX
iajs-17	110	7	pointed	point	VERB
iajs-17	110	8	out	out	ADP
iajs-17	110	9	that	that	SCONJ
iajs-17	110	10	the	the	DET
iajs-17	110	11	increase	increase	NOUN
iajs-17	110	12	in	in	ADP
iajs-17	110	13	the	the	DET
iajs-17	110	14	level	level	NOUN
iajs-17	110	15	of	of	ADP
iajs-17	110	16	blood	blood	NOUN
iajs-17	110	17	glucose	glucose	NOUN
iajs-17	110	18	is	be	AUX
iajs-17	110	19	associated	associate	VERB
iajs-17	110	20	with	with	ADP
iajs-17	110	21	an	an	DET
iajs-17	110	22	increase	increase	NOUN
iajs-17	110	23	in	in	ADP
iajs-17	110	24	incidence	incidence	NOUN
iajs-17	110	25	of	of	ADP
iajs-17	110	26	cardiovascular	cardiovascular	ADJ
iajs-17	110	27	disease	disease	NOUN
iajs-17	110	28	and	and	CCONJ
iajs-17	110	29	the	the	DET
iajs-17	110	30	high	high	ADJ
iajs-17	110	31	level	level	NOUN
iajs-17	110	32	of	of	ADP
iajs-17	110	33	glucose	glucose	NOUN
iajs-17	110	34	,	,	PUNCT
iajs-17	110	35	(	(	PUNCT
iajs-17	110	36	hyperglycemia	hyperglycemia	NOUN
iajs-17	110	37	)	)	PUNCT
iajs-17	110	38	leads	lead	VERB
iajs-17	110	39	to	to	PART
iajs-17	110	40	increase	increase	VERB
iajs-17	110	41	the	the	DET
iajs-17	110	42	generation	generation	NOUN
iajs-17	110	43	of	of	ADP
iajs-17	110	44	free	free	ADJ
iajs-17	110	45	radicals	radical	NOUN
iajs-17	110	46	and	and	CCONJ
iajs-17	110	47	then	then	ADV
iajs-17	110	48	activates	activate	VERB
iajs-17	110	49	oxidative	oxidative	ADJ
iajs-17	110	50	stress	stress	NOUN
iajs-17	110	51	and	and	CCONJ
iajs-17	110	52	would	would	AUX
iajs-17	110	53	be	be	AUX
iajs-17	110	54	an	an	DET
iajs-17	110	55	important	important	ADJ
iajs-17	110	56	causeof	causeof	ADJ
iajs-17	110	57	heart	heart	NOUN
iajs-17	110	58	and	and	CCONJ
iajs-17	110	59	blood	blood	NOUN
iajs-17	110	60	vessels	vessel	NOUN
iajs-17	110	61	disease	disease	NOUN
iajs-17	111	1	[	[	X
iajs-17	111	2	22	22	NUM
iajs-17	111	3	]	]	PUNCT
iajs-17	111	4	.	.	PUNCT
iajs-17	112	1	insulin	insulin	NOUN
iajs-17	112	2	is	be	AUX
iajs-17	112	3	a	a	DET
iajs-17	112	4	peptide	peptide	ADJ
iajs-17	112	5	hormone	hormone	NOUN
iajs-17	112	6	secreted	secrete	VERB
iajs-17	112	7	by	by	ADP
iajs-17	112	8	β	β	NOUN
iajs-17	112	9	-	-	NOUN
iajs-17	112	10	cell	cell	NOUN
iajs-17	112	11	of	of	ADP
iajs-17	112	12	the	the	DET
iajs-17	112	13	pancreatic	pancreatic	ADJ
iajs-17	112	14	islet	islet	NOUN
iajs-17	112	15	of	of	ADP
iajs-17	112	16	langerhans	langerhan	NOUN
iajs-17	112	17	for	for	ADP
iajs-17	112	18	maintaining	maintain	VERB
iajs-17	112	19	normal	normal	ADJ
iajs-17	112	20	blood	blood	NOUN
iajs-17	112	21	glucose	glucose	NOUN
iajs-17	112	22	level	level	NOUN
iajs-17	112	23	by	by	ADP
iajs-17	112	24	facilitating	facilitate	VERB
iajs-17	112	25	cellular	cellular	ADJ
iajs-17	112	26	glucose	glucose	NOUN
iajs-17	112	27	uptake	uptake	ADJ
iajs-17	112	28	[	[	X
iajs-17	112	29	23	23	NUM
iajs-17	112	30	]	]	PUNCT
iajs-17	112	31	.	.	PUNCT
iajs-17	113	1	the	the	DET
iajs-17	113	2	main	main	ADJ
iajs-17	113	3	pathophysiological	pathophysiological	ADJ
iajs-17	113	4	feature	feature	NOUN
iajs-17	113	5	of	of	ADP
iajs-17	113	6	t2	t2	NOUN
iajs-17	113	7	dm	dm	PROPN
iajs-17	113	8	is	be	AUX
iajs-17	113	9	impaired	impair	VERB
iajs-17	113	10	insulin	insulin	NOUN
iajs-17	113	11	secretion	secretion	NOUN
iajs-17	113	12	and	and	CCONJ
iajs-17	113	13	increased	increase	VERB
iajs-17	113	14	insulin	insulin	NOUN
iajs-17	113	15	resistance	resistance	NOUN
iajs-17	113	16	[	[	X
iajs-17	113	17	24	24	NUM
iajs-17	113	18	]	]	PUNCT
iajs-17	113	19	.	.	PUNCT
iajs-17	114	1	insulin	insulin	NOUN
iajs-17	114	2	resistance	resistance	NOUN
iajs-17	114	3	is	be	AUX
iajs-17	114	4	defined	define	VERB
iajs-17	114	5	as	as	ADP
iajs-17	114	6	reduced	reduce	VERB
iajs-17	114	7	sensitivity	sensitivity	NOUN
iajs-17	114	8	of	of	ADP
iajs-17	114	9	target	target	NOUN
iajs-17	114	10	organ	organ	VERB
iajs-17	114	11	to	to	ADP
iajs-17	114	12	the	the	DET
iajs-17	114	13	insulin	insulin	NOUN
iajs-17	114	14	biological	biological	ADJ
iajs-17	114	15	effects	effect	NOUN
iajs-17	114	16	or	or	CCONJ
iajs-17	114	17	a	a	DET
iajs-17	114	18	condition	condition	NOUN
iajs-17	114	19	in	in	ADP
iajs-17	114	20	which	which	PRON
iajs-17	114	21	the	the	DET
iajs-17	114	22	body‘s	body‘s	NOUN
iajs-17	114	23	muscle	muscle	NOUN
iajs-17	114	24	,	,	PUNCT
iajs-17	114	25	fat	fat	NOUN
iajs-17	114	26	,	,	PUNCT
iajs-17	114	27	and	and	CCONJ
iajs-17	114	28	liver	liver	NOUN
iajs-17	114	29	cells	cell	NOUN
iajs-17	114	30	do	do	AUX
iajs-17	114	31	not	not	PART
iajs-17	114	32	use	use	VERB
iajs-17	114	33	insulin	insulin	NOUN
iajs-17	114	34	effectively	effectively	ADV
iajs-17	114	35	[	[	X
iajs-17	114	36	25	25	NUM
iajs-17	114	37	]	]	PUNCT
iajs-17	114	38	.	.	PUNCT
iajs-17	115	1	insulin	insulin	NOUN
iajs-17	115	2	resistance	resistance	NOUN
iajs-17	115	3	has	have	VERB
iajs-17	115	4	a	a	DET
iajs-17	115	5	correlation	correlation	NOUN
iajs-17	115	6	with	with	ADP
iajs-17	115	7	the	the	DET
iajs-17	115	8	decrease	decrease	NOUN
iajs-17	115	9	of	of	ADP
iajs-17	115	10	fasting	fast	VERB
iajs-17	115	11	insulin	insulin	NOUN
iajs-17	115	12	value	value	NOUN
iajs-17	115	13	.	.	PUNCT
iajs-17	116	1	because	because	SCONJ
iajs-17	116	2	of	of	ADP
iajs-17	116	3	insulin	insulin	NOUN
iajs-17	116	4	function	function	NOUN
iajs-17	116	5	keeps	keeps	AUX
iajs-17	116	6	maintain	maintain	VERB
iajs-17	116	7	the	the	DET
iajs-17	116	8	glucose	glucose	NOUN
iajs-17	116	9	blood	blood	NOUN
iajs-17	116	10	homeostasis	homeostasis	NOUN
iajs-17	116	11	by	by	ADP
iajs-17	116	12	facilitating	facilitate	VERB
iajs-17	116	13	cellular	cellular	ADJ
iajs-17	116	14	glucose	glucose	NOUN
iajs-17	116	15	uptake	uptake	NOUN
iajs-17	116	16	,	,	PUNCT
iajs-17	116	17	so	so	SCONJ
iajs-17	116	18	the	the	DET
iajs-17	116	19	increaseof	increaseof	ADJ
iajs-17	116	20	serum	serum	NOUN
iajs-17	116	21	glucose	glucose	NOUN
iajs-17	116	22	will	will	AUX
iajs-17	116	23	induce	induce	VERB
iajs-17	116	24	β	β	NOUN
iajs-17	116	25	-	-	NOUN
iajs-17	116	26	cell	cell	NOUN
iajs-17	116	27	pancreatic	pancreatic	NOUN
iajs-17	116	28	to	to	PART
iajs-17	116	29	increase	increase	VERB
iajs-17	116	30	insulin	insulin	NOUN
iajs-17	116	31	secretion	secretion	NOUN
iajs-17	116	32	,	,	PUNCT
iajs-17	116	33	but	but	CCONJ
iajs-17	116	34	unfortunately	unfortunately	ADV
iajs-17	116	35	,	,	PUNCT
iajs-17	116	36	pancreatic	pancreatic	ADJ
iajs-17	116	37	langerhan	langerhan	NOUN
iajs-17	116	38	fail	fail	VERB
iajs-17	116	39	to	to	PART
iajs-17	116	40	process	process	VERB
iajs-17	116	41	proinsulin	proinsulin	NOUN
iajs-17	116	42	as	as	ADP
iajs-17	116	43	precursor	precursor	NOUN
iajs-17	116	44	to	to	PART
iajs-17	116	45	be	be	AUX
iajs-17	116	46	mature	mature	ADJ
iajs-17	116	47	insulin	insulin	NOUN
iajs-17	117	1	[	[	PUNCT
iajs-17	117	2	21	21	NUM
iajs-17	117	3	and	and	CCONJ
iajs-17	117	4	26	26	NUM
iajs-17	117	5	]	]	PUNCT
iajs-17	117	6	.	.	PUNCT
iajs-17	118	1	this	this	PRON
iajs-17	118	2	will	will	AUX
iajs-17	118	3	affect	affect	VERB
iajs-17	118	4	the	the	DET
iajs-17	118	5	increase	increase	NOUN
iajs-17	118	6	of	of	ADP
iajs-17	118	7	blood	blood	NOUN
iajs-17	118	8	glucose	glucose	NOUN
iajs-17	118	9	value	value	NOUN
iajs-17	118	10	.	.	PUNCT
iajs-17	119	1	the	the	DET
iajs-17	119	2	more	more	ADJ
iajs-17	119	3	fsg	fsg	NOUN
iajs-17	119	4	value	value	NOUN
iajs-17	119	5	increases	increase	NOUN
iajs-17	119	6	,	,	PUNCT
iajs-17	119	7	the	the	PRON
iajs-17	119	8	more	more	ADJ
iajs-17	119	9	hba1c	hba1c	PROPN
iajs-17	119	10	value	value	NOUN
iajs-17	119	11	increase	increase	NOUN
iajs-17	119	12	.	.	PUNCT
iajs-17	120	1	some	some	DET
iajs-17	120	2	researchers	researcher	NOUN
iajs-17	120	3	report	report	VERB
iajs-17	120	4	that	that	SCONJ
iajs-17	120	5	the	the	DET
iajs-17	120	6	glycation	glycation	NOUN
iajs-17	120	7	accour	accour	VERB
iajs-17	120	8	over	over	ADP
iajs-17	120	9	span	span	NOUN
iajs-17	120	10	of	of	ADP
iajs-17	120	11	90	90	NUM
iajs-17	120	12	-	-	SYM
iajs-17	120	13	120	120	NUM
iajs-17	120	14	red	red	ADJ
iajs-17	120	15	blood	blood	NOUN
iajs-17	120	16	cell	cell	NOUN
iajs-17	120	17	day	day	NOUN
iajs-17	120	18	life	life	NOUN
iajs-17	120	19	,	,	PUNCT
iajs-17	120	20	so	so	SCONJ
iajs-17	120	21	hba1c	hba1c	PRON
iajs-17	120	22	test	test	NOUN
iajs-17	120	23	is	be	AUX
iajs-17	120	24	a	a	DET
iajs-17	120	25	biochemical	biochemical	ADJ
iajs-17	120	26	test	test	NOUN
iajs-17	120	27	that	that	PRON
iajs-17	120	28	reflects	reflect	VERB
iajs-17	120	29	the	the	DET
iajs-17	120	30	average	average	ADJ
iajs-17	120	31	level	level	NOUN
iajs-17	120	32	of	of	ADP
iajs-17	120	33	glucose	glucose	NOUN
iajs-17	120	34	in	in	ADP
iajs-17	120	35	the	the	DET
iajs-17	120	36	blood	blood	NOUN
iajs-17	120	37	over	over	ADP
iajs-17	120	38	a	a	DET
iajs-17	120	39	three	three	NUM
iajs-17	120	40	month	month	NOUN
iajs-17	120	41	period	period	NOUN
iajs-17	120	42	by	by	ADP
iajs-17	120	43	measuring	measure	VERB
iajs-17	120	44	the	the	DET
iajs-17	120	45	proportion	proportion	NOUN
iajs-17	120	46	of	of	ADP
iajs-17	120	47	hemoglobin	hemoglobin	NOUN
iajs-17	120	48	that	that	PRON
iajs-17	120	49	has	have	AUX
iajs-17	120	50	become	become	VERB
iajs-17	120	51	glycosylated	glycosylated	ADJ
iajs-17	120	52	[	[	PUNCT
iajs-17	120	53	27	27	NUM
iajs-17	120	54	]	]	PUNCT
iajs-17	120	55	.	.	PUNCT
iajs-17	121	1	it	it	PRON
iajs-17	121	2	indicates	indicate	VERB
iajs-17	121	3	that	that	SCONJ
iajs-17	121	4	the	the	DET
iajs-17	121	5	increase	increase	NOUN
iajs-17	121	6	of	of	ADP
iajs-17	121	7	serum	serum	NOUN
iajs-17	121	8	glucose	glucose	NOUN
iajs-17	121	9	values	value	NOUN
iajs-17	121	10	contributes	contribute	VERB
iajs-17	121	11	to	to	PART
iajs-17	121	12	bind	bind	VERB
iajs-17	121	13	glucose	glucose	NOUN
iajs-17	121	14	-	-	PUNCT
iajs-17	121	15	hemoglobin	hemoglobin	NOUN
iajs-17	121	16	more	more	ADJ
iajs-17	121	17	(	(	PUNCT
iajs-17	121	18	glycation	glycation	NOUN
iajs-17	121	19	reaction	reaction	NOUN
iajs-17	121	20	)	)	PUNCT
iajs-17	121	21	and	and	CCONJ
iajs-17	121	22	chemistry	chemistry	NOUN
iajs-17	122	1	|	|	ADV
iajs-17	122	2	138	138	NUM
iajs-17	122	3	2016	2016	NUM
iajs-17	122	4	(	(	PUNCT
iajs-17	122	5	عاً	عاً	PROPN
iajs-17	122	6	3اىعذد	3اىعذد	NUM
iajs-17	122	7	)	)	PUNCT
iajs-17	122	8	29اىَديذ	29اىَديذ	NUM
iajs-17	122	9	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	122	10	ٍديت	ٍديت	VERB
iajs-17	122	11	إبِ	إبِ	X
iajs-17	122	12	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	122	13	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	122	14	اىصشفت	اىصشفت	VERB
iajs-17	122	15	ibn	ibn	PROPN
iajs-17	122	16	al	al	PROPN
iajs-17	122	17	-	-	PUNCT
iajs-17	122	18	haitham	haitham	PROPN
iajs-17	122	19	jour	jour	X
iajs-17	122	20	.	.	PROPN
iajs-17	123	1	for	for	ADP
iajs-17	123	2	pure	pure	ADJ
iajs-17	123	3	&	&	CCONJ
iajs-17	123	4	appl	appl	PROPN
iajs-17	123	5	.	.	PUNCT
iajs-17	124	1	sci	sci	PROPN
iajs-17	124	2	.	.	PUNCT
iajs-17	124	3	vol	vol	NOUN
iajs-17	124	4	.	.	PROPN
iajs-17	124	5	29	29	NUM
iajs-17	124	6	(	(	PUNCT
iajs-17	124	7	3	3	X
iajs-17	124	8	)	)	PUNCT
iajs-17	124	9	2016	2016	NUM
iajs-17	124	10	gives	give	VERB
iajs-17	124	11	consequently	consequently	ADV
iajs-17	124	12	to	to	PART
iajs-17	124	13	make	make	VERB
iajs-17	124	14	higher	high	ADJ
iajs-17	124	15	value	value	NOUN
iajs-17	124	16	of	of	ADP
iajs-17	124	17	glycosylated	glycosylated	ADJ
iajs-17	124	18	hemoglobin	hemoglobin	NOUN
iajs-17	124	19	(	(	PUNCT
iajs-17	124	20	hba1c	hba1c	PROPN
iajs-17	124	21	)	)	PUNCT
iajs-17	125	1	[	[	X
iajs-17	125	2	21	21	NUM
iajs-17	125	3	]	]	X
iajs-17	125	4	,	,	PUNCT
iajs-17	125	5	that	that	PRON
iajs-17	125	6	can	can	AUX
iajs-17	125	7	explain	explain	VERB
iajs-17	125	8	the	the	DET
iajs-17	125	9	results	result	NOUN
iajs-17	125	10	obtained	obtain	VERB
iajs-17	125	11	in	in	ADP
iajs-17	125	12	the	the	DET
iajs-17	125	13	current	current	ADJ
iajs-17	125	14	study	study	NOUN
iajs-17	125	15	,	,	PUNCT
iajs-17	125	16	the	the	DET
iajs-17	125	17	increase	increase	NOUN
iajs-17	125	18	of	of	ADP
iajs-17	125	19	fsg	fsg	PROPN
iajs-17	125	20	and	and	CCONJ
iajs-17	125	21	fsi	fsi	PROPN
iajs-17	125	22	as	as	ADP
iajs-17	125	23	hba1c	hba1c	NOUN
iajs-17	125	24	increase	increase	NOUN
iajs-17	125	25	,	,	PUNCT
iajs-17	125	26	i.e.	i.e.	X
iajs-17	125	27	fsg	fsg	PROPN
iajs-17	125	28	and	and	CCONJ
iajs-17	125	29	fasting	fast	VERB
iajs-17	125	30	serum	serum	NOUN
iajs-17	125	31	insulin	insulin	NOUN
iajs-17	125	32	in	in	ADP
iajs-17	125	33	group	group	NOUN
iajs-17	125	34	p3	p3	PROPN
iajs-17	125	35	was	be	AUX
iajs-17	125	36	higher	high	ADJ
iajs-17	125	37	than	than	ADP
iajs-17	125	38	group	group	NOUN
iajs-17	125	39	p2	p2	PROPN
iajs-17	125	40	and	and	CCONJ
iajs-17	125	41	that	that	ADV
iajs-17	125	42	higher	high	ADJ
iajs-17	125	43	than	than	ADP
iajs-17	125	44	group	group	NOUN
iajs-17	125	45	p1	p1	NOUN
iajs-17	125	46	,	,	PUNCT
iajs-17	125	47	table	table	NOUN
iajs-17	125	48	(	(	PUNCT
iajs-17	125	49	2	2	NUM
iajs-17	125	50	)	)	PUNCT
iajs-17	125	51	.	.	PUNCT
iajs-17	126	1	as	as	SCONJ
iajs-17	126	2	shown	show	VERB
iajs-17	126	3	in	in	ADP
iajs-17	126	4	table	table	NOUN
iajs-17	126	5	1	1	NUM
iajs-17	126	6	homa2	homa2	NOUN
iajs-17	126	7	-	-	PUNCT
iajs-17	126	8	s	s	X
iajs-17	126	9	(	(	PUNCT
iajs-17	126	10	%	%	NOUN
iajs-17	126	11	)	)	PUNCT
iajs-17	126	12	and	and	CCONJ
iajs-17	126	13	homa2	homa2	NOUN
iajs-17	126	14	-	-	PUNCT
iajs-17	126	15	β	β	NOUN
iajs-17	126	16	cell	cell	NOUN
iajs-17	126	17	(	(	PUNCT
iajs-17	126	18	%	%	INTJ
iajs-17	126	19	)	)	PUNCT
iajs-17	126	20	showed	show	VERB
iajs-17	126	21	significant	significant	ADJ
iajs-17	126	22	decrease	decrease	NOUN
iajs-17	126	23	in	in	ADP
iajs-17	126	24	group	group	NOUN
iajs-17	126	25	(	(	PUNCT
iajs-17	126	26	p	p	NOUN
iajs-17	126	27	)	)	PUNCT
iajs-17	126	28	in	in	ADP
iajs-17	126	29	comparison	comparison	NOUN
iajs-17	126	30	with	with	ADP
iajs-17	126	31	group	group	NOUN
iajs-17	126	32	(	(	PUNCT
iajs-17	126	33	c	c	NOUN
iajs-17	126	34	)	)	PUNCT
iajs-17	126	35	.	.	PUNCT
iajs-17	127	1	these	these	DET
iajs-17	127	2	findings	finding	NOUN
iajs-17	127	3	are	be	AUX
iajs-17	127	4	in	in	ADP
iajs-17	127	5	agreement	agreement	NOUN
iajs-17	127	6	with	with	ADP
iajs-17	127	7	previous	previous	ADJ
iajs-17	127	8	study	study	NOUN
iajs-17	127	9	of	of	ADP
iajs-17	127	10	al	al	PROPN
iajs-17	127	11	-	-	PUNCT
iajs-17	127	12	hakeim	hakeim	PROPN
iajs-17	127	13	et	et	PROPN
iajs-17	127	14	al	al	PROPN
iajs-17	127	15	.	.	PROPN
iajs-17	127	16	,	,	PUNCT
iajs-17	127	17	2012	2012	NUM
iajs-17	127	18	;	;	PUNCT
iajs-17	127	19	[	[	X
iajs-17	127	20	28	28	NUM
iajs-17	127	21	]	]	PUNCT
iajs-17	127	22	.	.	PUNCT
iajs-17	128	1	ß	ß	X
iajs-17	128	2	-	-	PUNCT
iajs-17	128	3	cell	cell	NOUN
iajs-17	128	4	mass	mass	NOUN
iajs-17	128	5	adapts	adapt	VERB
iajs-17	128	6	to	to	ADP
iajs-17	128	7	an	an	DET
iajs-17	128	8	increased	increase	VERB
iajs-17	128	9	metabolic	metabolic	NOUN
iajs-17	128	10	load	load	NOUN
iajs-17	128	11	which	which	PRON
iajs-17	128	12	caused	cause	VERB
iajs-17	128	13	by	by	ADP
iajs-17	128	14	obesity	obesity	NOUN
iajs-17	128	15	and	and	CCONJ
iajs-17	128	16	the	the	DET
iajs-17	128	17	inherent	inherent	ADJ
iajs-17	128	18	insulin	insulin	NOUN
iajs-17	128	19	resistance	resistance	NOUN
iajs-17	128	20	.	.	PUNCT
iajs-17	129	1	t2	t2	NOUN
iajs-17	129	2	dm	dm	PROPN
iajs-17	129	3	in	in	ADP
iajs-17	129	4	humans	human	NOUN
iajs-17	129	5	models	model	NOUN
iajs-17	129	6	is	be	AUX
iajs-17	129	7	accompanied	accompany	VERB
iajs-17	129	8	by	by	ADP
iajs-17	129	9	a	a	DET
iajs-17	129	10	progressive	progressive	ADJ
iajs-17	129	11	decrease	decrease	NOUN
iajs-17	129	12	in	in	ADP
iajs-17	129	13	beta	beta	ADJ
iajs-17	129	14	cell	cell	NOUN
iajs-17	129	15	mass	mass	NOUN
iajs-17	129	16	.	.	PUNCT
iajs-17	130	1	as	as	ADP
iajs-17	130	2	a	a	DET
iajs-17	130	3	result	result	NOUN
iajs-17	130	4	,	,	PUNCT
iajs-17	130	5	the	the	DET
iajs-17	130	6	body	body	NOUN
iajs-17	130	7	can	can	AUX
iajs-17	130	8	no	no	ADV
iajs-17	130	9	longer	long	ADV
iajs-17	130	10	able	able	ADJ
iajs-17	130	11	to	to	PART
iajs-17	130	12	adapt	adapt	VERB
iajs-17	130	13	to	to	ADP
iajs-17	130	14	any	any	DET
iajs-17	130	15	increase	increase	NOUN
iajs-17	130	16	in	in	ADP
iajs-17	130	17	metabolic	metabolic	NOUN
iajs-17	130	18	load	load	NOUN
iajs-17	130	19	,	,	PUNCT
iajs-17	130	20	including	include	VERB
iajs-17	130	21	insulin	insulin	NOUN
iajs-17	130	22	resistance	resistance	NOUN
iajs-17	130	23	related	relate	VERB
iajs-17	130	24	with	with	ADP
iajs-17	130	25	obesity	obesity	NOUN
iajs-17	130	26	.	.	PUNCT
iajs-17	131	1	this	this	DET
iajs-17	131	2	ß	ß	DET
iajs-17	131	3	-	-	PUNCT
iajs-17	131	4	cell	cell	NOUN
iajs-17	131	5	loss	loss	NOUN
iajs-17	131	6	elevates	elevate	VERB
iajs-17	131	7	from	from	ADP
iajs-17	131	8	a	a	DET
iajs-17	131	9	marked	mark	VERB
iajs-17	131	10	increase	increase	NOUN
iajs-17	131	11	in	in	ADP
iajs-17	131	12	ß	ß	PRON
iajs-17	131	13	-	-	NOUN
iajs-17	131	14	cell	cell	NOUN
iajs-17	131	15	apoptosis	apoptosis	NOUN
iajs-17	131	16	,	,	PUNCT
iajs-17	131	17	which	which	PRON
iajs-17	131	18	far	far	ADV
iajs-17	131	19	outweighs	outweigh	VERB
iajs-17	131	20	modest	modest	ADJ
iajs-17	131	21	increases	increase	NOUN
iajs-17	131	22	in	in	ADP
iajs-17	131	23	ß	ß	DET
iajs-17	131	24	-	-	NOUN
iajs-17	131	25	cell	cell	NOUN
iajs-17	131	26	replication	replication	NOUN
iajs-17	131	27	[	[	X
iajs-17	131	28	29	29	NUM
iajs-17	131	29	]	]	PUNCT
iajs-17	131	30	.	.	PUNCT
iajs-17	132	1	as	as	SCONJ
iajs-17	132	2	the	the	DET
iajs-17	132	3	t2	t2	NOUN
iajs-17	132	4	dm	dm	PROPN
iajs-17	132	5	state	state	NOUN
iajs-17	132	6	progresses	progress	NOUN
iajs-17	132	7	,	,	PUNCT
iajs-17	132	8	the	the	DET
iajs-17	132	9	situation	situation	NOUN
iajs-17	132	10	worsens	worsen	VERB
iajs-17	132	11	;	;	PUNCT
iajs-17	132	12	the	the	DET
iajs-17	132	13	incidence	incidence	NOUN
iajs-17	132	14	of	of	ADP
iajs-17	132	15	ß	ß	DET
iajs-17	132	16	-	-	PUNCT
iajs-17	132	17	cell	cell	NOUN
iajs-17	132	18	replication	replication	NOUN
iajs-17	132	19	decreases	decrease	NOUN
iajs-17	132	20	and	and	CCONJ
iajs-17	132	21	the	the	DET
iajs-17	132	22	ß	ß	PRON
iajs-17	132	23	-	-	PUNCT
iajs-17	132	24	cell	cell	NOUN
iajs-17	132	25	population	population	NOUN
iajs-17	132	26	declines	decline	VERB
iajs-17	132	27	.	.	PUNCT
iajs-17	133	1	the	the	DET
iajs-17	133	2	increased	increased	ADJ
iajs-17	133	3	ß	ß	NOUN
iajs-17	133	4	-	-	NOUN
iajs-17	133	5	cell	cell	NOUN
iajs-17	133	6	apoptosis	apoptosis	NOUN
iajs-17	133	7	in	in	ADP
iajs-17	133	8	t2	t2	NOUN
iajs-17	133	9	dm	dm	NUM
iajs-17	133	10	is	be	AUX
iajs-17	133	11	further	far	ADV
iajs-17	133	12	exacerbated	exacerbate	VERB
iajs-17	133	13	by	by	ADP
iajs-17	133	14	the	the	DET
iajs-17	133	15	formation	formation	NOUN
iajs-17	133	16	of	of	ADP
iajs-17	133	17	amyloid	amyloid	NOUN
iajs-17	133	18	plaque	plaque	NOUN
iajs-17	133	19	deposits	deposit	NOUN
iajs-17	133	20	in	in	ADP
iajs-17	133	21	islets	islet	NOUN
iajs-17	133	22	[	[	X
iajs-17	133	23	30	30	NUM
iajs-17	133	24	]	]	PUNCT
iajs-17	133	25	.	.	PUNCT
iajs-17	134	1	eventually	eventually	ADV
iajs-17	134	2	,	,	PUNCT
iajs-17	134	3	in	in	ADP
iajs-17	134	4	the	the	DET
iajs-17	134	5	most	most	ADV
iajs-17	134	6	severe	severe	ADJ
iajs-17	134	7	cases	case	NOUN
iajs-17	134	8	,	,	PUNCT
iajs-17	134	9	a	a	DET
iajs-17	134	10	‗‗point	‗‗point	NOUN
iajs-17	134	11	of	of	ADP
iajs-17	134	12	no	no	DET
iajs-17	134	13	return	return	NOUN
iajs-17	134	14	‘	'	PUNCT
iajs-17	134	15	‘	'	PUNCT
iajs-17	134	16	ß	ß	PRON
iajs-17	134	17	-	-	PUNCT
iajs-17	134	18	cell	cell	NOUN
iajs-17	134	19	mass	mass	NOUN
iajs-17	134	20	can	can	AUX
iajs-17	134	21	be	be	AUX
iajs-17	134	22	reached	reach	VERB
iajs-17	134	23	and	and	CCONJ
iajs-17	134	24	a	a	DET
iajs-17	134	25	permanent	permanent	ADJ
iajs-17	134	26	t2	t2	NOUN
iajs-17	134	27	dm	dm	NOUN
iajs-17	134	28	state	state	NOUN
iajs-17	134	29	arises	arise	VERB
iajs-17	134	30	that	that	PRON
iajs-17	134	31	should	should	AUX
iajs-17	134	32	be	be	AUX
iajs-17	134	33	treated	treat	VERB
iajs-17	134	34	with	with	ADP
iajs-17	134	35	insulin	insulin	NOUN
iajs-17	134	36	replacement	replacement	NOUN
iajs-17	134	37	therapy	therapy	NOUN
iajs-17	134	38	[	[	X
iajs-17	134	39	31	31	NUM
iajs-17	134	40	]	]	PUNCT
iajs-17	134	41	.	.	PUNCT
iajs-17	135	1	the	the	DET
iajs-17	135	2	brain	brain	NOUN
iajs-17	135	3	processes	process	VERB
iajs-17	135	4	information	information	NOUN
iajs-17	135	5	from	from	ADP
iajs-17	135	6	adiposity	adiposity	NOUN
iajs-17	135	7	signals	signal	NOUN
iajs-17	135	8	such	such	ADJ
iajs-17	135	9	as	as	ADP
iajs-17	135	10	insulin	insulin	NOUN
iajs-17	135	11	and	and	CCONJ
iajs-17	135	12	leptin	leptin	NOUN
iajs-17	135	13	,	,	PUNCT
iajs-17	135	14	which	which	PRON
iajs-17	135	15	circulate	circulate	VERB
iajs-17	135	16	in	in	ADP
iajs-17	135	17	proportion	proportion	NOUN
iajs-17	135	18	to	to	AUX
iajs-17	135	19	body	body	NOUN
iajs-17	135	20	fat	fat	ADJ
iajs-17	135	21	mass	mass	NOUN
iajs-17	135	22	,	,	PUNCT
iajs-17	135	23	and	and	CCONJ
iajs-17	135	24	integrates	integrate	VERB
iajs-17	135	25	this	this	DET
iajs-17	135	26	input	input	NOUN
iajs-17	135	27	with	with	ADP
iajs-17	135	28	signals	signal	NOUN
iajs-17	135	29	from	from	ADP
iajs-17	135	30	nutrients	nutrient	NOUN
iajs-17	135	31	such	such	ADJ
iajs-17	135	32	as	as	ADP
iajs-17	135	33	fas	fas	PROPN
iajs-17	135	34	then	then	ADV
iajs-17	135	35	sends	send	VERB
iajs-17	135	36	in	in	ADP
iajs-17	135	37	response	response	NOUN
iajs-17	135	38	signals	signal	NOUN
iajs-17	135	39	to	to	PART
iajs-17	135	40	control	control	VERB
iajs-17	135	41	feeding	feeding	NOUN
iajs-17	135	42	behavior	behavior	NOUN
iajs-17	135	43	and	and	CCONJ
iajs-17	135	44	substrate	substrate	NOUN
iajs-17	135	45	metabolism	metabolism	NOUN
iajs-17	135	46	in	in	ADP
iajs-17	135	47	ways	way	NOUN
iajs-17	135	48	that	that	PRON
iajs-17	135	49	promote	promote	VERB
iajs-17	135	50	homeostasis	homeostasis	NOUN
iajs-17	135	51	of	of	ADP
iajs-17	135	52	both	both	DET
iajs-17	135	53	energy	energy	NOUN
iajs-17	135	54	stores	store	NOUN
iajs-17	135	55	and	and	CCONJ
iajs-17	135	56	fuel	fuel	NOUN
iajs-17	135	57	metabolism	metabolism	NOUN
iajs-17	135	58	.	.	PUNCT
iajs-17	136	1	misalignment	misalignment	NOUN
iajs-17	136	2	of	of	ADP
iajs-17	136	3	food	food	NOUN
iajs-17	136	4	intake	intake	NOUN
iajs-17	136	5	with	with	ADP
iajs-17	136	6	the	the	DET
iajs-17	136	7	expression	expression	NOUN
iajs-17	136	8	levels	level	NOUN
iajs-17	136	9	of	of	ADP
iajs-17	136	10	neuroactive	neuroactive	ADJ
iajs-17	136	11	peptides	peptide	NOUN
iajs-17	136	12	,	,	PUNCT
iajs-17	136	13	such	such	ADJ
iajs-17	136	14	as	as	ADP
iajs-17	136	15	leptin	leptin	NOUN
iajs-17	136	16	,	,	PUNCT
iajs-17	136	17	could	could	AUX
iajs-17	136	18	create	create	VERB
iajs-17	136	19	metabolic	metabolic	NOUN
iajs-17	136	20	imbalances	imbalance	NOUN
iajs-17	136	21	that	that	PRON
iajs-17	136	22	alter	alter	VERB
iajs-17	136	23	insulin	insulin	NOUN
iajs-17	136	24	sensitivity	sensitivity	NOUN
iajs-17	136	25	[	[	PUNCT
iajs-17	136	26	32	32	NUM
iajs-17	136	27	and	and	CCONJ
iajs-17	136	28	33	33	NUM
iajs-17	136	29	]	]	PUNCT
iajs-17	136	30	.	.	PUNCT
iajs-17	137	1	the	the	DET
iajs-17	137	2	importance	importance	NOUN
iajs-17	137	3	of	of	ADP
iajs-17	137	4	chromium	chromium	NOUN
iajs-17	137	5	(	(	PUNCT
iajs-17	137	6	cr	cr	NOUN
iajs-17	137	7	)	)	PUNCT
iajs-17	137	8	for	for	ADP
iajs-17	137	9	glucose	glucose	NOUN
iajs-17	137	10	metabolic	metabolic	NOUN
iajs-17	137	11	regulation	regulation	NOUN
iajs-17	137	12	has	have	AUX
iajs-17	137	13	been	be	AUX
iajs-17	137	14	noteiced	noteice	VERB
iajs-17	137	15	in	in	ADP
iajs-17	137	16	clinical	clinical	ADJ
iajs-17	137	17	states	state	NOUN
iajs-17	137	18	of	of	ADP
iajs-17	137	19	relatively	relatively	ADV
iajs-17	137	20	severe	severe	ADJ
iajs-17	137	21	chromium	chromium	NOUN
iajs-17	137	22	deficiency	deficiency	NOUN
iajs-17	137	23	,	,	PUNCT
iajs-17	137	24	which	which	PRON
iajs-17	137	25	characterized	characterize	VERB
iajs-17	137	26	by	by	ADP
iajs-17	137	27	impaired	impaired	ADJ
iajs-17	137	28	glucose	glucose	NOUN
iajs-17	137	29	tolerance	tolerance	NOUN
iajs-17	137	30	,	,	PUNCT
iajs-17	137	31	hyperglycaemia	hyperglycaemia	NOUN
iajs-17	137	32	and	and	CCONJ
iajs-17	137	33	lipid	lipid	NOUN
iajs-17	137	34	disorders	disorder	NOUN
iajs-17	137	35	[	[	X
iajs-17	137	36	34	34	NUM
iajs-17	137	37	]	]	PUNCT
iajs-17	137	38	.	.	PUNCT
iajs-17	138	1	the	the	DET
iajs-17	138	2	current	current	ADJ
iajs-17	138	3	study	study	NOUN
iajs-17	138	4	shown	show	VERB
iajs-17	138	5	a	a	DET
iajs-17	138	6	significant	significant	ADJ
iajs-17	138	7	decreasing	decreasing	NOUN
iajs-17	138	8	in	in	ADP
iajs-17	138	9	chromium	chromium	NOUN
iajs-17	138	10	concentration	concentration	NOUN
iajs-17	138	11	in	in	ADP
iajs-17	138	12	patient	patient	ADJ
iajs-17	138	13	group	group	NOUN
iajs-17	138	14	as	as	SCONJ
iajs-17	138	15	compared	compare	VERB
iajs-17	138	16	to	to	ADP
iajs-17	138	17	control	control	PROPN
iajs-17	138	18	group	group	NOUN
iajs-17	138	19	,	,	PUNCT
iajs-17	138	20	and	and	CCONJ
iajs-17	138	21	this	this	DET
iajs-17	138	22	lowering	lower	VERB
iajs-17	138	23	was	be	AUX
iajs-17	138	24	manifested	manifest	VERB
iajs-17	138	25	as	as	SCONJ
iajs-17	138	26	hba1c	hba1c	PROPN
iajs-17	138	27	increased	increase	VERB
iajs-17	138	28	(	(	PUNCT
iajs-17	138	29	table	table	NOUN
iajs-17	138	30	1	1	NUM
iajs-17	138	31	and	and	CCONJ
iajs-17	138	32	table	table	NOUN
iajs-17	138	33	2	2	NUM
iajs-17	138	34	)	)	PUNCT
iajs-17	138	35	.	.	PUNCT
iajs-17	139	1	cr	cr	PROPN
iajs-17	139	2	is	be	AUX
iajs-17	139	3	one	one	NUM
iajs-17	139	4	of	of	ADP
iajs-17	139	5	the	the	DET
iajs-17	139	6	essential	essential	ADJ
iajs-17	139	7	nutrients	nutrient	NOUN
iajs-17	139	8	whose	whose	DET
iajs-17	139	9	metabolism	metabolism	NOUN
iajs-17	139	10	changes	change	NOUN
iajs-17	139	11	during	during	ADP
iajs-17	139	12	dm	dm	PROPN
iajs-17	139	13	.	.	PUNCT
iajs-17	140	1	cr	cr	PROPN
iajs-17	140	2	is	be	AUX
iajs-17	140	3	a	a	DET
iajs-17	140	4	co	co	NOUN
iajs-17	140	5	-	-	NOUN
iajs-17	140	6	factor	factor	NOUN
iajs-17	140	7	in	in	ADP
iajs-17	140	8	the	the	DET
iajs-17	140	9	action	action	NOUN
iajs-17	140	10	of	of	ADP
iajs-17	140	11	insulin	insulin	NOUN
iajs-17	140	12	and	and	CCONJ
iajs-17	140	13	it	it	PRON
iajs-17	140	14	potentiates	potentiate	VERB
iajs-17	140	15	the	the	DET
iajs-17	140	16	insulin	insulin	NOUN
iajs-17	140	17	action	action	NOUN
iajs-17	140	18	.	.	PUNCT
iajs-17	141	1	as	as	SCONJ
iajs-17	141	2	such	such	ADJ
iajs-17	141	3	cr	cr	NOUN
iajs-17	141	4	may	may	AUX
iajs-17	141	5	improve	improve	VERB
iajs-17	141	6	blood	blood	NOUN
iajs-17	141	7	glucose	glucose	NOUN
iajs-17	141	8	concentrations	concentration	NOUN
iajs-17	141	9	in	in	ADP
iajs-17	141	10	individuals	individual	NOUN
iajs-17	141	11	with	with	ADP
iajs-17	141	12	a	a	DET
iajs-17	141	13	tendency	tendency	NOUN
iajs-17	141	14	towards	towards	ADP
iajs-17	141	15	blood	blood	NOUN
iajs-17	141	16	glucose	glucose	NOUN
iajs-17	141	17	fluctuations	fluctuation	NOUN
iajs-17	141	18	related	relate	VERB
iajs-17	141	19	with	with	ADP
iajs-17	141	20	dm	dm	PROPN
iajs-17	141	21	(	(	PUNCT
iajs-17	141	22	hyperglycaemia	hyperglycaemia	PROPN
iajs-17	141	23	)	)	PUNCT
iajs-17	141	24	.	.	PUNCT
iajs-17	142	1	thus	thus	ADV
iajs-17	142	2	,	,	PUNCT
iajs-17	142	3	it	it	PRON
iajs-17	142	4	may	may	AUX
iajs-17	142	5	not	not	PART
iajs-17	142	6	be	be	AUX
iajs-17	142	7	surprising	surprising	ADJ
iajs-17	142	8	to	to	PART
iajs-17	142	9	find	find	VERB
iajs-17	142	10	an	an	DET
iajs-17	142	11	inverse	inverse	NOUN
iajs-17	142	12	relationship	relationship	NOUN
iajs-17	142	13	between	between	ADP
iajs-17	142	14	serum	serum	NOUN
iajs-17	142	15	cr	cr	PROPN
iajs-17	142	16	and	and	CCONJ
iajs-17	142	17	blood	blood	NOUN
iajs-17	142	18	glucose	glucose	NOUN
iajs-17	142	19	control	control	NOUN
iajs-17	142	20	[	[	X
iajs-17	142	21	35	35	NUM
iajs-17	142	22	]	]	PUNCT
iajs-17	142	23	.	.	PUNCT
iajs-17	143	1	hyperglycaemia	hyperglycaemia	NOUN
iajs-17	143	2	and	and	CCONJ
iajs-17	143	3	high	high	ADJ
iajs-17	143	4	levels	level	NOUN
iajs-17	143	5	of	of	ADP
iajs-17	143	6	insulin	insulin	NOUN
iajs-17	143	7	increase	increase	NOUN
iajs-17	143	8	cr	cr	ADP
iajs-17	143	9	excretion	excretion	NOUN
iajs-17	143	10	,	,	PUNCT
iajs-17	143	11	so	so	ADV
iajs-17	143	12	low	low	ADJ
iajs-17	143	13	serum	serum	NOUN
iajs-17	143	14	concentration	concentration	NOUN
iajs-17	143	15	of	of	ADP
iajs-17	143	16	cr	cr	PRON
iajs-17	143	17	seen	see	VERB
iajs-17	143	18	in	in	ADP
iajs-17	143	19	the	the	DET
iajs-17	143	20	dm	dm	PROPN
iajs-17	143	21	patients	patient	NOUN
iajs-17	143	22	has	have	AUX
iajs-17	143	23	been	be	AUX
iajs-17	143	24	attributed	attribute	VERB
iajs-17	143	25	to	to	ADP
iajs-17	143	26	insulin	insulin	NOUN
iajs-17	143	27	resistance	resistance	NOUN
iajs-17	143	28	,	,	PUNCT
iajs-17	143	29	hyperglycaemia	hyperglycaemia	NOUN
iajs-17	143	30	and	and	CCONJ
iajs-17	143	31	osmotic	osmotic	ADJ
iajs-17	143	32	diuresis	diuresis	NOUN
iajs-17	143	33	resulte	resulte	PROPN
iajs-17	143	34	to	to	ADP
iajs-17	143	35	from	from	ADP
iajs-17	143	36	glycosuria	glycosuria	NOUN
iajs-17	143	37	,	,	PUNCT
iajs-17	143	38	which	which	PRON
iajs-17	143	39	increase	increase	VERB
iajs-17	143	40	urine	urine	NOUN
iajs-17	143	41	cr	cr	ADP
iajs-17	143	42	excretion	excretion	NOUN
iajs-17	143	43	.	.	PUNCT
iajs-17	144	1	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-17	144	2	and	and	CCONJ
iajs-17	144	3	insulin	insulin	NOUN
iajs-17	144	4	resistance	resistance	NOUN
iajs-17	144	5	may	may	AUX
iajs-17	144	6	be	be	AUX
iajs-17	144	7	associated	associate	VERB
iajs-17	144	8	with	with	ADP
iajs-17	144	9	a	a	DET
iajs-17	144	10	reduce	reduce	NOUN
iajs-17	144	11	in	in	ADP
iajs-17	144	12	insulin	insulin	NOUN
iajs-17	144	13	receptors	receptor	NOUN
iajs-17	144	14	,	,	PUNCT
iajs-17	144	15	reduced	reduce	VERB
iajs-17	144	16	insulin	insulin	NOUN
iajs-17	144	17	binding	bind	VERB
iajs-17	144	18	,	,	PUNCT
iajs-17	144	19	or	or	CCONJ
iajs-17	144	20	post	post	ADJ
iajs-17	144	21	-	-	ADJ
iajs-17	144	22	insulinreceptor	insulinreceptor	NOUN
iajs-17	144	23	signaling	signal	VERB
iajs-17	144	24	defects	defect	NOUN
iajs-17	144	25	[	[	X
iajs-17	144	26	36	36	NUM
iajs-17	144	27	]	]	PUNCT
iajs-17	144	28	.	.	PUNCT
iajs-17	145	1	mda	mda	PROPN
iajs-17	145	2	is	be	AUX
iajs-17	145	3	a	a	DET
iajs-17	145	4	highly	highly	ADV
iajs-17	145	5	toxic	toxic	ADJ
iajs-17	145	6	by	by	ADP
iajs-17	145	7	-	-	PUNCT
iajs-17	145	8	product	product	NOUN
iajs-17	145	9	formed	form	VERB
iajs-17	145	10	partly	partly	ADV
iajs-17	145	11	by	by	ADP
iajs-17	145	12	oxidation	oxidation	NOUN
iajs-17	145	13	derived	derive	VERB
iajs-17	145	14	from	from	ADP
iajs-17	145	15	free	free	ADJ
iajs-17	145	16	lipid	lipid	NOUN
iajs-17	145	17	radicals	radical	NOUN
iajs-17	145	18	,	,	PUNCT
iajs-17	145	19	and	and	CCONJ
iajs-17	145	20	studies	study	NOUN
iajs-17	145	21	shown	show	VERB
iajs-17	145	22	considerably	considerably	ADV
iajs-17	145	23	raised	raise	VERB
iajs-17	145	24	concentrations	concentration	NOUN
iajs-17	145	25	in	in	ADP
iajs-17	145	26	dm	dm	PROPN
iajs-17	145	27	.	.	PUNCT
iajs-17	146	1	mda	mda	PROPN
iajs-17	146	2	reacts	react	VERB
iajs-17	146	3	both	both	CCONJ
iajs-17	146	4	irreversibly	irreversibly	ADV
iajs-17	146	5	and	and	CCONJ
iajs-17	146	6	reversibly	reversibly	ADV
iajs-17	146	7	with	with	ADP
iajs-17	146	8	proteins	protein	NOUN
iajs-17	146	9	and	and	CCONJ
iajs-17	146	10	phospholipids	phospholipid	NOUN
iajs-17	146	11	with	with	ADP
iajs-17	146	12	profound	profound	ADJ
iajs-17	146	13	effects	effect	NOUN
iajs-17	146	14	[	[	X
iajs-17	146	15	37	37	NUM
iajs-17	146	16	]	]	PUNCT
iajs-17	146	17	.	.	PUNCT
iajs-17	147	1	in	in	ADP
iajs-17	147	2	this	this	DET
iajs-17	147	3	study	study	NOUN
iajs-17	147	4	we	we	PRON
iajs-17	147	5	have	have	AUX
iajs-17	147	6	observed	observe	VERB
iajs-17	147	7	that	that	SCONJ
iajs-17	147	8	mda	mda	PROPN
iajs-17	147	9	levels	level	NOUN
iajs-17	147	10	as	as	ADP
iajs-17	147	11	a	a	DET
iajs-17	147	12	lipid	lipid	NOUN
iajs-17	147	13	peroxidation	peroxidation	NOUN
iajs-17	147	14	product	product	NOUN
iajs-17	147	15	and	and	CCONJ
iajs-17	147	16	a	a	DET
iajs-17	147	17	marker	marker	NOUN
iajs-17	147	18	of	of	ADP
iajs-17	147	19	oxidative	oxidative	ADJ
iajs-17	147	20	stress	stress	NOUN
iajs-17	147	21	,	,	PUNCT
iajs-17	147	22	was	be	AUX
iajs-17	147	23	highly	highly	ADV
iajs-17	147	24	statistically	statistically	ADV
iajs-17	147	25	significant	significant	ADJ
iajs-17	147	26	increase	increase	NOUN
iajs-17	147	27	in	in	ADP
iajs-17	147	28	between	between	ADP
iajs-17	147	29	group	group	NOUN
iajs-17	147	30	p	p	PROPN
iajs-17	147	31	and	and	CCONJ
iajs-17	147	32	control	control	PROPN
iajs-17	147	33	group	group	NOUN
iajs-17	147	34	(	(	PUNCT
iajs-17	147	35	c	c	NOUN
iajs-17	147	36	)	)	PUNCT
iajs-17	147	37	table	table	NOUN
iajs-17	147	38	(	(	PUNCT
iajs-17	147	39	1	1	NUM
iajs-17	147	40	)	)	PUNCT
iajs-17	147	41	,	,	PUNCT
iajs-17	147	42	these	these	DET
iajs-17	147	43	results	result	NOUN
iajs-17	147	44	are	be	AUX
iajs-17	147	45	in	in	ADP
iajs-17	147	46	agreement	agreement	NOUN
iajs-17	147	47	with	with	ADP
iajs-17	147	48	the	the	DET
iajs-17	147	49	findings	finding	NOUN
iajs-17	147	50	of	of	ADP
iajs-17	147	51	mahreen	mahreen	PROPN
iajs-17	147	52	et	et	PROPN
iajs-17	147	53	al	al	PROPN
iajs-17	147	54	,	,	PUNCT
iajs-17	147	55	2010	2010	NUM
iajs-17	147	56	and	and	CCONJ
iajs-17	147	57	a.	a.	NOUN
iajs-17	147	58	z.	z.	PROPN
iajs-17	147	59	hassan	hassan	PROPN
iajs-17	147	60	,	,	PUNCT
iajs-17	147	61	2011[38	2011[38	NUM
iajs-17	147	62	and	and	CCONJ
iajs-17	147	63	39	39	NUM
iajs-17	147	64	]	]	PUNCT
iajs-17	147	65	.	.	PUNCT
iajs-17	148	1	the	the	DET
iajs-17	148	2	most	most	ADV
iajs-17	148	3	probable	probable	ADJ
iajs-17	148	4	causes	cause	NOUN
iajs-17	148	5	for	for	ADP
iajs-17	148	6	the	the	DET
iajs-17	148	7	increased	increase	VERB
iajs-17	148	8	mda	mda	PROPN
iajs-17	148	9	levels	level	NOUN
iajs-17	148	10	in	in	ADP
iajs-17	148	11	serum	serum	NOUN
iajs-17	148	12	of	of	ADP
iajs-17	148	13	diabetic	diabetic	ADJ
iajs-17	148	14	groups	group	NOUN
iajs-17	148	15	may	may	AUX
iajs-17	148	16	be	be	AUX
iajs-17	148	17	due	due	ADJ
iajs-17	148	18	to	to	ADP
iajs-17	148	19	the	the	DET
iajs-17	148	20	abnormal	abnormal	ADJ
iajs-17	148	21	lipid	lipid	NOUN
iajs-17	148	22	metabolism	metabolism	NOUN
iajs-17	148	23	.	.	PUNCT
iajs-17	149	1	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-17	149	2	and	and	CCONJ
iajs-17	149	3	hyperglycemia	hyperglycemia	NOUN
iajs-17	149	4	may	may	AUX
iajs-17	149	5	enhance	enhance	VERB
iajs-17	149	6	the	the	DET
iajs-17	149	7	production	production	NOUN
iajs-17	149	8	of	of	ADP
iajs-17	149	9	free	free	ADJ
iajs-17	149	10	radicals	radical	NOUN
iajs-17	149	11	such	such	ADJ
iajs-17	149	12	as	as	ADP
iajs-17	149	13	mda	mda	NOUN
iajs-17	149	14	and	and	CCONJ
iajs-17	149	15	induce	induce	VERB
iajs-17	149	16	oxidative	oxidative	ADJ
iajs-17	149	17	stress	stress	NOUN
iajs-17	149	18	that	that	PRON
iajs-17	149	19	may	may	AUX
iajs-17	149	20	also	also	ADV
iajs-17	149	21	contribute	contribute	VERB
iajs-17	149	22	to	to	ADP
iajs-17	149	23	increased	increase	VERB
iajs-17	149	24	risk	risk	NOUN
iajs-17	149	25	for	for	ADP
iajs-17	149	26	coronary	coronary	ADJ
iajs-17	149	27	artery	artery	NOUN
iajs-17	149	28	disease	disease	NOUN
iajs-17	149	29	in	in	ADP
iajs-17	149	30	diabetes	diabetes	NOUN
iajs-17	149	31	[	[	X
iajs-17	149	32	40	40	NUM
iajs-17	149	33	]	]	PUNCT
iajs-17	149	34	.	.	PUNCT
iajs-17	150	1	hyperglycemia	hyperglycemia	NOUN
iajs-17	150	2	can	can	AUX
iajs-17	150	3	induce	induce	VERB
iajs-17	150	4	oxidative	oxidative	ADJ
iajs-17	150	5	stress	stress	NOUN
iajs-17	150	6	by	by	ADP
iajs-17	150	7	several	several	ADJ
iajs-17	150	8	different	different	ADJ
iajs-17	150	9	mechanisms	mechanism	NOUN
iajs-17	150	10	.	.	PUNCT
iajs-17	151	1	autooxidation	autooxidation	NOUN
iajs-17	151	2	of	of	ADP
iajs-17	151	3	glucose	glucose	NOUN
iajs-17	151	4	and	and	CCONJ
iajs-17	151	5	the	the	DET
iajs-17	151	6	non	non	ADJ
iajs-17	151	7	enzymatic	enzymatic	ADJ
iajs-17	151	8	glycation	glycation	NOUN
iajs-17	151	9	of	of	ADP
iajs-17	151	10	proteins	protein	NOUN
iajs-17	151	11	generate	generate	VERB
iajs-17	151	12	superoxide	superoxide	NOUN
iajs-17	151	13	(	(	PUNCT
iajs-17	151	14	.	.	PUNCT
iajs-17	152	1	o2¯	o2¯	X
iajs-17	152	2	)	)	PUNCT
iajs-17	153	1	[	[	X
iajs-17	153	2	41	41	NUM
iajs-17	153	3	]	]	PUNCT
iajs-17	153	4	.	.	PUNCT
iajs-17	154	1	comparative	comparative	ADJ
iajs-17	154	2	evaluation	evaluation	NOUN
iajs-17	154	3	of	of	ADP
iajs-17	154	4	the	the	DET
iajs-17	154	5	serum	serum	NOUN
iajs-17	154	6	levels	level	NOUN
iajs-17	154	7	of	of	ADP
iajs-17	154	8	mda	mda	PROPN
iajs-17	154	9	was	be	AUX
iajs-17	154	10	done	do	VERB
iajs-17	154	11	in	in	ADP
iajs-17	154	12	patients	patient	NOUN
iajs-17	154	13	of	of	ADP
iajs-17	154	14	diabetes	diabetes	NOUN
iajs-17	154	15	mellitus	mellitus	NOUN
iajs-17	154	16	chemistry	chemistry	NOUN
iajs-17	154	17	|	|	ADV
iajs-17	154	18	139	139	NUM
iajs-17	154	19	2016	2016	NUM
iajs-17	154	20	(	(	PUNCT
iajs-17	154	21	عاً	عاً	PROPN
iajs-17	154	22	3اىعذد	3اىعذد	NUM
iajs-17	154	23	)	)	PUNCT
iajs-17	154	24	29اىَديذ	29اىَديذ	NUM
iajs-17	154	25	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	154	26	ٍديت	ٍديت	VERB
iajs-17	154	27	إبِ	إبِ	X
iajs-17	154	28	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	154	29	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	154	30	اىصشفت	اىصشفت	VERB
iajs-17	154	31	ibn	ibn	PROPN
iajs-17	154	32	al	al	PROPN
iajs-17	154	33	-	-	PUNCT
iajs-17	154	34	haitham	haitham	PROPN
iajs-17	154	35	jour	jour	X
iajs-17	154	36	.	.	PROPN
iajs-17	155	1	for	for	ADP
iajs-17	155	2	pure	pure	ADJ
iajs-17	155	3	&	&	CCONJ
iajs-17	155	4	appl	appl	PROPN
iajs-17	155	5	.	.	PUNCT
iajs-17	156	1	sci	sci	PROPN
iajs-17	156	2	.	.	PUNCT
iajs-17	156	3	vol	vol	NOUN
iajs-17	156	4	.	.	PROPN
iajs-17	156	5	29	29	NUM
iajs-17	156	6	(	(	PUNCT
iajs-17	156	7	3	3	NUM
iajs-17	156	8	)	)	PUNCT
iajs-17	156	9	2016	2016	NUM
iajs-17	156	10	with	with	ADP
iajs-17	156	11	and	and	CCONJ
iajs-17	156	12	without	without	ADP
iajs-17	156	13	complications	complication	NOUN
iajs-17	156	14	by	by	ADP
iajs-17	156	15	b.mandal	b.mandal	NOUN
iajs-17	156	16	,	,	PUNCT
iajs-17	156	17	et	et	PROPN
iajs-17	156	18	al	al	PROPN
iajs-17	156	19	,	,	PUNCT
iajs-17	156	20	2010	2010	NUM
iajs-17	156	21	.	.	PUNCT
iajs-17	157	1	it	it	PRON
iajs-17	157	2	was	be	AUX
iajs-17	157	3	highly	highly	ADV
iajs-17	157	4	significant	significant	ADJ
iajs-17	157	5	increase	increase	NOUN
iajs-17	157	6	in	in	ADP
iajs-17	157	7	cases	case	NOUN
iajs-17	157	8	of	of	ADP
iajs-17	157	9	dm	dm	NUM
iajs-17	157	10	with	with	ADP
iajs-17	157	11	complications	complication	NOUN
iajs-17	157	12	in	in	ADP
iajs-17	157	13	comparison	comparison	NOUN
iajs-17	157	14	to	to	ADP
iajs-17	157	15	cases	case	NOUN
iajs-17	157	16	of	of	ADP
iajs-17	157	17	diabetes	diabetes	NOUN
iajs-17	157	18	mellitus	mellitus	NOUN
iajs-17	157	19	without	without	SCONJ
iajs-17	157	20	complications	complication	NOUN
iajs-17	157	21	indicate	indicate	VERB
iajs-17	157	22	more	more	ADJ
iajs-17	157	23	association	association	NOUN
iajs-17	157	24	of	of	ADP
iajs-17	157	25	oxidative	oxidative	ADJ
iajs-17	157	26	stress	stress	NOUN
iajs-17	157	27	with	with	ADP
iajs-17	157	28	diabetic	diabetic	ADJ
iajs-17	157	29	complications	complication	NOUN
iajs-17	157	30	[	[	X
iajs-17	157	31	42	42	NUM
iajs-17	157	32	]	]	PUNCT
iajs-17	157	33	.	.	PUNCT
iajs-17	158	1	free	free	ADJ
iajs-17	158	2	radical	radical	ADJ
iajs-17	158	3	interacts	interact	VERB
iajs-17	158	4	in	in	ADP
iajs-17	158	5	archidonic	archidonic	ADJ
iajs-17	158	6	acid	acid	NOUN
iajs-17	158	7	metabolism	metabolism	NOUN
iajs-17	158	8	forming	form	VERB
iajs-17	158	9	a	a	DET
iajs-17	158	10	toxic	toxic	ADJ
iajs-17	158	11	endoperoxidase	endoperoxidase	NOUN
iajs-17	158	12	.	.	PUNCT
iajs-17	159	1	the	the	DET
iajs-17	159	2	lipid	lipid	NOUN
iajs-17	159	3	peroxide	peroxide	NOUN
iajs-17	159	4	thus	thus	ADV
iajs-17	159	5	formed	form	VERB
iajs-17	159	6	stimulates	stimulate	VERB
iajs-17	159	7	the	the	DET
iajs-17	159	8	synthesis	synthesis	NOUN
iajs-17	159	9	of	of	ADP
iajs-17	159	10	cyclooxygenase	cyclooxygenase	NOUN
iajs-17	159	11	,	,	PUNCT
iajs-17	159	12	prostaglandin	prostaglandin	NOUN
iajs-17	159	13	and	and	CCONJ
iajs-17	159	14	thromboxane	thromboxane	NOUN
iajs-17	159	15	which	which	PRON
iajs-17	159	16	in	in	ADP
iajs-17	159	17	turn	turn	NOUN
iajs-17	159	18	causes	cause	VERB
iajs-17	159	19	increased	increase	VERB
iajs-17	159	20	platelets	platelet	NOUN
iajs-17	159	21	aggregation	aggregation	NOUN
iajs-17	159	22	leading	lead	VERB
iajs-17	159	23	to	to	ADP
iajs-17	159	24	vascular	vascular	ADJ
iajs-17	159	25	complications	complication	NOUN
iajs-17	159	26	[	[	X
iajs-17	159	27	43	43	NUM
iajs-17	159	28	]	]	PUNCT
iajs-17	159	29	.	.	PUNCT
iajs-17	160	1	ec	ec	PROPN
iajs-17	160	2	-	-	PUNCT
iajs-17	160	3	sod	sod	NOUN
iajs-17	160	4	is	be	AUX
iajs-17	160	5	a	a	DET
iajs-17	160	6	secretory	secretory	ADJ
iajs-17	160	7	glycoprotein	glycoprotein	NOUN
iajs-17	160	8	located	locate	VERB
iajs-17	160	9	in	in	ADP
iajs-17	160	10	blood	blood	NOUN
iajs-17	160	11	vessel	vessel	NOUN
iajs-17	160	12	walls	wall	NOUN
iajs-17	160	13	at	at	ADP
iajs-17	160	14	high	high	ADJ
iajs-17	160	15	levels	level	NOUN
iajs-17	160	16	and	and	CCONJ
iajs-17	160	17	may	may	AUX
iajs-17	160	18	be	be	AUX
iajs-17	160	19	important	important	ADJ
iajs-17	160	20	in	in	ADP
iajs-17	160	21	the	the	DET
iajs-17	160	22	antioxidant	antioxidant	ADJ
iajs-17	160	23	capability	capability	NOUN
iajs-17	160	24	of	of	ADP
iajs-17	160	25	vascular	vascular	ADJ
iajs-17	160	26	walls	wall	NOUN
iajs-17	160	27	[	[	X
iajs-17	160	28	12	12	NUM
iajs-17	160	29	]	]	PUNCT
iajs-17	160	30	.	.	PUNCT
iajs-17	161	1	ec	ec	PROPN
iajs-17	161	2	-	-	PUNCT
iajs-17	161	3	sod	sod	NOUN
iajs-17	161	4	with	with	ADP
iajs-17	161	5	an	an	DET
iajs-17	161	6	affinity	affinity	NOUN
iajs-17	161	7	for	for	ADP
iajs-17	161	8	heparan	heparan	NOUN
iajs-17	161	9	-	-	PUNCT
iajs-17	161	10	like	like	ADJ
iajs-17	161	11	substances	substance	NOUN
iajs-17	161	12	,	,	PUNCT
iajs-17	161	13	and	and	CCONJ
iajs-17	161	14	it	it	PRON
iajs-17	161	15	is	be	AUX
iajs-17	161	16	the	the	DET
iajs-17	161	17	principal	principal	ADJ
iajs-17	161	18	enzymatic	enzymatic	ADJ
iajs-17	161	19	scavenger	scavenger	NOUN
iajs-17	161	20	of	of	ADP
iajs-17	161	21	superoxide	superoxide	NOUN
iajs-17	161	22	in	in	ADP
iajs-17	161	23	the	the	DET
iajs-17	161	24	extracellular	extracellular	ADJ
iajs-17	161	25	space	space	NOUN
iajs-17	162	1	[	[	X
iajs-17	162	2	44	44	NUM
iajs-17	162	3	]	]	PUNCT
iajs-17	162	4	.	.	PUNCT
iajs-17	163	1	the	the	DET
iajs-17	163	2	vascular	vascular	ADJ
iajs-17	163	3	wall	wall	NOUN
iajs-17	163	4	contains	contain	VERB
iajs-17	163	5	abundant	abundant	ADJ
iajs-17	163	6	amounts	amount	NOUN
iajs-17	163	7	of	of	ADP
iajs-17	163	8	ec	ec	NOUN
iajs-17	163	9	-	-	PUNCT
iajs-17	163	10	sod	sod	NOUN
iajs-17	163	11	,	,	PUNCT
iajs-17	163	12	one	one	NUM
iajs-17	163	13	of	of	ADP
iajs-17	163	14	the	the	DET
iajs-17	163	15	sod	sod	NOUN
iajs-17	163	16	isozymes	isozyme	NOUN
iajs-17	163	17	produced	produce	VERB
iajs-17	163	18	and	and	CCONJ
iajs-17	163	19	secreted	secrete	VERB
iajs-17	163	20	to	to	ADP
iajs-17	163	21	the	the	DET
iajs-17	163	22	extracellular	extracellular	ADJ
iajs-17	163	23	space	space	NOUN
iajs-17	163	24	by	by	ADP
iajs-17	163	25	fibroblasts	fibroblast	NOUN
iajs-17	163	26	and	and	CCONJ
iajs-17	163	27	smooth	smooth	ADJ
iajs-17	163	28	muscle	muscle	NOUN
iajs-17	163	29	cells	cell	NOUN
iajs-17	163	30	[	[	X
iajs-17	163	31	45	45	NUM
iajs-17	163	32	]	]	PUNCT
iajs-17	163	33	.	.	PUNCT
iajs-17	164	1	in	in	ADP
iajs-17	164	2	current	current	ADJ
iajs-17	164	3	study	study	NOUN
iajs-17	164	4	ec	ec	PROPN
iajs-17	164	5	-	-	PUNCT
iajs-17	164	6	sod	sod	NOUN
iajs-17	164	7	showed	show	VERB
iajs-17	164	8	a	a	DET
iajs-17	164	9	highly	highly	ADV
iajs-17	164	10	significant	significant	ADJ
iajs-17	164	11	decrease	decrease	NOUN
iajs-17	164	12	in	in	ADP
iajs-17	164	13	t2	t2	NOUN
iajs-17	164	14	dm	dm	PROPN
iajs-17	164	15	as	as	SCONJ
iajs-17	164	16	compared	compare	VERB
iajs-17	164	17	to	to	ADP
iajs-17	164	18	healthy	healthy	ADJ
iajs-17	164	19	subjects	subject	NOUN
iajs-17	164	20	,	,	PUNCT
iajs-17	164	21	and	and	CCONJ
iajs-17	164	22	this	this	DET
iajs-17	164	23	decrease	decrease	NOUN
iajs-17	164	24	was	be	AUX
iajs-17	164	25	intensified	intensify	VERB
iajs-17	164	26	as	as	SCONJ
iajs-17	164	27	hba1c	hba1c	PROPN
iajs-17	164	28	increased	increase	VERB
iajs-17	164	29	(	(	PUNCT
iajs-17	164	30	table	table	NOUN
iajs-17	164	31	3	3	NUM
iajs-17	164	32	)	)	PUNCT
iajs-17	164	33	.	.	PUNCT
iajs-17	165	1	as	as	SCONJ
iajs-17	165	2	shown	show	VERB
iajs-17	165	3	in	in	ADP
iajs-17	165	4	table	table	NOUN
iajs-17	165	5	4	4	NUM
iajs-17	165	6	,	,	PUNCT
iajs-17	165	7	mda	mda	PROPN
iajs-17	165	8	in	in	ADP
iajs-17	165	9	group	group	NOUN
iajs-17	165	10	p1	p1	PROPN
iajs-17	165	11	and	and	CCONJ
iajs-17	165	12	group	group	NOUN
iajs-17	165	13	p2	p2	PROPN
iajs-17	165	14	showed	show	VERB
iajs-17	165	15	a	a	DET
iajs-17	165	16	significant	significant	ADJ
iajs-17	165	17	positive	positive	ADJ
iajs-17	165	18	correlation	correlation	NOUN
iajs-17	165	19	with	with	ADP
iajs-17	165	20	age	age	NOUN
iajs-17	165	21	(	(	PUNCT
iajs-17	165	22	table	table	NOUN
iajs-17	165	23	4	4	NUM
iajs-17	165	24	,	,	PUNCT
iajs-17	165	25	figure	figure	NOUN
iajs-17	165	26	1	1	NUM
iajs-17	165	27	and	and	CCONJ
iajs-17	165	28	figure	figure	VERB
iajs-17	165	29	2	2	NUM
iajs-17	165	30	)	)	PUNCT
iajs-17	165	31	.	.	PUNCT
iajs-17	166	1	in	in	ADP
iajs-17	166	2	group	group	PROPN
iajs-17	166	3	p3	p3	PROPN
iajs-17	166	4	,	,	PUNCT
iajs-17	166	5	mda	mda	PROPN
iajs-17	166	6	showed	show	VERB
iajs-17	166	7	a	a	DET
iajs-17	166	8	significant	significant	ADJ
iajs-17	166	9	negative	negative	ADJ
iajs-17	166	10	correlation	correlation	NOUN
iajs-17	166	11	with	with	ADP
iajs-17	166	12	serum	serum	NOUN
iajs-17	166	13	cr	cr	PROPN
iajs-17	166	14	level	level	NOUN
iajs-17	166	15	,	,	PUNCT
iajs-17	166	16	while	while	SCONJ
iajs-17	166	17	a	a	DET
iajs-17	166	18	significant	significant	ADJ
iajs-17	166	19	positive	positive	ADJ
iajs-17	166	20	correlation	correlation	NOUN
iajs-17	166	21	was	be	AUX
iajs-17	166	22	observed	observe	VERB
iajs-17	166	23	with	with	ADP
iajs-17	166	24	age	age	NOUN
iajs-17	166	25	,	,	PUNCT
iajs-17	166	26	duration	duration	NOUN
iajs-17	166	27	of	of	ADP
iajs-17	166	28	dm	dm	PROPN
iajs-17	166	29	,	,	PUNCT
iajs-17	166	30	and	and	CCONJ
iajs-17	166	31	hba1c	hba1c	PROPN
iajs-17	166	32	(	(	PUNCT
iajs-17	166	33	table	table	NOUN
iajs-17	166	34	4	4	NUM
iajs-17	166	35	and	and	CCONJ
iajs-17	166	36	figure	figure	VERB
iajs-17	166	37	3	3	NUM
iajs-17	166	38	)	)	PUNCT
iajs-17	166	39	.	.	PUNCT
iajs-17	167	1	conclusions	conclusion	NOUN
iajs-17	167	2	based	base	VERB
iajs-17	167	3	on	on	ADP
iajs-17	167	4	the	the	DET
iajs-17	167	5	findings	finding	NOUN
iajs-17	167	6	of	of	ADP
iajs-17	167	7	the	the	DET
iajs-17	167	8	present	present	ADJ
iajs-17	167	9	study	study	NOUN
iajs-17	167	10	,	,	PUNCT
iajs-17	167	11	it	it	PRON
iajs-17	167	12	is	be	AUX
iajs-17	167	13	possible	possible	ADJ
iajs-17	167	14	to	to	PART
iajs-17	167	15	reach	reach	VERB
iajs-17	167	16	the	the	DET
iajs-17	167	17	following	follow	VERB
iajs-17	167	18	most	most	ADV
iajs-17	167	19	important	important	ADJ
iajs-17	167	20	conclusions	conclusion	NOUN
iajs-17	167	21	:	:	PUNCT
iajs-17	167	22			PROPN
iajs-17	167	23	t2	t2	PROPN
iajs-17	167	24	dm	dm	AUX
iajs-17	167	25	have	have	VERB
iajs-17	167	26	a	a	DET
iajs-17	167	27	risk	risk	NOUN
iajs-17	167	28	of	of	ADP
iajs-17	167	29	oxidative	oxidative	ADJ
iajs-17	167	30	stress	stress	NOUN
iajs-17	167	31	due	due	ADP
iajs-17	167	32	to	to	ADP
iajs-17	167	33	increasing	increase	VERB
iajs-17	167	34	the	the	DET
iajs-17	167	35	level	level	NOUN
iajs-17	167	36	of	of	ADP
iajs-17	167	37	serum	serum	NOUN
iajs-17	167	38	mda	mda	PROPN
iajs-17	167	39	and	and	CCONJ
iajs-17	167	40	decreasing	decrease	VERB
iajs-17	167	41	extracellular	extracellular	ADJ
iajs-17	167	42	superoxide	superoxide	NOUN
iajs-17	167	43	dismutase	dismutase	NOUN
iajs-17	167	44	activity	activity	NOUN
iajs-17	167	45	.	.	PUNCT
iajs-17	168	1			NOUN
iajs-17	168	2	the	the	DET
iajs-17	168	3	hba1c	hba1c	PROPN
iajs-17	168	4	value	value	NOUN
iajs-17	168	5	between	between	ADP
iajs-17	168	6	7	7	NUM
iajs-17	168	7	to	to	PART
iajs-17	168	8	8	8	NUM
iajs-17	168	9	%	%	NOUN
iajs-17	168	10	can	can	AUX
iajs-17	168	11	not	not	PART
iajs-17	168	12	be	be	AUX
iajs-17	168	13	considered	consider	VERB
iajs-17	168	14	as	as	ADP
iajs-17	168	15	an	an	DET
iajs-17	168	16	acceptable	acceptable	ADJ
iajs-17	168	17	hba1c	hba1c	NOUN
iajs-17	168	18	value	value	NOUN
iajs-17	168	19	,	,	PUNCT
iajs-17	168	20	due	due	ADJ
iajs-17	168	21	the	the	DET
iajs-17	168	22	severing	severing	NOUN
iajs-17	168	23	of	of	ADP
iajs-17	168	24	oxidative	oxidative	ADJ
iajs-17	168	25	stress	stress	NOUN
iajs-17	168	26	rising	rise	VERB
iajs-17	168	27	manifested	manifest	VERB
iajs-17	168	28	clearly	clearly	ADV
iajs-17	168	29	in	in	ADP
iajs-17	168	30	this	this	DET
iajs-17	168	31	patients	patient	NOUN
iajs-17	168	32	group	group	NOUN
iajs-17	168	33	.	.	PUNCT
iajs-17	169	1	references	reference	NOUN
iajs-17	169	2	1	1	NUM
iajs-17	169	3	.	.	PUNCT
iajs-17	169	4	njolstad	njolstad	PROPN
iajs-17	169	5	,	,	PUNCT
iajs-17	169	6	pr	pr	NOUN
iajs-17	169	7	.	.	PUNCT
iajs-17	169	8	;	;	PUNCT
iajs-17	169	9	sagen	sagen	PROPN
iajs-17	169	10	,	,	PUNCT
iajs-17	169	11	jv	jv	PROPN
iajs-17	169	12	.	.	PUNCT
iajs-17	169	13	;	;	PUNCT
iajs-17	169	14	bjorkhaug	bjorkhaug	NOUN
iajs-17	169	15	,	,	PUNCT
iajs-17	169	16	l.	l.	PROPN
iajs-17	169	17	;	;	PUNCT
iajs-17	169	18	odili	odili	NOUN
iajs-17	169	19	,	,	PUNCT
iajs-17	169	20	s.	s.	PROPN
iajs-17	169	21	;	;	PUNCT
iajs-17	169	22	shehadeh	shehadeh	PROPN
iajs-17	169	23	,	,	PUNCT
iajs-17	169	24	n.	n.	NOUN
iajs-17	169	25	;	;	PUNCT
iajs-17	169	26	bakry	bakry	PROPN
iajs-17	169	27	,	,	PUNCT
iajs-17	169	28	d.	d.	PROPN
iajs-17	169	29	;	;	PUNCT
iajs-17	169	30	sarici	sarici	PROPN
iajs-17	169	31	,	,	PUNCT
iajs-17	169	32	s.	s.	PROPN
iajs-17	169	33	u.	u.	PROPN
iajs-17	169	34	;	;	PUNCT
iajs-17	169	35	alpay	alpay	PROPN
iajs-17	169	36	,	,	PUNCT
iajs-17	169	37	f.	f.	PROPN
iajs-17	169	38	;	;	PUNCT
iajs-17	169	39	molnes	molnes	PROPN
iajs-17	169	40	,	,	PUNCT
iajs-17	169	41	j.	j.	PROPN
iajs-17	169	42	,	,	PUNCT
iajs-17	169	43	;	;	PUNCT
iajs-17	169	44	molven	molven	NOUN
iajs-17	169	45	,	,	PUNCT
iajs-17	169	46	a.	a.	NOUN
iajs-17	169	47	sovik	sovik	NOUN
iajs-17	169	48	,	,	PUNCT
iajs-17	169	49	o.	o.	NOUN
iajs-17	169	50	and	and	CCONJ
iajs-17	169	51	matschinsky	matschinsky	PROPN
iajs-17	169	52	,	,	PUNCT
iajs-17	169	53	f.	f.	PROPN
iajs-17	169	54	m.(2003	m.(2003	PROPN
iajs-17	169	55	)	)	PUNCT
iajs-17	169	56	permanent	permanent	ADJ
iajs-17	169	57	neonatal	neonatal	ADJ
iajs-17	169	58	diabetes	diabetes	NOUN
iajs-17	169	59	caused	cause	VERB
iajs-17	169	60	by	by	ADP
iajs-17	169	61	glucokinase	glucokinase	NOUN
iajs-17	169	62	deficiency	deficiency	NOUN
iajs-17	169	63	:	:	PUNCT
iajs-17	169	64	inborn	inborn	ADJ
iajs-17	169	65	error	error	NOUN
iajs-17	169	66	of	of	ADP
iajs-17	169	67	the	the	DET
iajs-17	169	68	glucose	glucose	NOUN
iajs-17	169	69	-	-	PUNCT
iajs-17	169	70	insulin	insulin	NOUN
iajs-17	169	71	signaling	signal	VERB
iajs-17	169	72	pathway	pathway	NOUN
iajs-17	169	73	.	.	PUNCT
iajs-17	170	1	diabetes	diabetes	NOUN
iajs-17	170	2	.	.	PUNCT
iajs-17	171	1	52(11):2854	52(11):2854	NUM
iajs-17	171	2	-	-	SYM
iajs-17	171	3	60	60	NUM
iajs-17	171	4	.	.	PUNCT
iajs-17	172	1	2	2	NUM
iajs-17	172	2	.	.	X
iajs-17	172	3	piero	piero	PROPN
iajs-17	172	4	,	,	PUNCT
iajs-17	172	5	mn	mn	PROPN
iajs-17	172	6	.	.	PROPN
iajs-17	172	7	(	(	PUNCT
iajs-17	172	8	2006	2006	NUM
iajs-17	172	9	)	)	PUNCT
iajs-17	173	1	"	"	PUNCT
iajs-17	173	2	hypoglycemic	hypoglycemic	ADJ
iajs-17	173	3	effects	effect	NOUN
iajs-17	173	4	of	of	ADP
iajs-17	173	5	some	some	DET
iajs-17	173	6	kenyan	kenyan	ADJ
iajs-17	173	7	plants	plant	NOUN
iajs-17	173	8	traditionally	traditionally	ADV
iajs-17	173	9	used	use	VERB
iajs-17	173	10	in	in	ADP
iajs-17	173	11	management	management	NOUN
iajs-17	173	12	of	of	ADP
iajs-17	173	13	diabetes	diabetes	NOUN
iajs-17	173	14	mellitus	mellitus	NOUN
iajs-17	173	15	in	in	ADP
iajs-17	173	16	eastern	eastern	PROPN
iajs-17	173	17	province	province	NOUN
iajs-17	173	18	"	"	PUNCT
iajs-17	173	19	,	,	PUNCT
iajs-17	173	20	msc	msc	PROPN
iajs-17	173	21	thesis	thesis	PROPN
iajs-17	173	22	,	,	PUNCT
iajs-17	173	23	kenyatta	kenyatta	PROPN
iajs-17	173	24	university	university	PROPN
iajs-17	173	25	.	.	PUNCT
iajs-17	174	1	3	3	X
iajs-17	174	2	.	.	X
iajs-17	174	3	american	american	ADJ
iajs-17	174	4	diabetes	diabetes	PROPN
iajs-17	174	5	association(2010	association(2010	PROPN
iajs-17	174	6	)	)	PUNCT
iajs-17	174	7	,	,	PUNCT
iajs-17	174	8	diabetes	diabetes	NOUN
iajs-17	174	9	care	care	NOUN
iajs-17	174	10	,	,	PUNCT
iajs-17	174	11	supplement	supplement	VERB
iajs-17	174	12	1	1	NUM
iajs-17	174	13	,	,	PUNCT
iajs-17	174	14	33	33	NUM
iajs-17	174	15	.	.	NOUN
iajs-17	175	1	4	4	NUM
iajs-17	175	2	.	.	NOUN
iajs-17	175	3	barry	barry	PROPN
iajs-17	175	4	halliwell	halliwell	PROPN
iajs-17	175	5	.	.	PUNCT
iajs-17	176	1	(	(	PUNCT
iajs-17	176	2	2001	2001	NUM
iajs-17	176	3	)	)	PUNCT
iajs-17	176	4	.	.	PUNCT
iajs-17	177	1	free	free	ADJ
iajs-17	177	2	radicals	radical	NOUN
iajs-17	177	3	and	and	CCONJ
iajs-17	177	4	other	other	ADJ
iajs-17	177	5	reactive	reactive	ADJ
iajs-17	177	6	species	specie	NOUN
iajs-17	177	7	in	in	ADP
iajs-17	177	8	disease‖	disease‖	PROPN
iajs-17	177	9	encyclopedia	encyclopedia	NOUN
iajs-17	177	10	of	of	ADP
iajs-17	177	11	life	life	NOUN
iajs-17	177	12	sciences	sciences	PROPN
iajs-17	177	13	/	/	SYM
iajs-17	177	14	&	&	CCONJ
iajs-17	177	15	nature	nature	PROPN
iajs-17	177	16	publishing	publishing	NOUN
iajs-17	177	17	group	group	NOUN
iajs-17	177	18	.	.	PUNCT
iajs-17	178	1	5	5	X
iajs-17	178	2	.	.	X
iajs-17	178	3	helen	helen	PROPN
iajs-17	178	4	wiseman	wiseman	PROPN
iajs-17	178	5	and	and	CCONJ
iajs-17	178	6	barry	barry	PROPN
iajs-17	178	7	halliwell	halliwell	PROPN
iajs-17	178	8	(	(	PUNCT
iajs-17	178	9	1996	1996	NUM
iajs-17	178	10	)	)	PUNCT
iajs-17	178	11	,	,	PUNCT
iajs-17	178	12	review	review	NOUN
iajs-17	178	13	article	article	NOUN
iajs-17	178	14	.	.	PUNCT
iajs-17	179	1	damage	damage	NOUN
iajs-17	179	2	to	to	ADP
iajs-17	179	3	dna	dna	NOUN
iajs-17	179	4	by	by	ADP
iajs-17	179	5	reactive	reactive	ADJ
iajs-17	179	6	oxygen	oxygen	NOUN
iajs-17	179	7	and	and	CCONJ
iajs-17	179	8	nitrogen	nitrogen	NOUN
iajs-17	179	9	species	specie	NOUN
iajs-17	179	10	:	:	PUNCT
iajs-17	179	11	role	role	NOUN
iajs-17	179	12	in	in	ADP
iajs-17	179	13	inflammatory	inflammatory	ADJ
iajs-17	179	14	disease	disease	NOUN
iajs-17	179	15	and	and	CCONJ
iajs-17	179	16	progression	progression	NOUN
iajs-17	179	17	to	to	ADP
iajs-17	179	18	cancer‖	cancer‖	PROPN
iajs-17	179	19	biochem	biochem	PROPN
iajs-17	179	20	.	.	PUNCT
iajs-17	180	1	j	j	PROPN
iajs-17	180	2	,	,	PUNCT
iajs-17	180	3	313	313	NUM
iajs-17	180	4	.	.	NOUN
iajs-17	180	5	6	6	NUM
iajs-17	180	6	.	.	X
iajs-17	180	7	adelheid	adelheid	PROPN
iajs-17	180	8	weidinger	weidinger	NOUN
iajs-17	180	9	and	and	CCONJ
iajs-17	180	10	andrey	andrey	PROPN
iajs-17	180	11	,	,	PUNCT
iajs-17	180	12	v.	v.	PROPN
iajs-17	180	13	kozlov	kozlov	PROPN
iajs-17	180	14	(	(	PUNCT
iajs-17	180	15	2015	2015	NUM
iajs-17	180	16	)	)	PUNCT
iajs-17	180	17	,	,	PUNCT
iajs-17	180	18	biological	biological	ADJ
iajs-17	180	19	activities	activity	NOUN
iajs-17	180	20	of	of	ADP
iajs-17	180	21	reactive	reactive	ADJ
iajs-17	180	22	oxygen	oxygen	NOUN
iajs-17	180	23	and	and	CCONJ
iajs-17	180	24	nitrogen	nitrogen	NOUN
iajs-17	180	25	species	specie	NOUN
iajs-17	180	26	:	:	PUNCT
iajs-17	180	27	oxidative	oxidative	ADJ
iajs-17	180	28	stress	stress	NOUN
iajs-17	180	29	versus	versus	ADP
iajs-17	180	30	signal	signal	ADJ
iajs-17	180	31	transduction	transduction	NOUN
iajs-17	180	32	:	:	PUNCT
iajs-17	180	33	biomolecules,5	biomolecules,5	NOUN
iajs-17	180	34	,	,	PUNCT
iajs-17	180	35	472	472	NUM
iajs-17	180	36	-	-	SYM
iajs-17	180	37	484	484	NUM
iajs-17	180	38	.	.	PUNCT
iajs-17	181	1	chemistry	chemistry	NOUN
iajs-17	181	2	|	|	ADV
iajs-17	181	3	140	140	NUM
iajs-17	181	4	2016	2016	NUM
iajs-17	181	5	(	(	PUNCT
iajs-17	181	6	عاً	عاً	PROPN
iajs-17	181	7	3اىعذد	3اىعذد	NUM
iajs-17	181	8	)	)	PUNCT
iajs-17	181	9	29اىَديذ	29اىَديذ	NUM
iajs-17	182	1	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	182	2	ٍديت	ٍديت	VERB
iajs-17	182	3	إبِ	إبِ	X
iajs-17	182	4	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	182	5	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	182	6	اىصشفت	اىصشفت	VERB
iajs-17	182	7	ibn	ibn	PROPN
iajs-17	182	8	al	al	PROPN
iajs-17	182	9	-	-	PUNCT
iajs-17	182	10	haitham	haitham	PROPN
iajs-17	182	11	jour	jour	X
iajs-17	182	12	.	.	PROPN
iajs-17	183	1	for	for	ADP
iajs-17	183	2	pure	pure	ADJ
iajs-17	183	3	&	&	CCONJ
iajs-17	183	4	appl	appl	PROPN
iajs-17	183	5	.	.	PUNCT
iajs-17	184	1	sci	sci	PROPN
iajs-17	184	2	.	.	PUNCT
iajs-17	184	3	vol	vol	NOUN
iajs-17	184	4	.	.	PROPN
iajs-17	184	5	29	29	NUM
iajs-17	184	6	(	(	PUNCT
iajs-17	184	7	3	3	NUM
iajs-17	184	8	)	)	PUNCT
iajs-17	184	9	2016	2016	NUM
iajs-17	184	10	7	7	NUM
iajs-17	184	11	.	.	PUNCT
iajs-17	185	1	isabel	isabel	PROPN
iajs-17	185	2	,	,	PUNCT
iajs-17	185	3	a.	a.	NOUN
iajs-17	185	4	;	;	PUNCT
iajs-17	185	5	abreu	abreu	PROPN
iajs-17	185	6	and	and	CCONJ
iajs-17	185	7	diane	diane	PROPN
iajs-17	185	8	e.	e.	PROPN
iajs-17	185	9	cabelli	cabelli	PROPN
iajs-17	185	10	(	(	PUNCT
iajs-17	185	11	2010	2010	NUM
iajs-17	185	12	)	)	PUNCT
iajs-17	185	13	.	.	PUNCT
iajs-17	186	1	review	review	NOUN
iajs-17	186	2	―superoxide	―superoxide	ADP
iajs-17	186	3	dismutases	dismutase	NOUN
iajs-17	186	4	—	—	PUNCT
iajs-17	186	5	a	a	DET
iajs-17	186	6	review	review	NOUN
iajs-17	186	7	of	of	ADP
iajs-17	186	8	the	the	DET
iajs-17	186	9	metal	metal	NOUN
iajs-17	186	10	-	-	PUNCT
iajs-17	186	11	associated	associate	VERB
iajs-17	186	12	mechanistic	mechanistic	ADJ
iajs-17	186	13	variations‖	variations‖	PROPN
iajs-17	186	14	biochimica	biochimica	PROPN
iajs-17	186	15	et	et	PROPN
iajs-17	186	16	biophysica	biophysica	PROPN
iajs-17	186	17	acta	acta	PROPN
iajs-17	186	18	,	,	PUNCT
iajs-17	186	19	1804	1804	NUM
iajs-17	186	20	,	,	PUNCT
iajs-17	186	21	263–274	263–274	NUM
iajs-17	186	22	.	.	NOUN
iajs-17	187	1	8	8	NUM
iajs-17	187	2	.	.	PUNCT
iajs-17	187	3	mark	mark	PROPN
iajs-17	187	4	percival	percival	PROPN
iajs-17	187	5	(	(	PUNCT
iajs-17	187	6	1996	1996	NUM
iajs-17	187	7	)	)	PUNCT
iajs-17	187	8	.	.	PUNCT
iajs-17	188	1	antioxidants	antioxidant	NOUN
iajs-17	188	2	,	,	PUNCT
iajs-17	188	3	review	review	NOUN
iajs-17	188	4	article	article	NOUN
iajs-17	188	5	,	,	PUNCT
iajs-17	188	6	clinical	clinical	ADJ
iajs-17	188	7	nutrition	nutrition	NOUN
iajs-17	188	8	insights	insight	NOUN
iajs-17	188	9	,	,	PUNCT
iajs-17	188	10	9	9	NUM
iajs-17	188	11	.	.	X
iajs-17	188	12	toshikazu	toshikazu	PROPN
iajs-17	188	13	yoshikawa	yoshikawa	PROPN
iajs-17	188	14	and	and	CCONJ
iajs-17	188	15	yuji	yuji	PROPN
iajs-17	188	16	naito	naito	PROPN
iajs-17	188	17	(	(	PUNCT
iajs-17	188	18	2002	2002	NUM
iajs-17	188	19	)	)	PUNCT
iajs-17	188	20	.	.	PUNCT
iajs-17	189	1	what	what	PRON
iajs-17	189	2	is	be	AUX
iajs-17	189	3	oxidative	oxidative	ADJ
iajs-17	189	4	stress	stress	NOUN
iajs-17	189	5	?	?	PUNCT
iajs-17	189	6	.	.	PUNCT
iajs-17	190	1	jmaj	jmaj	PROPN
iajs-17	190	2	,	,	PUNCT
iajs-17	190	3	45(7	45(7	NUM
iajs-17	190	4	):	):	PUNCT
iajs-17	190	5	271–276	271–276	NUM
iajs-17	190	6	.	.	PUNCT
iajs-17	191	1	10	10	NUM
iajs-17	191	2	.	.	X
iajs-17	191	3	sastre	sastre	NOUN
iajs-17	191	4	,	,	PUNCT
iajs-17	191	5	j.	j.	PROPN
iajs-17	191	6	;	;	PUNCT
iajs-17	191	7	pallardo	pallardo	PROPN
iajs-17	191	8	,	,	PUNCT
iajs-17	191	9	fv	fv	X
iajs-17	191	10	.	.	PROPN
iajs-17	191	11	;	;	PUNCT
iajs-17	191	12	corcia	corcia	PROPN
iajs-17	191	13	de	de	PROPN
iajs-17	191	14	la	la	PROPN
iajs-17	191	15	asuncion	asuncion	PROPN
iajs-17	191	16	,	,	PUNCT
iajs-17	191	17	j	j	PROPN
iajs-17	191	18	,	,	PUNCT
iajs-17	191	19	vina	vina	PROPN
iajs-17	191	20	j.	j.	PROPN
iajs-17	191	21	(	(	PUNCT
iajs-17	191	22	2000	2000	NUM
iajs-17	191	23	)	)	PUNCT
iajs-17	191	24	.	.	PUNCT
iajs-17	192	1	mitochondria	mitochondria	PROPN
iajs-17	192	2	oxidative	oxidative	ADJ
iajs-17	192	3	stress	stress	NOUN
iajs-17	192	4	and	and	CCONJ
iajs-17	192	5	aging	aging	NOUN
iajs-17	192	6	.	.	PUNCT
iajs-17	193	1	free	free	ADJ
iajs-17	193	2	radic	radic	ADJ
iajs-17	193	3	res	re	NOUN
iajs-17	193	4	.	.	PUNCT
iajs-17	194	1	32	32	NUM
iajs-17	194	2	:	:	SYM
iajs-17	194	3	189	189	NUM
iajs-17	194	4	-	-	SYM
iajs-17	194	5	198	198	NUM
iajs-17	194	6	.	.	PUNCT
iajs-17	195	1	11	11	NUM
iajs-17	195	2	.	.	PUNCT
iajs-17	196	1	mosaad	mosaad	PROPN
iajs-17	196	2	,	,	PUNCT
iajs-17	196	3	a.	a.	NOUN
iajs-17	196	4	;	;	PUNCT
iajs-17	196	5	abou	abou	PROPN
iajs-17	196	6	-	-	PUNCT
iajs-17	196	7	seif	seif	PROPN
iajs-17	196	8	and	and	CCONJ
iajs-17	196	9	abd	abd	PROPN
iajs-17	196	10	-	-	PUNCT
iajs-17	196	11	allah	allah	PROPN
iajs-17	196	12	youssef	youssef	PROPN
iajs-17	196	13	(	(	PUNCT
iajs-17	196	14	2004	2004	NUM
iajs-17	196	15	)	)	PUNCT
iajs-17	196	16	.	.	PUNCT
iajs-17	197	1	evaluation	evaluation	NOUN
iajs-17	197	2	of	of	ADP
iajs-17	197	3	some	some	DET
iajs-17	197	4	biochemical	biochemical	ADJ
iajs-17	197	5	changes	change	NOUN
iajs-17	197	6	in	in	ADP
iajs-17	197	7	diabetic	diabetic	ADJ
iajs-17	197	8	patients‖	patients‖	PROPN
iajs-17	197	9	clinica	clinica	PROPN
iajs-17	197	10	chimica	chimica	PROPN
iajs-17	197	11	acta	acta	PROPN
iajs-17	197	12	,	,	PUNCT
iajs-17	197	13	346	346	NUM
iajs-17	197	14	,	,	PUNCT
iajs-17	197	15	161–170	161–170	NUM
iajs-17	197	16	12	12	NUM
iajs-17	197	17	.	.	PUNCT
iajs-17	198	1	adachi	adachi	PROPN
iajs-17	198	2	,	,	PUNCT
iajs-17	198	3	t.	t.	PROPN
iajs-17	198	4	,	,	PUNCT
iajs-17	198	5	inoue	inoue	PROPN
iajs-17	198	6	,	,	PUNCT
iajs-17	198	7	m.	m.	NOUN
iajs-17	198	8	;	;	PUNCT
iajs-17	198	9	hara	hara	PROPN
iajs-17	198	10	,	,	PUNCT
iajs-17	198	11	h.	h.	PROPN
iajs-17	198	12	;	;	PUNCT
iajs-17	198	13	maehata	maehata	PROPN
iajs-17	198	14	,	,	PUNCT
iajs-17	198	15	e.	e.	PROPN
iajs-17	198	16	and	and	CCONJ
iajs-17	198	17	suzuki	suzuki	PROPN
iajs-17	198	18	,	,	PUNCT
iajs-17	198	19	s;.(2004	s;.(2004	PROPN
iajs-17	198	20	)	)	PUNCT
iajs-17	198	21	relationship	relationship	NOUN
iajs-17	198	22	of	of	ADP
iajs-17	198	23	serum	serum	NOUN
iajs-17	198	24	extracellular	extracellular	ADJ
iajs-17	198	25	-	-	PUNCT
iajs-17	198	26	superoxide	superoxide	NOUN
iajs-17	198	27	dismutase	dismutase	NOUN
iajs-17	198	28	level	level	NOUN
iajs-17	198	29	with	with	ADP
iajs-17	198	30	insulin	insulin	NOUN
iajs-17	198	31	resistance	resistance	NOUN
iajs-17	198	32	in	in	ADP
iajs-17	198	33	type	type	NOUN
iajs-17	198	34	2	2	NUM
iajs-17	198	35	diabetic	diabetic	ADJ
iajs-17	198	36	patients	patient	NOUN
iajs-17	198	37	.	.	PUNCT
iajs-17	199	1	journal	journal	NOUN
iajs-17	199	2	of	of	ADP
iajs-17	199	3	endocrinology	endocrinology	NOUN
iajs-17	199	4	,	,	PUNCT
iajs-17	199	5	181	181	NUM
iajs-17	199	6	,	,	PUNCT
iajs-17	199	7	413–417	413–417	NUM
iajs-17	199	8	.	.	NOUN
iajs-17	199	9	13	13	NUM
iajs-17	199	10	.	.	X
iajs-17	200	1	umiaki	umiaki	ADJ
iajs-17	200	2	kimura	kimura	NOUN
iajs-17	200	3	;	;	PUNCT
iajs-17	200	4	goji	goji	PROPN
iajs-17	200	5	hasegawa	hasegawa	PROPN
iajs-17	200	6	;	;	PUNCT
iajs-17	200	7	hiroshi	hiroshi	PROPN
iajs-17	200	8	obayashi	obayashi	PROPN
iajs-17	200	9	,	,	PUNCT
iajs-17	200	10	tetsuo	tetsuo	PROPN
iajs-17	200	11	adachi	adachi	PROPN
iajs-17	200	12	,	,	PUNCT
iajs-17	200	13	hirokazu	hirokazu	NOUN
iajs-17	200	14	hara	hara	PROPN
iajs-17	200	15	,	,	PUNCT
iajs-17	200	16	mitsuhiro	mitsuhiro	NOUN
iajs-17	200	17	ohta	ohta	NOUN
iajs-17	200	18	,	,	PUNCT
iajs-17	200	19	michiaki	michiaki	PROPN
iajs-17	200	20	fukui	fukui	PROPN
iajs-17	200	21	,	,	PUNCT
iajs-17	200	22	yoshihiro	yoshihiro	PROPN
iajs-17	200	23	kitagawa	kitagawa	PROPN
iajs-17	200	24	,	,	PUNCT
iajs-17	200	25	hyohun	hyohun	PROPN
iajs-17	200	26	park	park	PROPN
iajs-17	200	27	,	,	PUNCT
iajs-17	200	28	naoto	naoto	PROPN
iajs-17	200	29	nakamura	nakamura	PROPN
iajs-17	200	30	,	,	PUNCT
iajs-17	200	31	koji	koji	PROPN
iajs-17	200	32	nakano	nakano	PROPN
iajs-17	200	33	and	and	CCONJ
iajs-17	200	34	toshikazu	toshikazu	PROPN
iajs-17	200	35	yoshikawa	yoshikawa	PROPN
iajs-17	200	36	(	(	PUNCT
iajs-17	200	37	2004	2004	NUM
iajs-17	200	38	)	)	PUNCT
iajs-17	200	39	.	.	PUNCT
iajs-17	201	1	serum	serum	VERB
iajs-17	201	2	extracellular	extracellular	ADJ
iajs-17	201	3	superoxide	superoxide	NOUN
iajs-17	201	4	dismutase	dismutase	NOUN
iajs-17	201	5	in	in	ADP
iajs-17	201	6	patients	patient	NOUN
iajs-17	201	7	with	with	ADP
iajs-17	201	8	type	type	NOUN
iajs-17	201	9	2	2	NUM
iajs-17	201	10	diabetes"diabetes	diabetes"diabete	NOUN
iajs-17	201	11	care	care	VERB
iajs-17	201	12	,	,	PUNCT
iajs-17	201	13	26	26	NUM
iajs-17	201	14	,	,	PUNCT
iajs-17	201	15	4	4	NUM
iajs-17	201	16	.	.	NOUN
iajs-17	201	17	14	14	NUM
iajs-17	201	18	.	.	PUNCT
iajs-17	202	1	wafa	wafa	PROPN
iajs-17	202	2	,	,	PUNCT
iajs-17	202	3	h	h	NOUN
iajs-17	202	4	;	;	PUNCT
iajs-17	202	5	ajam	ajam	PROPN
iajs-17	202	6	tariq	tariq	NOUN
iajs-17	202	7	;	;	PUNCT
iajs-17	202	8	h.	h.	PROPN
iajs-17	202	9	al	al	PROPN
iajs-17	202	10	-	-	PUNCT
iajs-17	202	11	khyat	khyat	PROPN
iajs-17	202	12	kadhum	kadhum	PROPN
iajs-17	202	13	and	and	CCONJ
iajs-17	202	14	j.	j.	PROPN
iajs-17	202	15	al	al	PROPN
iajs-17	202	16	-	-	PUNCT
iajs-17	202	17	hamdani	hamdani	NOUN
iajs-17	202	18	"	"	PUNCT
iajs-17	202	19	oxidative	oxidative	ADJ
iajs-17	202	20	status	status	NOUN
iajs-17	202	21	and	and	CCONJ
iajs-17	202	22	lipid	lipid	NOUN
iajs-17	202	23	profile	profile	NOUN
iajs-17	202	24	in	in	ADP
iajs-17	202	25	post	post	ADJ
iajs-17	202	26	-	-	ADJ
iajs-17	202	27	menopausal	menopausal	ADJ
iajs-17	202	28	women	woman	NOUN
iajs-17	202	29	with	with	ADP
iajs-17	202	30	diabetes	diabetes	NOUN
iajs-17	202	31	mellitus	mellitus	NOUN
iajs-17	202	32	(	(	PUNCT
iajs-17	202	33	dm	dm	NOUN
iajs-17	202	34	)	)	PUNCT
iajs-17	202	35	type	type	NOUN
iajs-17	202	36	2	2	NUM
iajs-17	202	37	in	in	ADP
iajs-17	202	38	babylon	babylon	PROPN
iajs-17	202	39	governorate	governorate	PROPN
iajs-17	202	40	.	.	PUNCT
iajs-17	203	1	medical	medical	ADJ
iajs-17	203	2	journal	journal	PROPN
iajs-17	203	3	of	of	ADP
iajs-17	203	4	babylon	babylon	PROPN
iajs-17	203	5	,	,	PUNCT
iajs-17	203	6	2012	2012	NUM
iajs-17	203	7	,	,	PUNCT
iajs-17	203	8	9	9	NUM
iajs-17	203	9	,	,	PUNCT
iajs-17	203	10	2	2	NUM
iajs-17	203	11	.	.	NOUN
iajs-17	203	12	15	15	NUM
iajs-17	203	13	.	.	PUNCT
iajs-17	204	1	armin	armin	PROPN
iajs-17	204	2	rashidi	rashidi	PROPN
iajs-17	204	3	;	;	PUNCT
iajs-17	204	4	manouchehr	manouchehr	NOUN
iajs-17	204	5	nakhjavani	nakhjavani	NOUN
iajs-17	204	6	;	;	PUNCT
iajs-17	204	7	alireza	alireza	PROPN
iajs-17	204	8	,	,	PUNCT
iajs-17	204	9	esteghamati	esteghamati	NOUN
iajs-17	204	10	;	;	PUNCT
iajs-17	204	11	firuzeh	firuzeh	NOUN
iajs-17	204	12	asgarani	asgarani	NOUN
iajs-17	204	13	;	;	PUNCT
iajs-17	204	14	omid	omid	PROPN
iajs-17	204	15	khalilzadeh	khalilzadeh	PROPN
iajs-17	204	16	;	;	PUNCT
iajs-17	204	17	mehrshad	mehrshad	PROPN
iajs-17	204	18	abbasi	abbasi	PROPN
iajs-17	204	19	and	and	CCONJ
iajs-17	204	20	reza	reza	ADJ
iajs-17	204	21	safari	safari	NOUN
iajs-17	204	22	(	(	PUNCT
iajs-17	204	23	2009	2009	NUM
iajs-17	204	24	)	)	PUNCT
iajs-17	204	25	.	.	PUNCT
iajs-17	205	1	association	association	NOUN
iajs-17	205	2	between	between	ADP
iajs-17	205	3	oxidant	oxidant	ADJ
iajs-17	205	4	/	/	SYM
iajs-17	205	5	antioxidant	antioxidant	ADJ
iajs-17	205	6	markers	marker	NOUN
iajs-17	205	7	and	and	CCONJ
iajs-17	205	8	proteinuria	proteinuria	NOUN
iajs-17	205	9	in	in	ADP
iajs-17	205	10	type	type	NOUN
iajs-17	205	11	2	2	NUM
iajs-17	205	12	diabetes	diabetes	NOUN
iajs-17	205	13	:	:	PUNCT
iajs-17	205	14	results	result	NOUN
iajs-17	205	15	in	in	ADP
iajs-17	205	16	142	142	NUM
iajs-17	205	17	patients	patient	NOUN
iajs-17	205	18	.	.	PUNCT
iajs-17	206	1	jnephrol	jnephrol	NOUN
iajs-17	206	2	;	;	PUNCT
iajs-17	206	3	22	22	NUM
iajs-17	206	4	(	(	PUNCT
iajs-17	206	5	6):733738	6):733738	NOUN
iajs-17	206	6	.	.	PUNCT
iajs-17	207	1	16	16	NUM
iajs-17	207	2	.	.	PUNCT
iajs-17	208	1	simi	simi	PROPN
iajs-17	208	2	kharb	kharb	PROPN
iajs-17	208	3	(	(	PUNCT
iajs-17	208	4	2013	2013	NUM
iajs-17	208	5	)	)	PUNCT
iajs-17	208	6	.	.	PUNCT
iajs-17	209	1	activity	activity	NOUN
iajs-17	209	2	of	of	ADP
iajs-17	209	3	extracellular	extracellular	ADJ
iajs-17	209	4	superoxide	superoxide	NOUN
iajs-17	209	5	dismutase	dismutase	NOUN
iajs-17	209	6	in	in	ADP
iajs-17	209	7	gestational	gestational	ADJ
iajs-17	209	8	diabetes	diabetes	NOUN
iajs-17	209	9	research	research	NOUN
iajs-17	209	10	journal	journal	NOUN
iajs-17	209	11	of	of	ADP
iajs-17	209	12	obstetrics	obstetric	NOUN
iajs-17	209	13	and	and	CCONJ
iajs-17	209	14	gynocology	gynocology	NOUN
iajs-17	209	15	,	,	PUNCT
iajs-17	209	16	3	3	NUM
iajs-17	209	17	(	(	PUNCT
iajs-17	209	18	1	1	NUM
iajs-17	209	19	)	)	PUNCT
iajs-17	209	20	,	,	PUNCT
iajs-17	209	21	1	1	NUM
iajs-17	209	22	-	-	SYM
iajs-17	209	23	4	4	NUM
iajs-17	209	24	.	.	NUM
iajs-17	209	25	17	17	NUM
iajs-17	209	26	.	.	PUNCT
iajs-17	210	1	minami	minami	PROPN
iajs-17	210	2	,	,	PUNCT
iajs-17	210	3	m.	m.	NOUN
iajs-17	210	4	,	,	PUNCT
iajs-17	210	5	and	and	CCONJ
iajs-17	210	6	yoshikawa	yoshikawa	PROPN
iajs-17	210	7	ha	ha	INTJ
iajs-17	210	8	.	.	PUNCT
iajs-17	210	9	(	(	PUNCT
iajs-17	210	10	1979	1979	NUM
iajs-17	210	11	)	)	PUNCT
iajs-17	210	12	.	.	PUNCT
iajs-17	211	1	simplified	simplify	VERB
iajs-17	211	2	assay	assay	NOUN
iajs-17	211	3	method	method	NOUN
iajs-17	211	4	of	of	ADP
iajs-17	211	5	superoxide	superoxide	NOUN
iajs-17	211	6	dismutase	dismutase	NOUN
iajs-17	211	7	activity	activity	NOUN
iajs-17	211	8	for	for	ADP
iajs-17	211	9	clinical	clinical	ADJ
iajs-17	211	10	use	use	NOUN
iajs-17	211	11	.	.	PUNCT
iajs-17	212	1	clin	clin	PROPN
iajs-17	212	2	chem	chem	PROPN
iajs-17	212	3	.	.	PUNCT
iajs-17	213	1	act	act	PROPN
iajs-17	213	2	.	.	PUNCT
iajs-17	214	1	1979;92:337	1979;92:337	PROPN
iajs-17	214	2	-	-	SYM
iajs-17	214	3	342	342	NUM
iajs-17	214	4	.	.	PUNCT
iajs-17	215	1	18	18	NUM
iajs-17	215	2	.	.	X
iajs-17	215	3	trivelli	trivelli	PROPN
iajs-17	215	4	,	,	PUNCT
iajs-17	215	5	la	la	ADJ
iajs-17	215	6	,	,	PUNCT
iajs-17	215	7	ranney	ranney	NOUN
iajs-17	215	8	,	,	PUNCT
iajs-17	215	9	hm	hm	INTJ
iajs-17	215	10	and	and	CCONJ
iajs-17	215	11	lai	lai	PROPN
iajs-17	215	12	ht	ht	PROPN
iajs-17	215	13	.	.	PUNCT
iajs-17	216	1	(	(	PUNCT
iajs-17	216	2	1971).new	1971).new	PROPN
iajs-17	216	3	eng	eng	PROPN
iajs-17	216	4	.	.	PUNCT
iajs-17	217	1	j.	j.	PROPN
iajs-17	217	2	med.;284:353	med.;284:353	PROPN
iajs-17	217	3	.	.	PROPN
iajs-17	217	4	19	19	NUM
iajs-17	217	5	.	.	PUNCT
iajs-17	217	6	zargar	zargar	NOUN
iajs-17	217	7	ah	ah	INTJ
iajs-17	217	8	,	,	PUNCT
iajs-17	217	9	shah	shah	PROPN
iajs-17	217	10	na	na	PROPN
iajs-17	217	11	,	,	PUNCT
iajs-17	217	12	masoodi	masoodi	PROPN
iajs-17	217	13	sr	sr	PROPN
iajs-17	217	14	,	,	PUNCT
iajs-17	217	15	laway	laway	PROPN
iajs-17	217	16	ba	ba	PROPN
iajs-17	217	17	,	,	PUNCT
iajs-17	217	18	dar	dar	PROPN
iajs-17	217	19	fa	fa	PROPN
iajs-17	217	20	,	,	PUNCT
iajs-17	217	21	khan	khan	PROPN
iajs-17	217	22	ar	ar	PROPN
iajs-17	217	23	,	,	PUNCT
iajs-17	217	24	sofi	sofi	PROPN
iajs-17	217	25	fa	fa	PROPN
iajs-17	217	26	and	and	CCONJ
iajs-17	217	27	wani	wani	PROPN
iajs-17	217	28	ai	ai	PROPN
iajs-17	217	29	.	.	PUNCT
iajs-17	218	1	(	(	PUNCT
iajs-17	218	2	2002	2002	NUM
iajs-17	218	3	)	)	PUNCT
iajs-17	218	4	.	.	PUNCT
iajs-17	219	1	copper	copper	NOUN
iajs-17	219	2	,	,	PUNCT
iajs-17	219	3	zinc	zinc	NOUN
iajs-17	219	4	and	and	CCONJ
iajs-17	219	5	magnesium	magnesium	NOUN
iajs-17	219	6	levels	level	NOUN
iajs-17	219	7	in	in	ADP
iajs-17	219	8	type-1	type-1	PROPN
iajs-17	219	9	diabetes	diabetes	NOUN
iajs-17	219	10	mellitus	mellitus	NOUN
iajs-17	219	11	.	.	PUNCT
iajs-17	220	1	saudi	saudi	PROPN
iajs-17	220	2	med;23	med;23	NOUN
iajs-17	220	3	:	:	PUNCT
iajs-17	220	4	539–542	539–542	NUM
iajs-17	220	5	.	.	NOUN
iajs-17	220	6	20	20	NUM
iajs-17	220	7	.	.	PUNCT
iajs-17	220	8	osman	osman	PROPN
iajs-17	220	9	,	,	PUNCT
iajs-17	220	10	e.	e.	PROPN
iajs-17	220	11	,	,	PUNCT
iajs-17	220	12	levent	levent	PROPN
iajs-17	220	13	,	,	PUNCT
iajs-17	220	14	k.	k.	PROPN
iajs-17	220	15	;	;	PUNCT
iajs-17	220	16	nuriye	nuriye	PROPN
iajs-17	220	17	,	,	PUNCT
iajs-17	220	18	u.	u.	PROPN
iajs-17	220	19	;	;	PUNCT
iajs-17	220	20	nazife	nazife	PROPN
iajs-17	220	21	,	,	PUNCT
iajs-17	220	22	k.	k.	PROPN
iajs-17	220	23	;	;	PUNCT
iajs-17	220	24	baysal	baysal	PROPN
iajs-17	220	25	.	.	PUNCT
iajs-17	221	1	k.	k.	PROPN
iajs-17	221	2	;	;	PUNCT
iajs-17	221	3	ruhan	ruhan	PROPN
iajs-17	221	4	k	k	PROPN
iajs-17	221	5	and	and	CCONJ
iajs-17	221	6	naciye	naciye	PROPN
iajs-17	221	7	y.	y.	PROPN
iajs-17	221	8	(	(	PUNCT
iajs-17	221	9	2004	2004	NUM
iajs-17	221	10	)	)	PUNCT
iajs-17	221	11	correlations	correlation	NOUN
iajs-17	221	12	of	of	ADP
iajs-17	221	13	serum	serum	NOUN
iajs-17	221	14	cu	cu	PROPN
iajs-17	221	15	+2	+2	PROPN
iajs-17	221	16	,	,	PUNCT
iajs-17	221	17	zn	zn	X
iajs-17	221	18	+2	+2	PROPN
iajs-17	221	19	,	,	PUNCT
iajs-17	221	20	mg	mg	ADP
iajs-17	221	21	+2	+2	PROPN
iajs-17	221	22	and	and	CCONJ
iajs-17	221	23	hba1c	hba1c	PROPN
iajs-17	221	24	in	in	ADP
iajs-17	221	25	type	type	NOUN
iajs-17	221	26	2	2	NUM
iajs-17	221	27	and	and	CCONJ
iajs-17	221	28	type	type	NOUN
iajs-17	221	29	2	2	NUM
iajs-17	221	30	diabetes	diabetes	NOUN
iajs-17	221	31	mellitus	mellitus	NOUN
iajs-17	221	32	.	.	PUNCT
iajs-17	222	1	turkish	turkish	ADJ
iajs-17	222	2	journal	journal	PROPN
iajs-17	222	3	of	of	ADP
iajs-17	222	4	endocrinology	endocrinology	NOUN
iajs-17	222	5	and	and	CCONJ
iajs-17	222	6	metabolism	metabolism	NOUN
iajs-17	222	7	;	;	PUNCT
iajs-17	222	8	2:75	2:75	NUM
iajs-17	222	9	-	-	SYM
iajs-17	222	10	79	79	NUM
iajs-17	222	11	.	.	PUNCT
iajs-17	223	1	21	21	NUM
iajs-17	223	2	.	.	X
iajs-17	223	3	arie	arie	PROPN
iajs-17	223	4	srihardyastutie	srihardyastutie	PROPN
iajs-17	223	5	,	,	PUNCT
iajs-17	223	6	soeatmadji	soeatmadji	PROPN
iajs-17	223	7	dw	dw	PROPN
iajs-17	223	8	,	,	PUNCT
iajs-17	223	9	fatchiyah	fatchiyah	NOUN
iajs-17	223	10	f	f	PROPN
iajs-17	223	11	and	and	CCONJ
iajs-17	223	12	aulanniam	aulanniam	PROPN
iajs-17	223	13	a.	a.	NOUN
iajs-17	223	14	(	(	PUNCT
iajs-17	223	15	2014	2014	NUM
iajs-17	223	16	)	)	PUNCT
iajs-17	223	17	.	.	PUNCT
iajs-17	224	1	the	the	DET
iajs-17	224	2	relationship	relationship	NOUN
iajs-17	224	3	between	between	ADP
iajs-17	224	4	hba1c	hba1c	PROPN
iajs-17	224	5	,	,	PUNCT
iajs-17	224	6	insulin	insulin	NOUN
iajs-17	224	7	resistance	resistance	NOUN
iajs-17	224	8	and	and	CCONJ
iajs-17	224	9	changes	change	NOUN
iajs-17	224	10	of	of	ADP
iajs-17	224	11	insulin	insulin	NOUN
iajs-17	224	12	secretion	secretion	NOUN
iajs-17	224	13	in	in	ADP
iajs-17	224	14	indonesian	indonesian	ADJ
iajs-17	224	15	type	type	NOUN
iajs-17	224	16	2	2	NUM
iajs-17	224	17	diabetic	diabetic	ADJ
iajs-17	224	18	subjects	subject	NOUN
iajs-17	224	19	.	.	PUNCT
iajs-17	225	1	adv	adv	PROPN
iajs-17	225	2	nat	nat	PROPN
iajs-17	225	3	appl	appl	PROPN
iajs-17	225	4	sci	sci	PROPN
iajs-17	225	5	;	;	PUNCT
iajs-17	225	6	8(8	8(8	NUM
iajs-17	225	7	):	):	PUNCT
iajs-17	225	8	25–30	25–30	NUM
iajs-17	225	9	.	.	PUNCT
iajs-17	226	1	22	22	NUM
iajs-17	226	2	.	.	PUNCT
iajs-17	227	1	soedamah	soedamah	PROPN
iajs-17	227	2	-	-	PUNCT
iajs-17	227	3	muthu	muthu	PROPN
iajs-17	227	4	,	,	PUNCT
iajs-17	227	5	s	s	NOUN
iajs-17	227	6	s	s	PROPN
iajs-17	227	7	,	,	PUNCT
iajs-17	227	8	chaturvedi	chaturvedi	PROPN
iajs-17	227	9	n	n	CCONJ
iajs-17	227	10	,	,	PUNCT
iajs-17	227	11	toeller	toeller	NOUN
iajs-17	227	12	m	m	PROPN
iajs-17	227	13	,	,	PUNCT
iajs-17	227	14	ferriss	ferriss	PROPN
iajs-17	227	15	b	b	PROPN
iajs-17	227	16	,	,	PUNCT
iajs-17	227	17	reboldi	reboldi	NOUN
iajs-17	227	18	p	p	PROPN
iajs-17	227	19	,	,	PUNCT
iajs-17	227	20	michel	michel	PROPN
iajs-17	227	21	g	g	PROPN
iajs-17	227	22	,	,	PUNCT
iajs-17	227	23	et	et	PROPN
iajs-17	227	24	al	al	PROPN
iajs-17	227	25	.	.	PUNCT
iajs-17	227	26	(	(	PUNCT
iajs-17	227	27	2008	2008	NUM
iajs-17	227	28	)	)	PUNCT
iajs-17	227	29	.	.	PUNCT
iajs-17	228	1	risk	risk	NOUN
iajs-17	228	2	factor	factor	NOUN
iajs-17	228	3	of	of	ADP
iajs-17	228	4	coronary	coronary	ADJ
iajs-17	228	5	heart	heart	NOUN
iajs-17	228	6	disease	disease	NOUN
iajs-17	228	7	,	,	PUNCT
iajs-17	228	8	circulation	circulation	NOUN
iajs-17	228	9	;	;	PUNCT
iajs-17	228	10	109	109	NUM
iajs-17	228	11	:	:	SYM
iajs-17	228	12	46	46	NUM
iajs-17	228	13	.	.	NOUN
iajs-17	228	14	23	23	NUM
iajs-17	228	15	.	.	PUNCT
iajs-17	229	1	gisela	gisela	PROPN
iajs-17	229	2	wilcox	wilcox	PROPN
iajs-17	229	3	(	(	PUNCT
iajs-17	229	4	2005	2005	NUM
iajs-17	229	5	)	)	PUNCT
iajs-17	229	6	.	.	PUNCT
iajs-17	230	1	insulin	insulin	NOUN
iajs-17	230	2	and	and	CCONJ
iajs-17	230	3	insulin	insulin	NOUN
iajs-17	230	4	resistance	resistance	NOUN
iajs-17	230	5	,	,	PUNCT
iajs-17	230	6	review	review	NOUN
iajs-17	230	7	article	article	NOUN
iajs-17	230	8	,	,	PUNCT
iajs-17	230	9	clin	clin	PROPN
iajs-17	230	10	biochem	biochem	PROPN
iajs-17	230	11	rev	rev	VERB
iajs-17	230	12	.	.	PROPN
iajs-17	230	13	;	;	PUNCT
iajs-17	230	14	26(2	26(2	NUM
iajs-17	230	15	):	):	PUNCT
iajs-17	230	16	19–39	19–39	NUM
iajs-17	230	17	.	.	PUNCT
iajs-17	231	1	24	24	NUM
iajs-17	231	2	.	.	PUNCT
iajs-17	232	1	kohei	kohei	PROPN
iajs-17	232	2	kaku	kaku	PROPN
iajs-17	232	3	(	(	PUNCT
iajs-17	232	4	2010	2010	NUM
iajs-17	232	5	)	)	PUNCT
iajs-17	232	6	.	.	PUNCT
iajs-17	233	1	pathophysiology	pathophysiology	NOUN
iajs-17	233	2	of	of	ADP
iajs-17	233	3	type	type	NOUN
iajs-17	233	4	2	2	NUM
iajs-17	233	5	diabetes	diabetes	NOUN
iajs-17	233	6	and	and	CCONJ
iajs-17	233	7	its	its	PRON
iajs-17	233	8	treatment	treatment	NOUN
iajs-17	233	9	policy	policy	NOUN
iajs-17	233	10	.	.	PUNCT
iajs-17	234	1	j	j	PROPN
iajs-17	234	2	japan	japan	PROPN
iajs-17	234	3	med	med	PROPN
iajs-17	234	4	assoc	assoc	PROPN
iajs-17	234	5	;	;	PUNCT
iajs-17	234	6	53(1):41–46	53(1):41–46	NUM
iajs-17	234	7	.	.	X
iajs-17	234	8	chemistry	chemistry	NOUN
iajs-17	234	9	|	|	ADV
iajs-17	234	10	141	141	NUM
iajs-17	234	11	2016	2016	NUM
iajs-17	234	12	(	(	PUNCT
iajs-17	234	13	عاً	عاً	PROPN
iajs-17	234	14	3اىعذد	3اىعذد	NUM
iajs-17	234	15	)	)	PUNCT
iajs-17	234	16	29اىَديذ	29اىَديذ	NUM
iajs-17	235	1	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	235	2	ٍديت	ٍديت	VERB
iajs-17	235	3	إبِ	إبِ	X
iajs-17	235	4	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	235	5	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	235	6	اىصشفت	اىصشفت	VERB
iajs-17	235	7	ibn	ibn	PROPN
iajs-17	235	8	al	al	PROPN
iajs-17	235	9	-	-	PUNCT
iajs-17	235	10	haitham	haitham	PROPN
iajs-17	235	11	jour	jour	X
iajs-17	235	12	.	.	PROPN
iajs-17	236	1	for	for	ADP
iajs-17	236	2	pure	pure	ADJ
iajs-17	236	3	&	&	CCONJ
iajs-17	236	4	appl	appl	PROPN
iajs-17	236	5	.	.	PUNCT
iajs-17	237	1	sci	sci	PROPN
iajs-17	237	2	.	.	PUNCT
iajs-17	237	3	vol	vol	NOUN
iajs-17	237	4	.	.	PROPN
iajs-17	237	5	29	29	NUM
iajs-17	237	6	(	(	PUNCT
iajs-17	237	7	3	3	NUM
iajs-17	237	8	)	)	PUNCT
iajs-17	237	9	2016	2016	NUM
iajs-17	237	10	25	25	NUM
iajs-17	237	11	.	.	PUNCT
iajs-17	238	1	xu	xu	PROPN
iajs-17	238	2	h	h	PROPN
iajs-17	238	3	;	;	PUNCT
iajs-17	238	4	huang	huang	PROPN
iajs-17	238	5	x	x	PROPN
iajs-17	238	6	;	;	PUNCT
iajs-17	238	7	arnlov	arnlov	PROPN
iajs-17	238	8	j	j	PROPN
iajs-17	238	9	;	;	PUNCT
iajs-17	238	10	cederholm	cederholm	PROPN
iajs-17	238	11	t	t	PROPN
iajs-17	238	12	;	;	PUNCT
iajs-17	238	13	stenvinkel	stenvinkel	PROPN
iajs-17	238	14	p	p	NOUN
iajs-17	238	15	;	;	PUNCT
iajs-17	238	16	lindholm	lindholm	PROPN
iajs-17	238	17	b	b	NOUN
iajs-17	238	18	;	;	PUNCT
iajs-17	238	19	riserus	riserus	NOUN
iajs-17	238	20	u	u	NOUN
iajs-17	238	21	;	;	PUNCT
iajs-17	238	22	and	and	CCONJ
iajs-17	238	23	carrero	carrero	PROPN
iajs-17	238	24	jj	jj	PROPN
iajs-17	238	25	.	.	PROPN
iajs-17	238	26	(	(	PUNCT
iajs-17	238	27	2014	2014	NUM
iajs-17	238	28	)	)	PUNCT
iajs-17	238	29	.	.	PUNCT
iajs-17	239	1	clinical	clinical	ADJ
iajs-17	239	2	correlates	correlate	NOUN
iajs-17	239	3	of	of	ADP
iajs-17	239	4	insulin	insulin	NOUN
iajs-17	239	5	sensitivity	sensitivity	NOUN
iajs-17	239	6	and	and	CCONJ
iajs-17	239	7	its	its	PRON
iajs-17	239	8	association	association	NOUN
iajs-17	239	9	with	with	ADP
iajs-17	239	10	mortality	mortality	NOUN
iajs-17	239	11	among	among	ADP
iajs-17	239	12	men	man	NOUN
iajs-17	239	13	with	with	ADP
iajs-17	239	14	ckd	ckd	PROPN
iajs-17	239	15	stage	stage	NOUN
iajs-17	239	16	3	3	NUM
iajs-17	239	17	and	and	CCONJ
iajs-17	239	18	4	4	NUM
iajs-17	239	19	.	.	X
iajs-17	240	1	clin	clin	PROPN
iajs-17	240	2	jam	jam	PROPN
iajs-17	240	3	soc	soc	PROPN
iajs-17	240	4	nephrol	nephrol	PROPN
iajs-17	240	5	;	;	PUNCT
iajs-17	240	6	9:1–8	9:1–8	NUM
iajs-17	240	7	.	.	PROPN
iajs-17	241	1	26	26	NUM
iajs-17	241	2	.	.	PUNCT
iajs-17	241	3	gomero	gomero	PROPN
iajs-17	241	4	ada	ada	PROPN
iajs-17	241	5	,	,	PUNCT
iajs-17	241	6	mcdade	mcdade	PROPN
iajs-17	241	7	t	t	PROPN
iajs-17	241	8	,	,	PUNCT
iajs-17	241	9	williams	williams	PROPN
iajs-17	241	10	s	s	PROPN
iajs-17	241	11	,	,	PUNCT
iajs-17	241	12	and	and	CCONJ
iajs-17	241	13	stacy	stacy	PROPN
iajs-17	241	14	tessler	tessler	PROPN
iajs-17	241	15	lindau	lindau	NOUN
iajs-17	241	16	(	(	PUNCT
iajs-17	241	17	2008	2008	NUM
iajs-17	241	18	)	)	PUNCT
iajs-17	241	19	.	.	PUNCT
iajs-17	242	1	dried	dry	VERB
iajs-17	242	2	blood	blood	NOUN
iajs-17	242	3	spot	spot	NOUN
iajs-17	242	4	measurement	measurement	NOUN
iajs-17	242	5	of	of	ADP
iajs-17	242	6	glycosylated	glycosylated	ADJ
iajs-17	242	7	hemoglobin	hemoglobin	NOUN
iajs-17	242	8	(	(	PUNCT
iajs-17	242	9	hba1c	hba1c	PROPN
iajs-17	242	10	)	)	PUNCT
iajs-17	242	11	in	in	ADP
iajs-17	242	12	wave	wave	NOUN
iajs-17	242	13	1	1	NUM
iajs-17	242	14	of	of	ADP
iajs-17	242	15	the	the	DET
iajs-17	242	16	national	national	ADJ
iajs-17	242	17	social	social	ADJ
iajs-17	242	18	life	life	NOUN
iajs-17	242	19	,	,	PUNCT
iajs-17	242	20	health	health	NOUN
iajs-17	242	21	and	and	CCONJ
iajs-17	242	22	aging	age	VERB
iajs-17	242	23	project	project	NOUN
iajs-17	242	24	(	(	PUNCT
iajs-17	242	25	nshap	nshap	NOUN
iajs-17	242	26	)	)	PUNCT
iajs-17	242	27	.	.	PUNCT
iajs-17	243	1	norc	norc	PROPN
iajs-17	243	2	univ	univ	PROPN
iajs-17	243	3	chicago	chicago	PROPN
iajs-17	243	4	.	.	PUNCT
iajs-17	244	1	27	27	NUM
iajs-17	244	2	.	.	PUNCT
iajs-17	245	1	goldenburg	goldenburg	NOUN
iajs-17	245	2	r	r	NOUN
iajs-17	245	3	,	,	PUNCT
iajs-17	245	4	and	and	CCONJ
iajs-17	245	5	punthakee	punthakee	PROPN
iajs-17	245	6	z.(2013	z.(2013	PROPN
iajs-17	245	7	)	)	PUNCT
iajs-17	245	8	,	,	PUNCT
iajs-17	245	9	canadian	canadian	ADJ
iajs-17	245	10	diabetes	diabetes	PROPN
iajs-17	245	11	association	association	NOUN
iajs-17	245	12	.	.	PUNCT
iajs-17	246	1	clinical	clinical	ADJ
iajs-17	246	2	practice	practice	NOUN
iajs-17	246	3	guidelines	guideline	NOUN
iajs-17	246	4	for	for	ADP
iajs-17	246	5	the	the	DET
iajs-17	246	6	prevention	prevention	NOUN
iajs-17	246	7	and	and	CCONJ
iajs-17	246	8	management	management	NOUN
iajs-17	246	9	of	of	ADP
iajs-17	246	10	diabetes	diabetes	NOUN
iajs-17	246	11	in	in	ADP
iajs-17	246	12	canada	canada	PROPN
iajs-17	246	13	.	.	PUNCT
iajs-17	247	1	definition	definition	NOUN
iajs-17	247	2	,	,	PUNCT
iajs-17	247	3	classification	classification	NOUN
iajs-17	247	4	and	and	CCONJ
iajs-17	247	5	diagnosis	diagnosis	NOUN
iajs-17	247	6	of	of	ADP
iajs-17	247	7	diabetes	diabetes	NOUN
iajs-17	247	8	,	,	PUNCT
iajs-17	247	9	pre	pre	ADJ
iajs-17	247	10	-	-	NOUN
iajs-17	247	11	diabetes	diabetes	ADJ
iajs-17	247	12	,	,	PUNCT
iajs-17	247	13	and	and	CCONJ
iajs-17	247	14	metabolic	metabolic	NOUN
iajs-17	247	15	syndrome	syndrome	NOUN
iajs-17	247	16	.	.	PUNCT
iajs-17	248	1	can	can	AUX
iajs-17	248	2	j	j	PROPN
iajs-17	248	3	diabetes	diabetes	NOUN
iajs-17	248	4	;	;	PUNCT
iajs-17	248	5	37	37	NUM
iajs-17	248	6	:	:	PUNCT
iajs-17	248	7	s8	s8	PROPN
iajs-17	248	8	-	-	PUNCT
iajs-17	248	9	s11	s11	PROPN
iajs-17	248	10	.	.	PUNCT
iajs-17	249	1	28	28	NUM
iajs-17	249	2	.	.	PUNCT
iajs-17	250	1	al	al	PROPN
iajs-17	250	2	-	-	PUNCT
iajs-17	250	3	hakeim	hakeim	PROPN
iajs-17	250	4	h	h	NOUN
iajs-17	250	5	and	and	CCONJ
iajs-17	250	6	alim	alim	NOUN
iajs-17	250	7	(	(	PUNCT
iajs-17	250	8	2012	2012	NUM
iajs-17	250	9	)	)	PUNCT
iajs-17	250	10	.	.	PUNCT
iajs-17	251	1	ghrelin	ghrelin	NOUN
iajs-17	251	2	level	level	NOUN
iajs-17	251	3	is	be	AUX
iajs-17	251	4	associated	associate	VERB
iajs-17	251	5	with	with	ADP
iajs-17	251	6	other	other	ADJ
iajs-17	251	7	biochemical	biochemical	ADJ
iajs-17	251	8	parameters	parameter	NOUN
iajs-17	251	9	in	in	ADP
iajs-17	251	10	obese	obese	ADJ
iajs-17	251	11	diabetic	diabetic	ADJ
iajs-17	251	12	patients	patient	NOUN
iajs-17	251	13	.	.	PUNCT
iajs-17	252	1	al	al	PROPN
iajs-17	252	2	-	-	PUNCT
iajs-17	252	3	kufa	kufa	PROPN
iajs-17	252	4	journal	journal	PROPN
iajs-17	252	5	for	for	ADP
iajs-17	252	6	biology	biology	NOUN
iajs-17	252	7	;	;	PUNCT
iajs-17	252	8	4(2):1	4(2):1	PROPN
iajs-17	252	9	-	-	PUNCT
iajs-17	252	10	13	13	NUM
iajs-17	252	11	.	.	PUNCT
iajs-17	252	12	29	29	NUM
iajs-17	252	13	.	.	PUNCT
iajs-17	253	1	lingohr	lingohr	PROPN
iajs-17	253	2	,	,	PUNCT
iajs-17	253	3	m.	m.	PROPN
iajs-17	253	4	k.	k.	PROPN
iajs-17	253	5	,	,	PUNCT
iajs-17	253	6	buettner	buettner	PROPN
iajs-17	253	7	r.	r.	PROPN
iajs-17	253	8	and	and	CCONJ
iajs-17	253	9	rhodes	rhodes	PROPN
iajs-17	253	10	c.	c.	PROPN
iajs-17	253	11	j.	j.	PROPN
iajs-17	253	12	(	(	PUNCT
iajs-17	253	13	2002	2002	NUM
iajs-17	253	14	)	)	PUNCT
iajs-17	253	15	,	,	PUNCT
iajs-17	253	16	trends	trend	NOUN
iajs-17	253	17	mol	mol	PROPN
iajs-17	253	18	.	.	PROPN
iajs-17	253	19	med	med	PROPN
iajs-17	253	20	.	.	PROPN
iajs-17	254	1	8	8	NUM
iajs-17	254	2	,	,	PUNCT
iajs-17	254	3	375	375	NUM
iajs-17	254	4	.	.	NOUN
iajs-17	254	5	30	30	NUM
iajs-17	254	6	.	.	PUNCT
iajs-17	255	1	jaikaran	jaikaran	PROPN
iajs-17	255	2	e.	e.	PROPN
iajs-17	255	3	t.	t.	PROPN
iajs-17	255	4	and	and	CCONJ
iajs-17	255	5	clark	clark	PROPN
iajs-17	255	6	a.	a.	PROPN
iajs-17	255	7	(	(	PUNCT
iajs-17	255	8	2001	2001	NUM
iajs-17	255	9	)	)	PUNCT
iajs-17	255	10	,	,	PUNCT
iajs-17	255	11	biochim	biochim	NOUN
iajs-17	255	12	.	.	PUNCT
iajs-17	256	1	biophys	biophy	NOUN
iajs-17	256	2	.	.	PUNCT
iajs-17	257	1	acta	acta	PROPN
iajs-17	257	2	1537	1537	NUM
iajs-17	257	3	,	,	PUNCT
iajs-17	257	4	179	179	NUM
iajs-17	257	5	.	.	PUNCT
iajs-17	257	6	31	31	NUM
iajs-17	257	7	.	.	PUNCT
iajs-17	258	1	weir	weir	PROPN
iajs-17	258	2	g.	g.	PROPN
iajs-17	258	3	c.	c.	PROPN
iajs-17	258	4	and	and	CCONJ
iajs-17	258	5	bonner	bonner	PROPN
iajs-17	258	6	-	-	PUNCT
iajs-17	258	7	weir	weir	PROPN
iajs-17	258	8	s.	s.	PROPN
iajs-17	258	9	(	(	PUNCT
iajs-17	258	10	2004	2004	NUM
iajs-17	258	11	)	)	PUNCT
iajs-17	258	12	,	,	PUNCT
iajs-17	258	13	diabetes	diabetes	NOUN
iajs-17	258	14	53	53	NUM
iajs-17	258	15	(	(	PUNCT
iajs-17	258	16	suppl	suppl	ADJ
iajs-17	258	17	.	.	PUNCT
iajs-17	258	18	3	3	NUM
iajs-17	258	19	)	)	PUNCT
iajs-17	258	20	,	,	PUNCT
iajs-17	258	21	s16	s16	NOUN
iajs-17	258	22	.	.	PUNCT
iajs-17	259	1	32	32	NUM
iajs-17	259	2	.	.	PUNCT
iajs-17	260	1	suwazono	suwazono	PROPN
iajs-17	260	2	y	y	PROPN
iajs-17	260	3	,	,	PUNCT
iajs-17	260	4	sakata	sakata	PROPN
iajs-17	260	5	k	k	PROPN
iajs-17	260	6	,	,	PUNCT
iajs-17	260	7	okubo	okubo	PROPN
iajs-17	260	8	y	y	PROPN
iajs-17	260	9	,	,	PUNCT
iajs-17	260	10	harada	harada	PROPN
iajs-17	260	11	h	h	PROPN
iajs-17	260	12	,	,	PUNCT
iajs-17	260	13	oishi	oishi	PROPN
iajs-17	260	14	m	m	PROPN
iajs-17	260	15	,	,	PUNCT
iajs-17	260	16	kobayashi	kobayashi	PROPN
iajs-17	260	17	e	e	PROPN
iajs-17	260	18	,	,	PUNCT
iajs-17	260	19	uetani	uetani	PROPN
iajs-17	260	20	m	m	PROPN
iajs-17	260	21	,	,	PUNCT
iajs-17	260	22	kido	kido	PROPN
iajs-17	260	23	t	t	PROPN
iajs-17	260	24	and	and	CCONJ
iajs-17	260	25	nogawa	nogawa	PROPN
iajs-17	260	26	k(2006	k(2006	PROPN
iajs-17	260	27	)	)	PUNCT
iajs-17	260	28	.	.	PUNCT
iajs-17	261	1	long	long	ADJ
iajs-17	261	2	-	-	PUNCT
iajs-17	261	3	term	term	NOUN
iajs-17	261	4	longitudinal	longitudinal	ADJ
iajs-17	261	5	study	study	NOUN
iajs-17	261	6	on	on	ADP
iajs-17	261	7	the	the	DET
iajs-17	261	8	relationship	relationship	NOUN
iajs-17	261	9	between	between	ADP
iajs-17	261	10	alternating	alternate	VERB
iajs-17	261	11	shift	shift	NOUN
iajs-17	261	12	work	work	NOUN
iajs-17	261	13	and	and	CCONJ
iajs-17	261	14	the	the	DET
iajs-17	261	15	onset	onset	NOUN
iajs-17	261	16	of	of	ADP
iajs-17	261	17	diabetes	diabetes	NOUN
iajs-17	261	18	mellitus	mellitus	NOUN
iajs-17	261	19	in	in	ADP
iajs-17	261	20	male	male	ADJ
iajs-17	261	21	japanese	japanese	ADJ
iajs-17	261	22	workers	worker	NOUN
iajs-17	261	23	.	.	PUNCT
iajs-17	262	1	j	j	PROPN
iajs-17	262	2	occup	occup	PROPN
iajs-17	262	3	environ	environ	PROPN
iajs-17	262	4	med.;48	med.;48	PROPN
iajs-17	262	5	:	:	PUNCT
iajs-17	262	6	455–461	455–461	NUM
iajs-17	262	7	.	.	NOUN
iajs-17	263	1	33	33	NUM
iajs-17	263	2	.	.	PUNCT
iajs-17	263	3	unger	unger	PROPN
iajs-17	263	4	rh	rh	PROPN
iajs-17	263	5	&	&	CCONJ
iajs-17	263	6	orcil	orcil	PROPN
iajs-17	263	7	(	(	PUNCT
iajs-17	263	8	2000	2000	NUM
iajs-17	263	9	)	)	PUNCT
iajs-17	263	10	.	.	PUNCT
iajs-17	264	1	lipotoxic	lipotoxic	ADJ
iajs-17	264	2	diseases	disease	NOUN
iajs-17	264	3	of	of	ADP
iajs-17	264	4	nonadipose	nonadipose	ADJ
iajs-17	264	5	tissues	tissue	NOUN
iajs-17	264	6	in	in	ADP
iajs-17	264	7	obesity	obesity	NOUN
iajs-17	264	8	.	.	PUNCT
iajs-17	265	1	int	int	NOUN
iajs-17	265	2	.	.	PUNCT
iajs-17	266	1	j.	j.	PROPN
iajs-17	266	2	obes	obes	PROPN
iajs-17	266	3	.	.	PUNCT
iajs-17	267	1	relat.metab	relat.metab	PROPN
iajs-17	267	2	.	.	PROPN
iajs-17	267	3	disord.;24	disord.;24	VERB
iajs-17	268	1	(	(	PUNCT
iajs-17	268	2	suppl	suppl	ADJ
iajs-17	268	3	4	4	NUM
iajs-17	268	4	):	):	PUNCT
iajs-17	268	5	s28	s28	PROPN
iajs-17	268	6	–	–	PUNCT
iajs-17	268	7	s32	s32	PROPN
iajs-17	268	8	.	.	PUNCT
iajs-17	268	9	34	34	NUM
iajs-17	268	10	.	.	PUNCT
iajs-17	269	1	goldhaber	goldhaber	PROPN
iajs-17	269	2	sb	sb	PROPN
iajs-17	269	3	:	:	PUNCT
iajs-17	269	4	trace	trace	NOUN
iajs-17	269	5	element	element	ADJ
iajs-17	269	6	risk	risk	NOUN
iajs-17	269	7	assessment	assessment	NOUN
iajs-17	269	8	:	:	PUNCT
iajs-17	269	9	essentiality	essentiality	NOUN
iajs-17	269	10	vs	vs	ADP
iajs-17	269	11	toxicity.regul	toxicity.regul	NUM
iajs-17	269	12	toxicol	toxicol	NOUN
iajs-17	269	13	pharmacol	pharmacol	PROPN
iajs-17	269	14	2003	2003	NUM
iajs-17	269	15	,	,	PUNCT
iajs-17	269	16	38:232	38:232	NUM
iajs-17	269	17	-	-	SYM
iajs-17	269	18	242	242	NUM
iajs-17	269	19	.	.	PUNCT
iajs-17	269	20	35	35	NUM
iajs-17	269	21	.	.	PUNCT
iajs-17	270	1	kimura	kimura	NOUN
iajs-17	270	2	k.	k.	PROPN
iajs-17	270	3	(	(	PUNCT
iajs-17	270	4	2009	2009	NUM
iajs-17	270	5	)	)	PUNCT
iajs-17	270	6	.	.	PUNCT
iajs-17	271	1	role	role	NOUN
iajs-17	271	2	of	of	ADP
iajs-17	271	3	essential	essential	ADJ
iajs-17	271	4	trace	trace	NOUN
iajs-17	271	5	elements	element	NOUN
iajs-17	271	6	in	in	ADP
iajs-17	271	7	the	the	DET
iajs-17	271	8	disturbance	disturbance	NOUN
iajs-17	271	9	of	of	ADP
iajs-17	271	10	carbohydrate	carbohydrate	NOUN
iajs-17	271	11	metabolism‖.	metabolism‖.	PROPN
iajs-17	271	12	nippon	nippon	PROPN
iajs-17	271	13	rinsho	rinsho	NOUN
iajs-17	271	14	;	;	PUNCT
iajs-17	271	15	54	54	NUM
iajs-17	271	16	:	:	PUNCT
iajs-17	271	17	79–84	79–84	NOUN
iajs-17	271	18	36	36	NUM
iajs-17	271	19	.	.	PUNCT
iajs-17	272	1	hamid	hamid	PROPN
iajs-17	272	2	ghaffoori	ghaffoori	PROPN
iajs-17	272	3	hasan	hasan	PROPN
iajs-17	272	4	,	,	PUNCT
iajs-17	272	5	.parween	.parween	PRON
iajs-17	272	6	a.	a.	PROPN
iajs-17	272	7	ismael	ismael	PROPN
iajs-17	272	8	and	and	CCONJ
iajs-17	272	9	nazk	nazk	PROPN
iajs-17	272	10	mohammed	mohammed	PROPN
iajs-17	272	11	aziz	aziz	PROPN
iajs-17	272	12	(	(	PUNCT
iajs-17	272	13	2012	2012	NUM
iajs-17	272	14	)	)	PUNCT
iajs-17	272	15	.	.	PUNCT
iajs-17	273	1	evaluation	evaluation	NOUN
iajs-17	273	2	of	of	ADP
iajs-17	273	3	serum	serum	NOUN
iajs-17	273	4	chromium	chromium	NOUN
iajs-17	273	5	levels	level	NOUN
iajs-17	273	6	in	in	ADP
iajs-17	273	7	patients	patient	NOUN
iajs-17	273	8	with	with	ADP
iajs-17	273	9	type1	type1	NOUN
iajs-17	273	10	and	and	CCONJ
iajs-17	273	11	2	2	NUM
iajs-17	273	12	diabetes	diabetes	NOUN
iajs-17	273	13	mellitus	mellitus	NOUN
iajs-17	273	14	and	and	CCONJ
iajs-17	273	15	insulin	insulin	NOUN
iajs-17	273	16	resistance	resistance	NOUN
iajs-17	273	17	international	international	PROPN
iajs-17	273	18	journal	journal	NOUN
iajs-17	273	19	of	of	ADP
iajs-17	273	20	basic	basic	ADJ
iajs-17	273	21	&	&	CCONJ
iajs-17	273	22	applied	apply	VERB
iajs-17	273	23	sciences	science	NOUN
iajs-17	273	24	ijbas	ijbas	ADJ
iajs-17	273	25	-	-	PUNCT
iajs-17	273	26	ijens:12:04	ijens:12:04	NOUN
iajs-17	273	27	.	.	PUNCT
iajs-17	274	1	37	37	NUM
iajs-17	274	2	.	.	PUNCT
iajs-17	275	1	slatter	slatter	PROPN
iajs-17	275	2	,	,	PUNCT
iajs-17	275	3	da	da	INTJ
iajs-17	275	4	,	,	PUNCT
iajs-17	275	5	botton	botton	NOUN
iajs-17	275	6	,	,	PUNCT
iajs-17	275	7	ch	ch	NOUN
iajs-17	275	8	,	,	PUNCT
iajs-17	275	9	and	and	CCONJ
iajs-17	275	10	bailey	bailey	PROPN
iajs-17	275	11	,	,	PUNCT
iajs-17	275	12	aj	aj	PROPN
iajs-17	275	13	.	.	PROPN
iajs-17	275	14	(	(	PUNCT
iajs-17	275	15	2000	2000	NUM
iajs-17	275	16	)	)	PUNCT
iajs-17	275	17	.	.	PUNCT
iajs-17	276	1	the	the	DET
iajs-17	276	2	importance	importance	NOUN
iajs-17	276	3	of	of	ADP
iajs-17	276	4	lipidderived	lipidderive	VERB
iajs-17	276	5	malondialdehyde	malondialdehyde	PROPN
iajs-17	276	6	in	in	ADP
iajs-17	276	7	diabetes	diabetes	NOUN
iajs-17	276	8	mellitus	mellitus	NOUN
iajs-17	276	9	.	.	PUNCT
iajs-17	277	1	diabetologia	diabetologia	NOUN
iajs-17	277	2	,	,	PUNCT
iajs-17	277	3	43:550−557	43:550−557	PROPN
iajs-17	277	4	.	.	PROPN
iajs-17	277	5	38	38	NUM
iajs-17	277	6	.	.	PUNCT
iajs-17	278	1	mahreen	mahreen	ADJ
iajs-17	278	2	,	,	PUNCT
iajs-17	278	3	r	r	NOUN
iajs-17	278	4	;	;	PUNCT
iajs-17	278	5	mohsin	mohsin	PROPN
iajs-17	278	6	m;nasreen	m;nasreen	VERB
iajs-17	278	7	z	z	PROPN
iajs-17	278	8	;	;	PUNCT
iajs-17	278	9	siraj	siraj	PROPN
iajs-17	278	10	m	m	PROPN
iajs-17	278	11	;	;	PUNCT
iajs-17	278	12	and	and	CCONJ
iajs-17	278	13	ishaq	ishaq	PROPN
iajs-17	278	14	m.	m.	PROPN
iajs-17	278	15	(	(	PUNCT
iajs-17	278	16	2010	2010	NUM
iajs-17	278	17	)	)	PUNCT
iajs-17	278	18	.	.	PUNCT
iajs-17	279	1	significantly	significantly	ADV
iajs-17	279	2	increased	increase	VERB
iajs-17	279	3	levels	level	NOUN
iajs-17	279	4	of	of	ADP
iajs-17	279	5	serum	serum	PROPN
iajs-17	279	6	malonaldehyde	malonaldehyde	PROPN
iajs-17	279	7	in	in	ADP
iajs-17	279	8	type	type	NOUN
iajs-17	279	9	2	2	NUM
iajs-17	279	10	diabetics	diabetic	NOUN
iajs-17	279	11	with	with	ADP
iajs-17	279	12	myocardial	myocardial	ADJ
iajs-17	279	13	infarction	infarction	NOUN
iajs-17	279	14	.	.	PUNCT
iajs-17	280	1	int	int	NOUN
iajs-17	280	2	j	j	PROPN
iajs-17	280	3	diabetes	diabetes	PROPN
iajs-17	280	4	dev	dev	PROPN
iajs-17	280	5	ctries	ctrie	NOUN
iajs-17	280	6	,	,	PUNCT
iajs-17	280	7	30:49−51	30:49−51	NUM
iajs-17	280	8	.	.	NOUN
iajs-17	280	9	39	39	NUM
iajs-17	280	10	.	.	PUNCT
iajs-17	281	1	amanj	amanj	PROPN
iajs-17	281	2	zrar	zrar	PROPN
iajs-17	281	3	hassan	hassan	PROPN
iajs-17	281	4	,	,	PUNCT
iajs-17	281	5	and	and	CCONJ
iajs-17	281	6	leweza	leweza	ADV
iajs-17	281	7	b.abbass	b.abbass	VERB
iajs-17	281	8	(	(	PUNCT
iajs-17	281	9	2011	2011	NUM
iajs-17	281	10	)	)	PUNCT
iajs-17	281	11	evaluation	evaluation	NOUN
iajs-17	281	12	of	of	ADP
iajs-17	281	13	serum	serum	NOUN
iajs-17	281	14	vitamin	vitamin	NOUN
iajs-17	281	15	c	c	NOUN
iajs-17	281	16	,	,	PUNCT
iajs-17	281	17	malondialdehyde	malondialdehyde	PROPN
iajs-17	281	18	&	&	CCONJ
iajs-17	281	19	lipid	lipid	PROPN
iajs-17	281	20	profile	profile	PROPN
iajs-17	281	21	levels	level	NOUN
iajs-17	281	22	in	in	ADP
iajs-17	281	23	type	type	NOUN
iajs-17	281	24	2	2	NUM
iajs-17	281	25	diabetic	diabetic	ADJ
iajs-17	281	26	patient	patient	NOUN
iajs-17	281	27	in	in	ADP
iajs-17	281	28	hawler	hawler	PROPN
iajs-17	281	29	city	city	NOUN
iajs-17	281	30	.	.	PUNCT
iajs-17	282	1	zanco	zanco	PROPN
iajs-17	282	2	j.	j.	PROPN
iajs-17	282	3	med	med	PROPN
iajs-17	282	4	.	.	PUNCT
iajs-17	283	1	sci	sci	PROPN
iajs-17	283	2	.	.	PROPN
iajs-17	284	1	15	15	NUM
iajs-17	284	2	,	,	PUNCT
iajs-17	284	3	no	no	INTJ
iajs-17	284	4	.	.	PUNCT
iajs-17	285	1	(	(	PUNCT
iajs-17	285	2	3	3	NUM
iajs-17	285	3	)	)	PUNCT
iajs-17	285	4	40	40	NUM
iajs-17	285	5	.	.	PUNCT
iajs-17	286	1	bikkad	bikkad	PROPN
iajs-17	286	2	,	,	PUNCT
iajs-17	286	3	md	md	PROPN
iajs-17	286	4	,	,	PUNCT
iajs-17	286	5	somwanshi	somwanshi	PROPN
iajs-17	286	6	sd	sd	NOUN
iajs-17	286	7	,	,	PUNCT
iajs-17	286	8	and	and	CCONJ
iajs-17	286	9	ghuge	ghuge	VERB
iajs-17	286	10	sh	sh	PROPN
iajs-17	286	11	,	,	PUNCT
iajs-17	286	12	nagane	nagane	PROPN
iajs-17	286	13	ns	ns	INTJ
iajs-17	286	14	.	.	PUNCT
iajs-17	286	15	(	(	PUNCT
iajs-17	286	16	2014	2014	NUM
iajs-17	286	17	)	)	PUNCT
iajs-17	286	18	.	.	PUNCT
iajs-17	287	1	oxidative	oxidative	ADJ
iajs-17	287	2	stress	stress	NOUN
iajs-17	287	3	in	in	ADP
iajs-17	287	4	type	type	NOUN
iajs-17	287	5	ii	ii	NOUN
iajs-17	287	6	diabetes	diabetes	NOUN
iajs-17	287	7	mellitus	mellitus	NOUN
iajs-17	287	8	.	.	PUNCT
iajs-17	288	1	biomedical	biomedical	ADJ
iajs-17	288	2	research	research	NOUN
iajs-17	288	3	;	;	PUNCT
iajs-17	288	4	25	25	NUM
iajs-17	288	5	(	(	PUNCT
iajs-17	288	6	1	1	NUM
iajs-17	288	7	):	):	PUNCT
iajs-17	288	8	84	84	NUM
iajs-17	288	9	-	-	SYM
iajs-17	288	10	87	87	NUM
iajs-17	288	11	.	.	PUNCT
iajs-17	289	1	41	41	NUM
iajs-17	289	2	.	.	PUNCT
iajs-17	290	1	baynes	baynes	PROPN
iajs-17	290	2	,	,	PUNCT
iajs-17	290	3	jw	jw	PROPN
iajs-17	290	4	.	.	PROPN
iajs-17	290	5	(	(	PUNCT
iajs-17	290	6	1991	1991	NUM
iajs-17	290	7	)	)	PUNCT
iajs-17	290	8	.	.	PUNCT
iajs-17	291	1	role	role	NOUN
iajs-17	291	2	of	of	ADP
iajs-17	291	3	oxidative	oxidative	ADJ
iajs-17	291	4	stress	stress	NOUN
iajs-17	291	5	in	in	ADP
iajs-17	291	6	development	development	NOUN
iajs-17	291	7	of	of	ADP
iajs-17	291	8	complications	complication	NOUN
iajs-17	291	9	in	in	ADP
iajs-17	291	10	diabetes	diabetes	NOUN
iajs-17	291	11	,	,	PUNCT
iajs-17	291	12	diabetes	diabetes	NOUN
iajs-17	291	13	,	,	PUNCT
iajs-17	291	14	40	40	NUM
iajs-17	291	15	:	:	SYM
iajs-17	291	16	405	405	NUM
iajs-17	291	17	-	-	SYM
iajs-17	291	18	412	412	NUM
iajs-17	291	19	.	.	PUNCT
iajs-17	292	1	42	42	NUM
iajs-17	292	2	.	.	PUNCT
iajs-17	293	1	biplab	biplab	PROPN
iajs-17	293	2	,	,	PUNCT
iajs-17	293	3	mandal	mandal	PROPN
iajs-17	293	4	,	,	PUNCT
iajs-17	293	5	ramtanu	ramtanu	PROPN
iajs-17	293	6	bandyopadhyay	bandyopadhyay	NOUN
iajs-17	293	7	,	,	PUNCT
iajs-17	293	8	srabani	srabani	PROPN
iajs-17	293	9	chakrabarti	chakrabarti	PROPN
iajs-17	293	10	,	,	PUNCT
iajs-17	293	11	tushar	tushar	PROPN
iajs-17	293	12	kanti	kanti	PROPN
iajs-17	293	13	bandyopadhyay	bandyopadhyay	PROPN
iajs-17	293	14	(	(	PUNCT
iajs-17	293	15	2010	2010	NUM
iajs-17	293	16	)	)	PUNCT
iajs-17	293	17	.	.	PUNCT
iajs-17	294	1	assessment	assessment	NOUN
iajs-17	294	2	of	of	ADP
iajs-17	294	3	oxidative	oxidative	ADJ
iajs-17	294	4	stress	stress	NOUN
iajs-17	294	5	in	in	ADP
iajs-17	294	6	patients	patient	NOUN
iajs-17	294	7	of	of	ADP
iajs-17	294	8	diabetes	diabetes	NOUN
iajs-17	294	9	mellitus	mellitus	NOUN
iajs-17	294	10	with	with	ADP
iajs-17	294	11	and	and	CCONJ
iajs-17	294	12	without	without	ADP
iajs-17	294	13	complications	complication	NOUN
iajs-17	294	14	‘	'	PUNCT
iajs-17	294	15	‘	'	PUNCT
iajs-17	294	16	jiacm	jiacm	ADJ
iajs-17	294	17	,	,	PUNCT
iajs-17	294	18	11	11	NUM
iajs-17	294	19	,	,	PUNCT
iajs-17	294	20	1	1	NUM
iajs-17	294	21	20	20	NUM
iajs-17	294	22	-	-	SYM
iajs-17	294	23	5	5	NUM
iajs-17	294	24	.	.	PUNCT
iajs-17	294	25	chemistry	chemistry	NOUN
iajs-17	294	26	|	|	ADV
iajs-17	294	27	142	142	NUM
iajs-17	294	28	2016	2016	NUM
iajs-17	294	29	(	(	PUNCT
iajs-17	294	30	عاً	عاً	PROPN
iajs-17	294	31	3اىعذد	3اىعذد	NUM
iajs-17	294	32	)	)	PUNCT
iajs-17	294	33	29اىَديذ	29اىَديذ	NUM
iajs-17	295	1	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	295	2	ٍديت	ٍديت	VERB
iajs-17	295	3	إبِ	إبِ	X
iajs-17	295	4	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	295	5	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	295	6	اىصشفت	اىصشفت	VERB
iajs-17	295	7	ibn	ibn	PROPN
iajs-17	295	8	al	al	PROPN
iajs-17	295	9	-	-	PUNCT
iajs-17	295	10	haitham	haitham	PROPN
iajs-17	295	11	jour	jour	X
iajs-17	295	12	.	.	PROPN
iajs-17	296	1	for	for	ADP
iajs-17	296	2	pure	pure	ADJ
iajs-17	296	3	&	&	CCONJ
iajs-17	296	4	appl	appl	PROPN
iajs-17	296	5	.	.	PUNCT
iajs-17	297	1	sci	sci	PROPN
iajs-17	297	2	.	.	PUNCT
iajs-17	297	3	vol	vol	NOUN
iajs-17	297	4	.	.	PROPN
iajs-17	297	5	29	29	NUM
iajs-17	297	6	(	(	PUNCT
iajs-17	297	7	3	3	NUM
iajs-17	297	8	)	)	PUNCT
iajs-17	297	9	2016	2016	NUM
iajs-17	297	10	43	43	NUM
iajs-17	297	11	.	.	PUNCT
iajs-17	298	1	suryawanshi	suryawanshi	NOUN
iajs-17	298	2	,	,	PUNCT
iajs-17	298	3	n.p	n.p	PROPN
iajs-17	298	4	.	.	PROPN
iajs-17	298	5	,	,	PUNCT
iajs-17	298	6	bhutey	bhutey	PROPN
iajs-17	298	7	,	,	PUNCT
iajs-17	298	8	a.k	a.k	PROPN
iajs-17	298	9	.	.	PROPN
iajs-17	298	10	,	,	PUNCT
iajs-17	298	11	nagdeote	nagdeote	PROPN
iajs-17	298	12	,	,	PUNCT
iajs-17	298	13	a.n	a.n	PROPN
iajs-17	298	14	.	.	PROPN
iajs-17	298	15	,	,	PUNCT
iajs-17	298	16	jadhav	jadhav	PROPN
iajs-17	298	17	,	,	PUNCT
iajs-17	298	18	a.a	a.a	PROPN
iajs-17	298	19	.	.	PROPN
iajs-17	298	20	and	and	CCONJ
iajs-17	298	21	manoorkar	manoorkar	PROPN
iajs-17	298	22	,	,	PUNCT
iajs-17	298	23	g.s	g.s	PROPN
iajs-17	298	24	.	.	PROPN
iajs-17	298	25	(	(	PUNCT
iajs-17	298	26	2014	2014	NUM
iajs-17	298	27	)	)	PUNCT
iajs-17	298	28	.	.	PUNCT
iajs-17	299	1	study	study	NOUN
iajs-17	299	2	of	of	ADP
iajs-17	299	3	lipid	lipid	ADJ
iajs-17	299	4	peroxide	peroxide	NOUN
iajs-17	299	5	and	and	CCONJ
iajs-17	299	6	lipid	lipid	NOUN
iajs-17	299	7	profile	profile	NOUN
iajs-17	299	8	in	in	ADP
iajs-17	299	9	diabetes	diabetes	NOUN
iajs-17	299	10	mellitus	mellitus	NOUN
iajs-17	299	11	.	.	PUNCT
iajs-17	300	1	indian	indian	PROPN
iajs-17	300	2	journal	journal	PROPN
iajs-17	300	3	of	of	ADP
iajs-17	300	4	clinical	clinical	ADJ
iajs-17	300	5	biochemstry	biochemstry	NOUN
iajs-17	300	6	;	;	PUNCT
iajs-17	300	7	21(1	21(1	NUM
iajs-17	300	8	):	):	PUNCT
iajs-17	300	9	126	126	NUM
iajs-17	300	10	-	-	SYM
iajs-17	300	11	130	130	NUM
iajs-17	300	12	44	44	NUM
iajs-17	300	13	.	.	PUNCT
iajs-17	301	1	fumiaki	fumiaki	PROPN
iajs-17	301	2	kimura	kimura	PROPN
iajs-17	301	3	,	,	PUNCT
iajs-17	301	4	goji	goji	PROPN
iajs-17	301	5	hasegawa	hasegawa	PROPN
iajs-17	301	6	,	,	PUNCT
iajs-17	301	7	hiroshi	hiroshi	PROPN
iajs-17	301	8	obayashi	obayashi	PROPN
iajs-17	301	9	,	,	PUNCT
iajs-17	301	10	tetsuo	tetsuo	PROPN
iajs-17	301	11	adachi	adachi	PROPN
iajs-17	301	12	,	,	PUNCT
iajs-17	301	13	hirokazu	hirokazu	NOUN
iajs-17	301	14	hara	hara	PROPN
iajs-17	301	15	,	,	PUNCT
iajs-17	301	16	mitsuhiro	mitsuhiro	NOUN
iajs-17	301	17	ohta,(2003	ohta,(2003	NOUN
iajs-17	301	18	)	)	PUNCT
iajs-17	301	19	.	.	PUNCT
iajs-17	302	1	serum	serum	PROPN
iajs-17	302	2	extracellular	extracellular	ADJ
iajs-17	302	3	superoxide	superoxide	NOUN
iajs-17	302	4	dismutase	dismutase	NOUN
iajs-17	302	5	in	in	ADP
iajs-17	302	6	patients	patient	NOUN
iajs-17	302	7	with	with	ADP
iajs-17	302	8	type	type	NOUN
iajs-17	302	9	2	2	NUM
iajs-17	302	10	diabetes	diabetes	NOUN
iajs-17	302	11	.	.	PUNCT
iajs-17	303	1	diabetes	diabetes	NOUN
iajs-17	303	2	care	care	NOUN
iajs-17	303	3	,	,	PUNCT
iajs-17	303	4	26	26	NUM
iajs-17	303	5	(	(	PUNCT
iajs-17	303	6	4	4	NUM
iajs-17	303	7	)	)	PUNCT
iajs-17	303	8	.	.	PUNCT
iajs-17	304	1	45	45	NUM
iajs-17	304	2	.	.	PUNCT
iajs-17	304	3	marklund	marklund	PROPN
iajs-17	304	4	sl	sl	INTJ
iajs-17	304	5	(	(	PUNCT
iajs-17	304	6	1990	1990	NUM
iajs-17	304	7	)	)	PUNCT
iajs-17	304	8	.	.	PUNCT
iajs-17	305	1	expreion	expreion	NOUN
iajs-17	305	2	of	of	ADP
iajs-17	305	3	extracellular	extracellular	ADJ
iajs-17	305	4	superoxide	superoxide	NOUN
iajs-17	305	5	dismutase	dismutase	NOUN
iajs-17	305	6	by	by	ADP
iajs-17	305	7	human	human	ADJ
iajs-17	305	8	cell	cell	NOUN
iajs-17	305	9	lines	line	NOUN
iajs-17	305	10	.	.	PUNCT
iajs-17	306	1	biochemical	biochemical	ADJ
iajs-17	306	2	journa	journa	PROPN
iajs-17	306	3	,	,	PUNCT
iajs-17	306	4	l	l	PROPN
iajs-17	306	5	266	266	NUM
iajs-17	306	6	213–219	213–219	NUM
iajs-17	306	7	.	.	PUNCT
iajs-17	307	1	table	table	NOUN
iajs-17	307	2	(	(	PUNCT
iajs-17	307	3	1	1	NUM
iajs-17	307	4	):	):	PUNCT
iajs-17	307	5	mean	mean	PROPN
iajs-17	307	6	±	±	PROPN
iajs-17	307	7	s.d	s.d	PROPN
iajs-17	307	8	in	in	ADP
iajs-17	307	9	patients	patient	NOUN
iajs-17	307	10	and	and	CCONJ
iajs-17	307	11	control	control	NOUN
iajs-17	307	12	groups	group	NOUN
iajs-17	307	13	.	.	PUNCT
iajs-17	308	1	parameter	parameter	PROPN
iajs-17	308	2	group	group	PROPN
iajs-17	308	3	(	(	PUNCT
iajs-17	308	4	c	c	NOUN
iajs-17	308	5	)	)	PUNCT
iajs-17	308	6	(	(	PUNCT
iajs-17	308	7	n=35	n=35	PROPN
iajs-17	308	8	)	)	PUNCT
iajs-17	308	9	group	group	NOUN
iajs-17	308	10	(	(	PUNCT
iajs-17	308	11	p	p	NOUN
iajs-17	308	12	)	)	PUNCT
iajs-17	308	13	(	(	PUNCT
iajs-17	308	14	n=130	n=130	NOUN
iajs-17	308	15	)	)	PUNCT
iajs-17	308	16	p	p	NOUN
iajs-17	308	17	value	value	NOUN
iajs-17	308	18	age	age	NOUN
iajs-17	308	19	(	(	PUNCT
iajs-17	308	20	years	year	NOUN
iajs-17	308	21	)	)	PUNCT
iajs-17	308	22	45	45	NUM
iajs-17	308	23	±	±	NUM
iajs-17	308	24	6.4	6.4	NUM
iajs-17	308	25	49	49	NUM
iajs-17	308	26	±	±	NUM
iajs-17	308	27	6.2	6.2	NUM
iajs-17	308	28	0.001	0.001	NUM
iajs-17	308	29	duration	duration	NOUN
iajs-17	308	30	of	of	ADP
iajs-17	308	31	dm	dm	PROPN
iajs-17	308	32	(	(	PUNCT
iajs-17	308	33	years	year	NOUN
iajs-17	308	34	)	)	PUNCT
iajs-17	309	1	_	_	PUNCT
iajs-17	310	1	_	_	PUNCT
iajs-17	311	1	6.23	6.23	NUM
iajs-17	311	2	±	±	NUM
iajs-17	311	3	3.72	3.72	NUM
iajs-17	311	4	_	_	PUNCT
iajs-17	312	1	_	_	PUNCT
iajs-17	313	1	bmi	bmi	NOUN
iajs-17	313	2	(	(	PUNCT
iajs-17	313	3	kg	kg	NOUN
iajs-17	313	4	/	/	SYM
iajs-17	313	5	m	m	PROPN
iajs-17	313	6	2	2	NUM
iajs-17	313	7	)	)	PUNCT
iajs-17	313	8	27.06	27.06	NUM
iajs-17	313	9	±	±	NUM
iajs-17	313	10	3.8	3.8	NUM
iajs-17	313	11	30.62	30.62	NUM
iajs-17	313	12	±	±	NUM
iajs-17	313	13	6.9	6.9	NUM
iajs-17	313	14	n.s	n.s	PROPN
iajs-17	313	15	.	.	PUNCT
iajs-17	314	1	fsg	fsg	PROPN
iajs-17	314	2	(	(	PUNCT
iajs-17	314	3	mg	mg	PROPN
iajs-17	314	4	/	/	SYM
iajs-17	314	5	dl	dl	PROPN
iajs-17	314	6	)	)	PUNCT
iajs-17	314	7	87.31	87.31	NUM
iajs-17	314	8	±	±	NUM
iajs-17	314	9	9.93	9.93	NUM
iajs-17	314	10	197.61±	197.61±	NUM
iajs-17	314	11	73.7	73.7	NUM
iajs-17	314	12	0.000	0.000	NUM
iajs-17	314	13	insulin	insulin	NOUN
iajs-17	314	14	(	(	PUNCT
iajs-17	314	15	µlu	µlu	PROPN
iajs-17	314	16	/	/	SYM
iajs-17	314	17	ml	ml	VERB
iajs-17	314	18	)	)	PUNCT
iajs-17	314	19	11.89	11.89	NUM
iajs-17	314	20	±	±	NUM
iajs-17	314	21	1.9	1.9	NUM
iajs-17	314	22	16.86	16.86	NUM
iajs-17	314	23	±	±	NUM
iajs-17	314	24	4.1	4.1	NUM
iajs-17	314	25	0.000	0.000	NUM
iajs-17	314	26	homa2	homa2	NOUN
iajs-17	314	27	-	-	PUNCT
iajs-17	314	28	β	β	NOUN
iajs-17	314	29	cell	cell	NOUN
iajs-17	314	30	(	(	PUNCT
iajs-17	314	31	%	%	INTJ
iajs-17	314	32	)	)	PUNCT
iajs-17	314	33	140.42	140.42	NUM
iajs-17	314	34	±	±	NUM
iajs-17	314	35	34.4	34.4	NUM
iajs-17	314	36	49.53	49.53	NUM
iajs-17	314	37	±	±	NUM
iajs-17	314	38	27.3	27.3	NUM
iajs-17	314	39	0.000	0.000	NUM
iajs-17	314	40	homa2	homa2	NOUN
iajs-17	314	41	-	-	PUNCT
iajs-17	314	42	s	s	X
iajs-17	314	43	(	(	PUNCT
iajs-17	314	44	%	%	NOUN
iajs-17	314	45	)	)	PUNCT
iajs-17	314	46	67.36	67.36	NUM
iajs-17	314	47	±	±	NUM
iajs-17	314	48	17.0	17.0	NUM
iajs-17	314	49	40.29	40.29	NUM
iajs-17	314	50	±	±	NUM
iajs-17	314	51	13.1	13.1	NUM
iajs-17	314	52	0.000	0.000	NUM
iajs-17	314	53	homa2	homa2	NOUN
iajs-17	314	54	-	-	PUNCT
iajs-17	314	55	ir	ir	PROPN
iajs-17	314	56	1.51	1.51	NUM
iajs-17	314	57	±	±	NUM
iajs-17	314	58	0.25	0.25	NUM
iajs-17	314	59	3.38	3.38	NUM
iajs-17	314	60	±	±	NUM
iajs-17	314	61	16.6	16.6	NUM
iajs-17	314	62	0.004	0.004	NUM
iajs-17	314	63	cr	cr	PROPN
iajs-17	314	64	(	(	PUNCT
iajs-17	314	65	μg	μg	PROPN
iajs-17	314	66	/	/	SYM
iajs-17	314	67	l	l	NOUN
iajs-17	314	68	)	)	PUNCT
iajs-17	314	69	0.44	0.44	NUM
iajs-17	314	70	±	±	NUM
iajs-17	314	71	0.03	0.03	NUM
iajs-17	314	72	0.034	0.034	NUM
iajs-17	314	73	±	±	NUM
iajs-17	314	74	0.01	0.01	NUM
iajs-17	314	75	0.000	0.000	NUM
iajs-17	314	76	mda	mda	PROPN
iajs-17	314	77	(	(	PUNCT
iajs-17	314	78	mmol	mmol	NOUN
iajs-17	314	79	/	/	SYM
iajs-17	314	80	l	l	NOUN
iajs-17	314	81	)	)	PUNCT
iajs-17	314	82	1.232	1.232	NUM
iajs-17	314	83	±	±	NUM
iajs-17	314	84	0.53	0.53	NUM
iajs-17	314	85	1.91	1.91	NUM
iajs-17	314	86	±	±	NUM
iajs-17	314	87	0.55	0.55	NUM
iajs-17	314	88	0.000	0.000	NUM
iajs-17	314	89	p<0.05	p<0.05	NOUN
iajs-17	314	90	:	:	PUNCT
iajs-17	314	91	significant	significant	ADJ
iajs-17	314	92	.	.	PUNCT
iajs-17	315	1	table	table	NOUN
iajs-17	315	2	(	(	PUNCT
iajs-17	315	3	2	2	NUM
iajs-17	315	4	):	):	PUNCT
iajs-17	315	5	mean	mean	PROPN
iajs-17	315	6	±	±	PROPN
iajs-17	315	7	s.d	s.d	PROPN
iajs-17	315	8	in	in	ADP
iajs-17	315	9	controlled	control	VERB
iajs-17	315	10	dm	dm	PROPN
iajs-17	315	11	,	,	PUNCT
iajs-17	315	12	medium	medium	NOUN
iajs-17	315	13	controlled	control	VERB
iajs-17	315	14	dm	dm	PROPN
iajs-17	315	15	,	,	PUNCT
iajs-17	315	16	uncontrolled	uncontrolled	ADJ
iajs-17	315	17	dm	dm	NOUN
iajs-17	315	18	,	,	PUNCT
iajs-17	315	19	and	and	CCONJ
iajs-17	315	20	control	control	NOUN
iajs-17	315	21	groups	group	NOUN
iajs-17	315	22	.	.	PUNCT
iajs-17	316	1	parameter	parameter	PROPN
iajs-17	316	2	group	group	PROPN
iajs-17	316	3	(	(	PUNCT
iajs-17	316	4	c	c	NOUN
iajs-17	316	5	)	)	PUNCT
iajs-17	316	6	(	(	PUNCT
iajs-17	316	7	n=35	n=35	PROPN
iajs-17	316	8	)	)	PUNCT
iajs-17	316	9	group	group	NOUN
iajs-17	316	10	(	(	PUNCT
iajs-17	316	11	p1	p1	PROPN
iajs-17	316	12	)	)	PUNCT
iajs-17	316	13	(	(	PUNCT
iajs-17	316	14	n=30	n=30	NOUN
iajs-17	316	15	)	)	PUNCT
iajs-17	316	16	group	group	NOUN
iajs-17	316	17	(	(	PUNCT
iajs-17	316	18	p2	p2	PROPN
iajs-17	316	19	)	)	PUNCT
iajs-17	316	20	(	(	PUNCT
iajs-17	316	21	n=40	n=40	ADJ
iajs-17	316	22	)	)	PUNCT
iajs-17	316	23	group	group	NOUN
iajs-17	316	24	(	(	PUNCT
iajs-17	316	25	p3	p3	PROPN
iajs-17	316	26	)	)	PUNCT
iajs-17	316	27	(	(	PUNCT
iajs-17	316	28	n=60	n=60	NOUN
iajs-17	316	29	)	)	PUNCT
iajs-17	316	30	p	p	NOUN
iajs-17	316	31	value	value	NOUN
iajs-17	316	32	age	age	NOUN
iajs-17	316	33	(	(	PUNCT
iajs-17	316	34	years	year	NOUN
iajs-17	316	35	)	)	PUNCT
iajs-17	316	36	45	45	NUM
iajs-17	316	37	±	±	NUM
iajs-17	316	38	9.50	9.50	NUM
iajs-17	316	39	48	48	NUM
iajs-17	316	40	±	±	NUM
iajs-17	316	41	6.30	6.30	NUM
iajs-17	316	42	50.8	50.8	NUM
iajs-17	316	43	±	±	NUM
iajs-17	316	44	4.2	4.2	NUM
iajs-17	316	45	49	49	NUM
iajs-17	316	46	±	±	NUM
iajs-17	316	47	5.2	5.2	NUM
iajs-17	316	48	n.s	n.s	PROPN
iajs-17	316	49	duration	duration	NOUN
iajs-17	316	50	of	of	ADP
iajs-17	316	51	dm	dm	PROPN
iajs-17	316	52	(	(	PUNCT
iajs-17	316	53	years	year	NOUN
iajs-17	316	54	)	)	PUNCT
iajs-17	316	55	00.00	00.00	NUM
iajs-17	316	56	3.8	3.8	NUM
iajs-17	316	57	±	±	NUM
iajs-17	316	58	82	82	NUM
iajs-17	316	59	4.48	4.48	NUM
iajs-17	316	60	±	±	NUM
iajs-17	316	61	8.12	8.12	NUM
iajs-17	316	62	8.6	8.6	NUM
iajs-17	316	63	±	±	NUM
iajs-17	316	64	11.3	11.3	NUM
iajs-17	316	65	0.005	0.005	NUM
iajs-17	316	66	bmi	bmi	NOUN
iajs-17	316	67	(	(	PUNCT
iajs-17	316	68	kg	kg	NOUN
iajs-17	316	69	/	/	SYM
iajs-17	316	70	m	m	PROPN
iajs-17	316	71	2	2	NUM
iajs-17	316	72	)	)	PUNCT
iajs-17	316	73	27.07±	27.07±	NUM
iajs-17	316	74	3.89	3.89	NUM
iajs-17	316	75	30.91±	30.91±	NUM
iajs-17	316	76	5.62	5.62	NUM
iajs-17	316	77	30.85±	30.85±	NUM
iajs-17	316	78	9.36	9.36	NUM
iajs-17	316	79	30.33	30.33	NUM
iajs-17	316	80	±	±	NUM
iajs-17	316	81	5.64	5.64	NUM
iajs-17	316	82	n.s	n.s	PROPN
iajs-17	316	83	fsg	fsg	PROPN
iajs-17	316	84	(	(	PUNCT
iajs-17	316	85	mg	mg	PROPN
iajs-17	316	86	/	/	SYM
iajs-17	316	87	dl	dl	PROPN
iajs-17	316	88	)	)	PUNCT
iajs-17	316	89	87.31±	87.31±	NUM
iajs-17	316	90	9.93	9.93	NUM
iajs-17	316	91	153.90±	153.90±	NUM
iajs-17	316	92	35.11	35.11	NUM
iajs-17	316	93	163.83±	163.83±	NUM
iajs-17	316	94	47.70	47.70	NUM
iajs-17	316	95	241.98±	241.98±	NUM
iajs-17	317	1	77.52	77.52	NUM
iajs-17	317	2	0.000	0.000	NUM
iajs-17	317	3	insulin	insulin	NOUN
iajs-17	317	4	(	(	PUNCT
iajs-17	317	5	µlu	µlu	ADJ
iajs-17	317	6	/	/	SYM
iajs-17	317	7	ml	ml	VERB
iajs-17	317	8	)	)	PUNCT
iajs-17	317	9	11.89±	11.89±	NUM
iajs-17	317	10	1.86	1.86	NUM
iajs-17	317	11	13.62±	13.62±	NUM
iajs-17	317	12	13.62	13.62	NUM
iajs-17	317	13	16.4	16.4	NUM
iajs-17	317	14	±	±	NUM
iajs-17	317	15	3.29	3.29	NUM
iajs-17	317	16	18.79±	18.79±	NUM
iajs-17	317	17	4.18	4.18	NUM
iajs-17	317	18	0.000	0.000	NUM
iajs-17	317	19	homa2	homa2	NOUN
iajs-17	317	20	-	-	PUNCT
iajs-17	317	21	β	β	NOUN
iajs-17	317	22	cell	cell	NOUN
iajs-17	317	23	(	(	PUNCT
iajs-17	317	24	%	%	INTJ
iajs-17	317	25	)	)	PUNCT
iajs-17	317	26	140.42±	140.42±	NUM
iajs-17	317	27	34.42	34.42	NUM
iajs-17	317	28	57.35±	57.35±	NUM
iajs-17	317	29	23.66	23.66	NUM
iajs-17	317	30	62.00±30.23	62.00±30.23	NUM
iajs-17	317	31	37.29±	37.29±	NUM
iajs-17	317	32	21.61	21.61	NUM
iajs-17	317	33	0.000	0.000	NUM
iajs-17	317	34	homa2	homa2	NOUN
iajs-17	317	35	-	-	PUNCT
iajs-17	317	36	s	s	X
iajs-17	317	37	(	(	PUNCT
iajs-17	317	38	%	%	INTJ
iajs-17	317	39	)	)	PUNCT
iajs-17	317	40	67.37±	67.37±	NUM
iajs-17	317	41	16.99	16.99	NUM
iajs-17	317	42	52.25±	52.25±	NUM
iajs-17	317	43	9.89	9.89	NUM
iajs-17	317	44	43.29	43.29	NUM
iajs-17	317	45	±	±	NUM
iajs-17	317	46	9.62	9.62	NUM
iajs-17	317	47	32.30±	32.30±	NUM
iajs-17	317	48	11.03	11.03	NUM
iajs-17	317	49	0.000	0.000	NUM
iajs-17	317	50	homa2	homa2	NOUN
iajs-17	317	51	-	-	PUNCT
iajs-17	317	52	ir	ir	PROPN
iajs-17	317	53	1.51	1.51	NUM
iajs-17	317	54	±	±	NUM
iajs-17	317	55	0.25	0.25	NUM
iajs-17	317	56	1.97	1.97	NUM
iajs-17	317	57	±	±	NUM
iajs-17	317	58	0.35	0.35	NUM
iajs-17	317	59	2.42	2.42	NUM
iajs-17	317	60	±	±	NUM
iajs-17	317	61	0.52	0.52	NUM
iajs-17	317	62	4.73	4.73	NUM
iajs-17	317	63	±	±	NUM
iajs-17	317	64	10.41	10.41	NUM
iajs-17	317	65	n.s	n.s	PROPN
iajs-17	317	66	cr	cr	PROPN
iajs-17	317	67	(	(	PUNCT
iajs-17	317	68	μg	μg	PROPN
iajs-17	317	69	/	/	SYM
iajs-17	317	70	l	l	NOUN
iajs-17	317	71	)	)	PUNCT
iajs-17	317	72	0.44	0.44	NUM
iajs-17	317	73	±0.05	±0.05	PROPN
iajs-17	317	74	0.05	0.05	NUM
iajs-17	317	75	±	±	NUM
iajs-17	317	76	0.00	0.00	NUM
iajs-17	317	77	0.03	0.03	NUM
iajs-17	317	78	±	±	NUM
iajs-17	317	79	0.002	0.002	NUM
iajs-17	317	80	0.026±	0.026±	NUM
iajs-17	317	81	0.001	0.001	NUM
iajs-17	317	82	0.000	0.000	NUM
iajs-17	317	83	mda	mda	PROPN
iajs-17	317	84	(	(	PUNCT
iajs-17	317	85	mmol	mmol	NOUN
iajs-17	317	86	/	/	SYM
iajs-17	317	87	l	l	NOUN
iajs-17	317	88	)	)	PUNCT
iajs-17	317	89	1.23	1.23	NUM
iajs-17	317	90	±	±	NUM
iajs-17	317	91	0.53	0.53	NUM
iajs-17	317	92	1.88	1.88	NUM
iajs-17	317	93	±	±	NUM
iajs-17	317	94	0.57	0.57	NUM
iajs-17	317	95	1.92	1.92	NUM
iajs-17	317	96	±	±	NUM
iajs-17	317	97	0.43	0.43	NUM
iajs-17	317	98	1.92	1.92	NUM
iajs-17	317	99	±	±	NUM
iajs-17	317	100	0.61	0.61	NUM
iajs-17	317	101	0.000	0.000	NUM
iajs-17	317	102	*	*	PUNCT
iajs-17	317	103	p<0.05	p<0.05	NOUN
iajs-17	317	104	;	;	PUNCT
iajs-17	317	105	*	*	PUNCT
iajs-17	317	106	*	*	PUNCT
iajs-17	317	107	p<0.01;***p<0.001	p<0.01;***p<0.001	NOUN
iajs-17	317	108	;	;	PUNCT
iajs-17	317	109	no	no	DET
iajs-17	317	110	asterisk	asterisk	NOUN
iajs-17	317	111	:	:	PUNCT
iajs-17	317	112	p≥0.05	p≥0.05	NOUN
iajs-17	317	113	.	.	PUNCT
iajs-17	318	1	chemistry	chemistry	NOUN
iajs-17	319	1	|	|	ADV
iajs-17	319	2	143	143	NUM
iajs-17	319	3	2016	2016	NUM
iajs-17	319	4	(	(	PUNCT
iajs-17	319	5	عاً	عاً	PROPN
iajs-17	319	6	3اىعذد	3اىعذد	NUM
iajs-17	319	7	)	)	PUNCT
iajs-17	319	8	29اىَديذ	29اىَديذ	NUM
iajs-17	319	9	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	319	10	ٍديت	ٍديت	VERB
iajs-17	319	11	إبِ	إبِ	X
iajs-17	319	12	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	319	13	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	319	14	اىصشفت	اىصشفت	VERB
iajs-17	319	15	ibn	ibn	PROPN
iajs-17	319	16	al	al	PROPN
iajs-17	319	17	-	-	PUNCT
iajs-17	319	18	haitham	haitham	PROPN
iajs-17	319	19	jour	jour	X
iajs-17	319	20	.	.	PROPN
iajs-17	320	1	for	for	ADP
iajs-17	320	2	pure	pure	ADJ
iajs-17	320	3	&	&	CCONJ
iajs-17	320	4	appl	appl	PROPN
iajs-17	320	5	.	.	PUNCT
iajs-17	321	1	sci	sci	PROPN
iajs-17	321	2	.	.	PUNCT
iajs-17	321	3	vol	vol	NOUN
iajs-17	321	4	.	.	PROPN
iajs-17	321	5	29	29	NUM
iajs-17	321	6	(	(	PUNCT
iajs-17	321	7	3	3	NUM
iajs-17	321	8	)	)	SYM
iajs-17	321	9	2016	2016	NUM
iajs-17	321	10	table	table	NOUN
iajs-17	321	11	(	(	PUNCT
iajs-17	321	12	3	3	NUM
iajs-17	321	13	):	):	PUNCT
iajs-17	321	14	ec	ec	NOUN
iajs-17	321	15	-	-	PUNCT
iajs-17	321	16	sod	sod	NOUN
iajs-17	321	17	activity	activity	NOUN
iajs-17	321	18	in	in	ADP
iajs-17	321	19	total	total	ADJ
iajs-17	321	20	patients	patient	NOUN
iajs-17	321	21	(	(	PUNCT
iajs-17	321	22	p	p	NOUN
iajs-17	321	23	)	)	PUNCT
iajs-17	321	24	,	,	PUNCT
iajs-17	321	25	controlled	control	VERB
iajs-17	321	26	dm	dm	PROPN
iajs-17	321	27	(	(	PUNCT
iajs-17	321	28	p1	p1	PROPN
iajs-17	321	29	)	)	PUNCT
iajs-17	321	30	,	,	PUNCT
iajs-17	321	31	medium	medium	NOUN
iajs-17	321	32	controlled	control	VERB
iajs-17	321	33	dm	dm	PROPN
iajs-17	321	34	(	(	PUNCT
iajs-17	321	35	p2	p2	PROPN
iajs-17	321	36	)	)	PUNCT
iajs-17	321	37	,	,	PUNCT
iajs-17	321	38	uncontrolled	uncontrolled	ADJ
iajs-17	321	39	dm	dm	PROPN
iajs-17	321	40	(	(	PUNCT
iajs-17	321	41	p3	p3	PROPN
iajs-17	321	42	)	)	PUNCT
iajs-17	321	43	,	,	PUNCT
iajs-17	321	44	and	and	CCONJ
iajs-17	321	45	control	control	NOUN
iajs-17	321	46	groups	group	NOUN
iajs-17	321	47	(	(	PUNCT
iajs-17	321	48	c	c	NOUN
iajs-17	321	49	)	)	PUNCT
iajs-17	321	50	.	.	PUNCT
iajs-17	322	1	group	group	NOUN
iajs-17	322	2	parameter	parameter	PROPN
iajs-17	322	3	control	control	PROPN
iajs-17	322	4	group	group	PROPN
iajs-17	322	5	(	(	PUNCT
iajs-17	322	6	c	c	NOUN
iajs-17	322	7	)	)	PUNCT
iajs-17	322	8	(	(	PUNCT
iajs-17	322	9	n	n	NOUN
iajs-17	322	10	=	=	SYM
iajs-17	322	11	35	35	NUM
iajs-17	322	12	)	)	PUNCT
iajs-17	322	13	(	(	PUNCT
iajs-17	322	14	pooled	pool	VERB
iajs-17	322	15	)	)	PUNCT
iajs-17	322	16	patients	patient	NOUN
iajs-17	322	17	group	group	NOUN
iajs-17	322	18	(	(	PUNCT
iajs-17	322	19	p	p	NOUN
iajs-17	322	20	)	)	PUNCT
iajs-17	322	21	(	(	PUNCT
iajs-17	322	22	n	n	NOUN
iajs-17	322	23	=	=	SYM
iajs-17	322	24	130	130	NUM
iajs-17	322	25	)	)	PUNCT
iajs-17	322	26	(	(	PUNCT
iajs-17	322	27	pooled	pool	VERB
iajs-17	322	28	)	)	PUNCT
iajs-17	322	29	controlled	control	VERB
iajs-17	322	30	dm	dm	PROPN
iajs-17	322	31	(	(	PUNCT
iajs-17	322	32	p1	p1	PROPN
iajs-17	322	33	)	)	PUNCT
iajs-17	322	34	(	(	PUNCT
iajs-17	322	35	n	n	NOUN
iajs-17	322	36	=	=	SYM
iajs-17	322	37	30	30	NUM
iajs-17	322	38	)	)	PUNCT
iajs-17	322	39	(	(	PUNCT
iajs-17	322	40	pooled	pool	VERB
iajs-17	322	41	)	)	PUNCT
iajs-17	322	42	medium	medium	NOUN
iajs-17	322	43	controlled	control	VERB
iajs-17	322	44	dm	dm	PROPN
iajs-17	322	45	(	(	PUNCT
iajs-17	322	46	p2	p2	PROPN
iajs-17	322	47	)	)	PUNCT
iajs-17	322	48	(	(	PUNCT
iajs-17	322	49	n	n	NOUN
iajs-17	322	50	=	=	SYM
iajs-17	322	51	40	40	NUM
iajs-17	322	52	)	)	PUNCT
iajs-17	322	53	(	(	PUNCT
iajs-17	322	54	pooled	pool	VERB
iajs-17	322	55	)	)	PUNCT
iajs-17	322	56	uncontrolled	uncontrolled	ADJ
iajs-17	322	57	dm	dm	PROPN
iajs-17	322	58	(	(	PUNCT
iajs-17	322	59	n	n	NOUN
iajs-17	322	60	=	=	SYM
iajs-17	322	61	60	60	NUM
iajs-17	322	62	)	)	PUNCT
iajs-17	322	63	(	(	PUNCT
iajs-17	322	64	pooled	pool	VERB
iajs-17	322	65	)	)	PUNCT
iajs-17	322	66	ec	ec	PROPN
iajs-17	322	67	-	-	PUNCT
iajs-17	322	68	sod	sod	NOUN
iajs-17	322	69	(	(	PUNCT
iajs-17	322	70	u	u	NOUN
iajs-17	322	71	/	/	SYM
iajs-17	322	72	ml	ml	VERB
iajs-17	322	73	)	)	PUNCT
iajs-17	322	74	12.43	12.43	NUM
iajs-17	322	75	10.05	10.05	NUM
iajs-17	322	76	11.78	11.78	NUM
iajs-17	322	77	10.5	10.5	NUM
iajs-17	322	78	7.86	7.86	NUM
iajs-17	322	79	table	table	NOUN
iajs-17	322	80	(	(	PUNCT
iajs-17	322	81	4	4	NUM
iajs-17	322	82	):	):	PUNCT
iajs-17	322	83	pearson	pearson	NOUN
iajs-17	322	84	correlation	correlation	NOUN
iajs-17	322	85	analysis	analysis	NOUN
iajs-17	322	86	of	of	ADP
iajs-17	322	87	mda	mda	PROPN
iajs-17	322	88	in	in	ADP
iajs-17	322	89	group	group	PROPN
iajs-17	322	90	p1	p1	PROPN
iajs-17	322	91	,	,	PUNCT
iajs-17	322	92	p2	p2	PROPN
iajs-17	322	93	and	and	CCONJ
iajs-17	322	94	p3	p3	PROPN
iajs-17	322	95	.	.	PUNCT
iajs-17	323	1	parameters	parameter	NOUN
iajs-17	323	2	mda	mda	PROPN
iajs-17	323	3	(	(	PUNCT
iajs-17	323	4	mmol	mmol	NOUN
iajs-17	323	5	/	/	SYM
iajs-17	323	6	l	l	NOUN
iajs-17	323	7	)	)	PUNCT
iajs-17	323	8	r	r	NOUN
iajs-17	323	9	value	value	NOUN
iajs-17	323	10	group	group	NOUN
iajs-17	323	11	(	(	PUNCT
iajs-17	323	12	p1	p1	PROPN
iajs-17	323	13	)	)	PUNCT
iajs-17	323	14	p	p	NOUN
iajs-17	323	15	value	value	NOUN
iajs-17	323	16	group	group	NOUN
iajs-17	323	17	(	(	PUNCT
iajs-17	323	18	p1	p1	NOUN
iajs-17	323	19	)	)	PUNCT
iajs-17	323	20	r	r	NOUN
iajs-17	323	21	value	value	NOUN
iajs-17	323	22	group	group	NOUN
iajs-17	323	23	(	(	PUNCT
iajs-17	323	24	p2	p2	PROPN
iajs-17	323	25	)	)	PUNCT
iajs-17	323	26	p	p	NOUN
iajs-17	323	27	value	value	NOUN
iajs-17	323	28	group	group	NOUN
iajs-17	323	29	(	(	PUNCT
iajs-17	323	30	p3	p3	NOUN
iajs-17	323	31	)	)	PUNCT
iajs-17	323	32	r	r	NOUN
iajs-17	323	33	value	value	NOUN
iajs-17	323	34	group	group	NOUN
iajs-17	323	35	(	(	PUNCT
iajs-17	323	36	p3	p3	PROPN
iajs-17	323	37	)	)	PUNCT
iajs-17	323	38	p	p	NOUN
iajs-17	323	39	value	value	NOUN
iajs-17	323	40	group	group	NOUN
iajs-17	323	41	(	(	PUNCT
iajs-17	323	42	p3	p3	PROPN
iajs-17	323	43	)	)	PUNCT
iajs-17	323	44	age	age	NOUN
iajs-17	323	45	(	(	PUNCT
iajs-17	323	46	year	year	NOUN
iajs-17	323	47	)	)	PUNCT
iajs-17	323	48	.785	.785	NUM
iajs-17	323	49	*	*	PUNCT
iajs-17	323	50	*	*	PUNCT
iajs-17	323	51	0.000	0.000	NUM
iajs-17	323	52	.886	.886	NUM
iajs-17	323	53	*	*	PUNCT
iajs-17	323	54	*	*	PUNCT
iajs-17	323	55	0.000	0.000	NUM
iajs-17	323	56	.737	.737	NUM
iajs-17	323	57	*	*	PUNCT
iajs-17	323	58	*	*	PUNCT
iajs-17	323	59	0.000	0.000	NUM
iajs-17	323	60	duration	duration	NOUN
iajs-17	323	61	(	(	PUNCT
iajs-17	323	62	year	year	NOUN
iajs-17	323	63	)	)	PUNCT
iajs-17	323	64	.128	.128	NUM
iajs-17	323	65	0.176	0.176	NUM
iajs-17	323	66	.244	.244	NUM
iajs-17	323	67	0.128	0.128	NUM
iajs-17	323	68	.401	.401	NUM
iajs-17	323	69	*	*	PUNCT
iajs-17	324	1	*	*	PUNCT
iajs-17	324	2	0.002	0.002	NUM
iajs-17	324	3	hba1c	hba1c	PROPN
iajs-17	324	4	.016	.016	NUM
iajs-17	324	5	0.450	0.450	NUM
iajs-17	324	6	-.119	-.119	PROPN
iajs-17	324	7	0.464	0.464	NUM
iajs-17	324	8	.379	.379	NUM
iajs-17	324	9	*	*	PROPN
iajs-17	324	10	*	*	PROPN
iajs-17	324	11	0.003	0.003	NUM
iajs-17	324	12	fsg	fsg	NOUN
iajs-17	324	13	(	(	PUNCT
iajs-17	324	14	mg	mg	PROPN
iajs-17	324	15	/	/	SYM
iajs-17	324	16	dl	dl	NOUN
iajs-17	324	17	)	)	PUNCT
iajs-17	324	18	-.019	-.019	PROPN
iajs-17	324	19	0.543	0.543	NUM
iajs-17	324	20	.080	.080	NUM
iajs-17	324	21	0.625	0.625	NUM
iajs-17	324	22	.066	.066	NUM
iajs-17	324	23	0.616	0.616	NUM
iajs-17	324	24	insulin	insulin	NOUN
iajs-17	324	25	(	(	PUNCT
iajs-17	324	26	µlu	µlu	PROPN
iajs-17	324	27	/	/	SYM
iajs-17	324	28	ml	ml	VERB
iajs-17	324	29	)	)	PUNCT
iajs-17	324	30	.145	.145	NUM
iajs-17	324	31	0.347	0.347	NUM
iajs-17	324	32	.250	.250	NUM
iajs-17	324	33	0.120	0.120	NUM
iajs-17	324	34	.055	.055	NUM
iajs-17	324	35	0.677	0.677	NUM
iajs-17	324	36	homa2	homa2	NOUN
iajs-17	324	37	-	-	PUNCT
iajs-17	324	38	β	β	NOUN
iajs-17	324	39	cell	cell	NOUN
iajs-17	324	40	(	(	PUNCT
iajs-17	324	41	%	%	INTJ
iajs-17	324	42	)	)	PUNCT
iajs-17	324	43	.042	.042	NUM
iajs-17	324	44	0.765	0.765	NUM
iajs-17	324	45	-.058	-.058	NOUN
iajs-17	324	46	0.723	0.723	NUM
iajs-17	324	47	.005	.005	NUM
iajs-17	324	48	0.972	0.972	NUM
iajs-17	324	49	homa2	homa2	NOUN
iajs-17	324	50	-	-	PUNCT
iajs-17	324	51	s	s	X
iajs-17	324	52	(	(	PUNCT
iajs-17	324	53	%	%	NOUN
iajs-17	324	54	)	)	PUNCT
iajs-17	324	55	-.109	-.109	VERB
iajs-17	324	56	0.356	0.356	NUM
iajs-17	325	1	-.216	-.216	VERB
iajs-17	325	2	0.181	0.181	NUM
iajs-17	325	3	-.100	-.100	NOUN
iajs-17	325	4	0.449	0.449	NUM
iajs-17	325	5	homa2	homa2	NOUN
iajs-17	325	6	-	-	PUNCT
iajs-17	325	7	ir	ir	PROPN
iajs-17	325	8	.108	.108	NUM
iajs-17	325	9	0.213	0.213	NUM
iajs-17	325	10	.270	.270	NUM
iajs-17	325	11	0.091	0.091	NUM
iajs-17	325	12	.069	.069	NUM
iajs-17	325	13	0.600	0.600	NUM
iajs-17	325	14	cr	cr	PROPN
iajs-17	325	15	(	(	PUNCT
iajs-17	325	16	μg	μg	PROPN
iajs-17	325	17	/	/	SYM
iajs-17	325	18	l	l	NOUN
iajs-17	325	19	)	)	PUNCT
iajs-17	325	20	-.017	-.017	PROPN
iajs-17	325	21	0.076	0.076	NUM
iajs-17	325	22	.143	.143	NUM
iajs-17	325	23	0.380	0.380	NUM
iajs-17	325	24	-.443	-.443	PROPN
iajs-17	325	25	*	*	PUNCT
iajs-17	325	26	*	*	PUNCT
iajs-17	325	27	0.000	0.000	NUM
iajs-17	325	28	figure	figure	NOUN
iajs-17	325	29	(	(	PUNCT
iajs-17	325	30	1	1	NUM
iajs-17	325	31	):	):	PUNCT
iajs-17	325	32	significant	significant	ADJ
iajs-17	325	33	correlation	correlation	NOUN
iajs-17	325	34	between	between	ADP
iajs-17	325	35	mda	mda	PROPN
iajs-17	325	36	and	and	CCONJ
iajs-17	325	37	age	age	NOUN
iajs-17	325	38	in	in	ADP
iajs-17	325	39	group	group	PROPN
iajs-17	325	40	p1	p1	PROPN
iajs-17	325	41	.	.	PUNCT
iajs-17	326	1	figure	figure	NOUN
iajs-17	326	2	(	(	PUNCT
iajs-17	326	3	2	2	NUM
iajs-17	326	4	):	):	PUNCT
iajs-17	326	5	significant	significant	ADJ
iajs-17	326	6	correlation	correlation	NOUN
iajs-17	326	7	between	between	ADP
iajs-17	326	8	mda	mda	PROPN
iajs-17	326	9	and	and	CCONJ
iajs-17	326	10	age	age	NOUN
iajs-17	326	11	in	in	ADP
iajs-17	326	12	group	group	NOUN
iajs-17	326	13	p2	p2	PROPN
iajs-17	326	14	.	.	PUNCT
iajs-17	327	1	chemistry	chemistry	NOUN
iajs-17	327	2	|	|	ADV
iajs-17	327	3	144	144	NUM
iajs-17	327	4	2016	2016	NUM
iajs-17	327	5	(	(	PUNCT
iajs-17	327	6	عاً	عاً	PROPN
iajs-17	327	7	3اىعذد	3اىعذد	NUM
iajs-17	327	8	)	)	PUNCT
iajs-17	327	9	29اىَديذ	29اىَديذ	NUM
iajs-17	328	1	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	328	2	ٍديت	ٍديت	VERB
iajs-17	328	3	إبِ	إبِ	X
iajs-17	328	4	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	328	5	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	328	6	اىصشفت	اىصشفت	VERB
iajs-17	328	7	ibn	ibn	PROPN
iajs-17	328	8	al	al	PROPN
iajs-17	328	9	-	-	PUNCT
iajs-17	328	10	haitham	haitham	PROPN
iajs-17	328	11	jour	jour	X
iajs-17	328	12	.	.	PROPN
iajs-17	329	1	for	for	ADP
iajs-17	329	2	pure	pure	ADJ
iajs-17	329	3	&	&	CCONJ
iajs-17	329	4	appl	appl	PROPN
iajs-17	329	5	.	.	PUNCT
iajs-17	330	1	sci	sci	PROPN
iajs-17	330	2	.	.	PUNCT
iajs-17	330	3	vol	vol	NOUN
iajs-17	330	4	.	.	PROPN
iajs-17	330	5	29	29	NUM
iajs-17	330	6	(	(	PUNCT
iajs-17	330	7	3	3	NUM
iajs-17	330	8	)	)	PUNCT
iajs-17	330	9	2016	2016	NUM
iajs-17	330	10	(	(	PUNCT
iajs-17	330	11	b	b	NOUN
iajs-17	330	12	)	)	PUNCT
iajs-17	330	13	(	(	PUNCT
iajs-17	330	14	a	a	X
iajs-17	330	15	)	)	PUNCT
iajs-17	330	16	(	(	PUNCT
iajs-17	330	17	d	d	X
iajs-17	330	18	)	)	PUNCT
iajs-17	330	19	(	(	PUNCT
iajs-17	330	20	c	c	X
iajs-17	330	21	)	)	PUNCT
iajs-17	330	22	figure	figure	NOUN
iajs-17	330	23	(	(	PUNCT
iajs-17	330	24	3	3	NUM
iajs-17	330	25	):	):	PUNCT
iajs-17	330	26	significant	significant	ADJ
iajs-17	330	27	correlation	correlation	NOUN
iajs-17	330	28	in	in	ADP
iajs-17	330	29	group	group	NOUN
iajs-17	330	30	p3	p3	PROPN
iajs-17	330	31	between	between	ADP
iajs-17	330	32	mda	mda	PROPN
iajs-17	330	33	and	and	CCONJ
iajs-17	330	34	(	(	PUNCT
iajs-17	330	35	a	a	X
iajs-17	330	36	)	)	PUNCT
iajs-17	330	37	age	age	NOUN
iajs-17	330	38	,	,	PUNCT
iajs-17	330	39	(	(	PUNCT
iajs-17	330	40	b	b	X
iajs-17	330	41	)	)	PUNCT
iajs-17	330	42	duration	duration	NOUN
iajs-17	330	43	of	of	ADP
iajs-17	330	44	dm	dm	PROPN
iajs-17	330	45	,	,	PUNCT
iajs-17	330	46	(	(	PUNCT
iajs-17	330	47	c	c	X
iajs-17	330	48	)	)	PUNCT
iajs-17	330	49	hba1c	hba1c	PROPN
iajs-17	330	50	and	and	CCONJ
iajs-17	330	51	(	(	PUNCT
iajs-17	330	52	d	d	X
iajs-17	330	53	)	)	PUNCT
iajs-17	330	54	serum	serum	NOUN
iajs-17	330	55	cr	cr	PROPN
iajs-17	330	56	level	level	NOUN
iajs-17	330	57	.	.	PUNCT
iajs-17	331	1	chemistry	chemistry	NOUN
iajs-17	331	2	|	|	ADV
iajs-17	331	3	145	145	NUM
iajs-17	331	4	2016	2016	NUM
iajs-17	331	5	(	(	PUNCT
iajs-17	331	6	عاً	عاً	PROPN
iajs-17	331	7	3اىعذد	3اىعذد	NUM
iajs-17	331	8	)	)	PUNCT
iajs-17	331	9	29اىَديذ	29اىَديذ	NUM
iajs-17	332	1	ٗاىخطبٞقٞت	ٗاىخطبٞقٞت	PRON
iajs-17	332	2	ٍديت	ٍديت	VERB
iajs-17	332	3	إبِ	إبِ	X
iajs-17	332	4	اىٖٞثٌ	اىٖٞثٌ	PROPN
iajs-17	332	5	ىيعيً٘	ىيعيً٘	PROPN
iajs-17	332	6	اىصشفت	اىصشفت	VERB
iajs-17	332	7	ibn	ibn	PROPN
iajs-17	332	8	al	al	PROPN
iajs-17	332	9	-	-	PUNCT
iajs-17	332	10	haitham	haitham	PROPN
iajs-17	332	11	jour	jour	X
iajs-17	332	12	.	.	PROPN
iajs-17	333	1	for	for	ADP
iajs-17	333	2	pure	pure	ADJ
iajs-17	333	3	&	&	CCONJ
iajs-17	333	4	appl	appl	PROPN
iajs-17	333	5	.	.	PUNCT
iajs-17	334	1	sci	sci	PROPN
iajs-17	334	2	.	.	PUNCT
iajs-17	334	3	vol	vol	NOUN
iajs-17	334	4	.	.	PROPN
iajs-17	334	5	29	29	NUM
iajs-17	334	6	(	(	PUNCT
iajs-17	334	7	3	3	NUM
iajs-17	334	8	)	)	SYM
iajs-17	334	9	2016	2016	NUM
iajs-17	335	1	اىثاّٜ	اىثاّٜ	NOUN
iajs-17	335	2	عيٚ	عيٚ	NOUN
iajs-17	335	3	اىس٘بش	اىس٘بش	NOUN
iajs-17	335	4	أٗمسٞذ	أٗمسٞذ	NOUN
iajs-17	335	5	دٝسَٞ٘حٞض	دٝسَٞ٘حٞض	ADJ
iajs-17	335	6	بِٞ	بِٞ	ADJ
iajs-17	335	7	اىَشظٚ	اىَشظٚ	NOUN
iajs-17	335	8	حأثٞش	حأثٞش	ADJ
iajs-17	335	9	داء	داء	ADJ
iajs-17	335	10	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	335	11	اىَْػ	اىَْػ	PROPN
iajs-17	335	12	اىعشاقِٞٞ	اىعشاقِٞٞ	NOUN
iajs-17	335	13	ومير	ومير	NOUN
iajs-17	335	14	إبراهين	إبراهين	NOUN
iajs-17	335	15	حذاد	حذاد	PROPN
iajs-17	335	16	قسٌ	قسٌ	PROPN
iajs-17	335	17	اىنَٞٞاء	اىنَٞٞاء	PROPN
iajs-17	335	18	/	/	SYM
iajs-17	335	19	ميٞت	ميٞت	PROPN
iajs-17	335	20	اىعيً٘/خاٍعت	اىعيً٘/خاٍعت	PROPN
iajs-17	335	21	بغذاد	بغذاد	PROPN
iajs-17	335	22	عصام	عصام	PROPN
iajs-17	335	23	ووري	ووري	PROPN
iajs-17	335	24	اىداٍعت	اىداٍعت	PROPN
iajs-17	335	25	اىَسخْصشٝت	اىَسخْصشٝت	PROPN
iajs-17	335	26	/ميٞت	/ميٞت	PROPN
iajs-17	335	27	اىطب	اىطب	PROPN
iajs-17	335	28	/ٗبح٘د	/ٗبح٘د	PUNCT
iajs-17	336	1	اىسنشٛاىَشمض	اىسنشٛاىَشمض	PROPN
iajs-17	336	2	اى٘غْٜ	اى٘غْٜ	PROPN
iajs-17	336	3	ىعالج	ىعالج	PROPN
iajs-17	336	4	سىاء	سىاء	PROPN
iajs-17	336	5	حسيه	حسيه	PROPN
iajs-17	336	6	علي	علي	PROPN
iajs-17	336	7	بغذادقسٌ	بغذادقسٌ	PUNCT
iajs-17	336	8	اىنَٞٞاء	اىنَٞٞاء	PROPN
iajs-17	336	9	/	/	SYM
iajs-17	336	10	ميٞت	ميٞت	PROPN
iajs-17	336	11	اىعيً٘/خاٍعت	اىعيً٘/خاٍعت	PROPN
iajs-17	336	12	2102	2102	NUM
iajs-17	336	13	/	/	SYM
iajs-17	336	14	ويسان/5،قبل	ويسان/5،قبل	PROPN
iajs-17	336	15	في	في	X
iajs-17	336	16	:	:	PUNCT
iajs-17	336	17	2102	2102	NUM
iajs-17	336	18	/	/	SYM
iajs-17	336	19	ارار/22استلن	ارار/22استلن	NOUN
iajs-17	336	20	في	في	ADP
iajs-17	336	21	:	:	PUNCT
iajs-17	336	22	الخالصة	الخالصة	NOUN
iajs-17	336	23	إّثٚ	إّثٚ	X
iajs-17	336	24	(	(	PUNCT
iajs-17	336	25	حخشاٗذ	حخشاٗذ	PROPN
iajs-17	336	26	أعَاسٌٕ	أعَاسٌٕ	PROPN
iajs-17	336	27	بِٞ	بِٞ	NOUN
iajs-17	336	28	59رمشا	59رمشا	NUM
iajs-17	336	29	ٗ	ٗ	VERB
iajs-17	336	30	71َدَ٘عت	71َدَ٘عت	NUM
iajs-17	336	31	)	)	PUNCT
iajs-17	336	32	اى	اى	PROPN
iajs-17	336	33	2	2	NUM
iajs-17	336	34	ٍشٝعا	ٍشٝعا	VERB
iajs-17	336	35	باىسنشٛ	باىسنشٛ	PROPN
iajs-17	336	36	ٍِ	ٍِ	PROPN
iajs-17	336	37	اىَْػ	اىَْػ	PROPN
iajs-17	336	38	(	(	PUNCT
iajs-17	336	39	130حخعَِ	130حخعَِ	PROPN
iajs-17	336	40	ٕزٓ	ٕزٓ	PROPN
iajs-17	336	41	اىذساست	اىذساست	ADJ
iajs-17	336	42	)	)	PUNCT
iajs-17	337	1	ماّج	ماّج	PROPN
iajs-17	337	2	ّخٞدت	ّخٞدت	PROPN
iajs-17	337	3	حٌ	حٌ	NOUN
iajs-17	337	4	حصْٞفٌٖ	حصْٞفٌٖ	VERB
iajs-17	337	5	اىٚ	اىٚ	PROPN
iajs-17	337	6	ثالد	ثالد	ADV
iajs-17	337	7	ٍداٍٞع	ٍداٍٞع	ADV
iajs-17	337	8	حسب	حسب	NOUN
iajs-17	337	9	ّخٞدت	ّخٞدت	NOUN
iajs-17	337	10	فحص	فحص	NOUN
iajs-17	337	11	اىسنش	اىسنش	PROPN
iajs-17	337	12	اىخشامَٜ	اىخشامَٜ	PRON
iajs-17	337	13	ىذٌٖٝ	ىذٌٖٝ	PROPN
iajs-17	337	14	,	,	PUNCT
iajs-17	337	15	إر	إر	PRON
iajs-17	337	16	اىَشظٚ	اىَشظٚ	NOUN
iajs-17	337	17	اىزِٝ	اىزِٝ	NOUN
iajs-17	337	18	(	(	PUNCT
iajs-17	337	19	سْت	سْت	NOUN
iajs-17	337	20	.55	.55	NUM
iajs-17	337	21	30	30	NUM
iajs-17	337	22	)	)	PUNCT
iajs-17	337	23	أٍا	أٍا	NOUN
iajs-17	337	24	اىَشظٚ	اىَشظٚ	NOUN
iajs-17	337	25	اىزِٝ	اىزِٝ	NOUN
iajs-17	337	26	ماّج	ماّج	PROPN
iajs-17	337	27	ّخٞدت	ّخٞدت	PROPN
iajs-17	337	28	(	(	PUNCT
iajs-17	337	29	ٍشٝط,30	ٍشٝط,30	NOUN
iajs-17	337	30	%	%	X
iajs-17	337	31	صْف٘ا	صْف٘ا	SYM
iajs-17	337	32	عيٚ	عيٚ	PROPN
iajs-17	337	33	إٌّٖ	إٌّٖ	NOUN
iajs-17	337	34	ٍدَ٘عت	ٍدَ٘عت	X
iajs-17	337	35	ٍسٞطشة	ٍسٞطشة	NOUN
iajs-17	337	36	)	)	PUNCT
iajs-17	337	37	7اىسنش	7اىسنش	NUM
iajs-17	337	38	اىخشامَٜ	اىخشامَٜ	NOUN
iajs-17	337	39	ىذٌٖٝ	ىذٌٖٝ	SYM
iajs-17	337	40	أقو	أقو	NOUN
iajs-17	337	41	ٍِ	ٍِ	PROPN
iajs-17	337	42	ٍشٝط	ٍشٝط	PROPN
iajs-17	337	43	(	(	PUNCT
iajs-17	337	44	صْف٘ا	صْف٘ا	SYM
iajs-17	337	45	عيٚ	عيٚ	PROPN
iajs-17	337	46	إٌّٖ	إٌّٖ	NOUN
iajs-17	337	47	ٍدَ٘عت	ٍدَ٘عت	PROPN
iajs-17	337	48	شبٔ	شبٔ	PROPN
iajs-17	337	49	ٍسٞطشة	ٍسٞطشة	NOUN
iajs-17	337	50	عيٚ	عيٚ	PROPN
iajs-17	337	51	ٍسخ٘ٙ	ٍسخ٘ٙ	ADJ
iajs-17	337	52	اىسنش	اىسنش	NOUN
iajs-17	337	53	ٗ	ٗ	VERB
iajs-17	337	54	40	40	NUM
iajs-17	337	55	%	%	NOUN
iajs-17	337	56	)	)	PUNCT
iajs-17	337	57	8اىٚ	8اىٚ	NUM
iajs-17	337	58	7فحص	7فحص	NUM
iajs-17	337	59	اىسنش	اىسنش	NOUN
iajs-17	337	60	اىخشامَٜ	اىخشامَٜ	ADP
iajs-17	337	61	ىذٌٖٝ	ىذٌٖٝ	X
iajs-17	337	62	بِٞ	بِٞ	VERB
iajs-17	338	1	ٍشٝط	ٍشٝط	PROPN
iajs-17	338	2	(	(	PUNCT
iajs-17	338	3	عيٚ	عيٚ	PROPN
iajs-17	338	4	إٌّٖ	إٌّٖ	NOUN
iajs-17	338	5	ٍدَ٘عت	ٍدَ٘عت	NOUN
iajs-17	338	6	غٞش	غٞش	NUM
iajs-17	338	7	50	50	NUM
iajs-17	338	8	%	%	NOUN
iajs-17	338	9	)	)	PUNCT
iajs-17	338	10	8مَٜ	8مَٜ	PROPN
iajs-17	338	11	ىذٌٖٝ	ىذٌٖٝ	NUM
iajs-17	338	12	أمثش	أمثش	PROPN
iajs-17	338	13	ٍِ	ٍِ	PROPN
iajs-17	338	14	صْف	صْف	NOUN
iajs-17	338	15	اىَشظٚ	اىَشظٚ	NOUN
iajs-17	338	16	اىزِٝ	اىزِٝ	NOUN
iajs-17	338	17	ماّج	ماّج	PROPN
iajs-17	338	18	ّخٞدت	ّخٞدت	PROPN
iajs-17	338	19	فحص	فحص	NOUN
iajs-17	338	20	اىسنش	اىسنش	NOUN
iajs-17	338	21	اىخشا	اىخشا	PROPN
iajs-17	338	22	اىْخائح	اىْخائح	NOUN
iajs-17	338	23	اىَسخحصيت	اىَسخحصيت	PROPN
iajs-17	338	24	ٍِ	ٍِ	NOUN
iajs-17	338	25	قٞاساث	قٞاساث	NOUN
iajs-17	338	26	بعط	بعط	PRON
iajs-17	338	27	اىَخغٞشاث	اىَخغٞشاث	PROPN
iajs-17	338	28	فٜ	فٜ	PUNCT
iajs-17	338	29	ٍص٘ه	ٍص٘ه	PROPN
iajs-17	338	30	ٍشظٚ	ٍشظٚ	PROPN
iajs-17	338	31	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	338	32	ق٘سّج	ق٘سّج	PUNCT
iajs-17	338	33	ٍع	ٍع	PROPN
iajs-17	338	34	.	.	PUNCT
iajs-17	339	1	ٍسٞطشة	ٍسٞطشة	NOUN
iajs-17	339	2	عيٚ	عيٚ	PROPN
iajs-17	339	3	ٍسخ٘ٙ	ٍسخ٘ٙ	VERB
iajs-17	339	4	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	339	5	رمش	رمش	PRON
iajs-17	339	6	ٗ	ٗ	VERB
iajs-17	339	7	14	14	NUM
iajs-17	339	8	(	(	PUNCT
iajs-17	339	9	ٍِ	ٍِ	PROPN
iajs-17	339	10	األصحاء	األصحاء	PROPN
iajs-17	339	11	)	)	PUNCT
iajs-17	339	12	35حيل	35حيل	NOUN
iajs-17	339	13	اىَسخحصيت	اىَسخحصيت	PROPN
iajs-17	339	14	ٍِ	ٍِ	NOUN
iajs-17	339	15	قٞاط	قٞاط	PROPN
iajs-17	339	16	راث	راث	PROPN
iajs-17	339	17	اىَخغٞشاث	اىَخغٞشاث	PROPN
iajs-17	339	18	اىَقاست	اىَقاست	PROPN
iajs-17	339	19	فٜ	فٜ	PUNCT
iajs-17	339	20	ٍص٘ه	ٍص٘ه	PROPN
iajs-17	340	1	ٍدَ٘عت	ٍدَ٘عت	X
iajs-17	340	2	اىسٞطشة	اىسٞطشة	PROPN
iajs-17	340	3	اىخٜ	اىخٜ	X
iajs-17	340	4	حشَو	حشَو	NOUN
iajs-17	340	5	)	)	PUNCT
iajs-17	340	6	(	(	PUNCT
iajs-17	340	7	سْت	سْت	PROPN
iajs-17	340	8	.	.	PUNCT
iajs-17	341	1	5530ٚ	5530ٚ	NUM
iajs-17	341	2	(	(	PUNCT
iajs-17	341	3	اىزِٝ	اىزِٝ	NOUN
iajs-17	341	4	حخشاٗذ	حخشاٗذ	PROPN
iajs-17	341	5	أعَاسٌٕ	أعَاسٌٕ	PROPN
iajs-17	341	6	بِٞ	بِٞ	PUNCT
iajs-17	341	7	)	)	PUNCT
iajs-17	341	8	أّث	أّث	NUM
iajs-17	341	9	21	21	NUM
iajs-17	341	10	حٌ	حٌ	NOUN
iajs-17	341	11	خَع	خَع	ADP
iajs-17	341	12	اىبٞاّاث	اىبٞاّاث	INTJ
iajs-17	341	13	اىذَٝ٘غشافٞت	اىذَٝ٘غشافٞت	PROPN
iajs-17	341	14	ىيَشظٚ	ىيَشظٚ	X
iajs-17	341	15	ٗ	ٗ	VERB
iajs-17	341	16	األصحاء	األصحاء	NOUN
iajs-17	341	17	ٗحَج	ٗحَج	PUNCT
iajs-17	341	18	ٍقاسّخٖا	ٍقاسّخٖا	PROPN
iajs-17	341	19	ٗ	ٗ	VERB
iajs-17	341	20	ٕٜ	ٕٜ	NOUN
iajs-17	341	21	اىعَش	اىعَش	NOUN
iajs-17	341	22	)	)	PUNCT
iajs-17	341	23	اىسْت	اىسْت	PROPN
iajs-17	341	24	(	(	PUNCT
iajs-17	341	25	,	,	PUNCT
iajs-17	341	26	ٍذة	ٍذة	PROPN
iajs-17	341	27	اإلصابت	اإلصابت	PROPN
iajs-17	341	28	باىَشض	باىَشض	PROPN
iajs-17	341	29	)	)	PUNCT
iajs-17	341	30	اىسْت	اىسْت	PROPN
iajs-17	341	31	(	(	PUNCT
iajs-17	341	32	ٗ	ٗ	PROPN
iajs-17	341	33	ٍؤشش	ٍؤشش	X
iajs-17	341	34	مخيت	مخيت	NOUN
iajs-17	341	35	اىدسٌ	اىدسٌ	X
iajs-17	341	36	)	)	PUNCT
iajs-17	341	37	مغ	مغ	PROPN
iajs-17	341	38	/ً	/ً	SYM
iajs-17	341	39	2	2	NUM
iajs-17	341	40	.	.	PUNCT
iajs-17	341	41	)	)	PUNCT
iajs-17	342	1	اىني٘م٘ص	اىني٘م٘ص	NOUN
iajs-17	342	2	فٜ	فٜ	PUNCT
iajs-17	342	3	اىَصو	اىَصو	PROPN
iajs-17	342	4	بعذ	بعذ	ADJ
iajs-17	342	5	اىصٞاً	اىصٞاً	PROPN
iajs-17	342	6	)	)	PUNCT
iajs-17	342	7	حٌ	حٌ	NOUN
iajs-17	342	8	قٞاط	قٞاط	PROPN
iajs-17	342	9	اىَخغٞشاث	اىَخغٞشاث	PROPN
iajs-17	342	10	اىسشٝشٝت	اىسشٝشٝت	PROPN
iajs-17	342	11	ىَداٍٞع	ىَداٍٞع	ADJ
iajs-17	342	12	اىَشظٚ	اىَشظٚ	NOUN
iajs-17	342	13	ٍٗدَ٘عت	ٍٗدَ٘عت	ADP
iajs-17	342	14	اىسٞطشة	اىسٞطشة	PROPN
iajs-17	342	15	ٗ	ٗ	VERB
iajs-17	342	16	حشَو	حشَو	NOUN
iajs-17	342	17	ٍسخ٘ٙ	ٍسخ٘ٙ	VERB
iajs-17	342	18	ٍيغٌ	ٍيغٌ	PUNCT
iajs-17	342	19	/	/	SYM
iajs-17	342	20	ده	ده	NOUN
iajs-17	342	21	(	(	PUNCT
iajs-17	342	22	بئسخعَاه	بئسخعَاه	ADJ
iajs-17	342	23	اىعذد	اىعذد	NOUN
iajs-17	342	24	اىَخ٘فشة	اىَخ٘فشة	PROPN
iajs-17	342	25	حداسٝا	حداسٝا	PROPN
iajs-17	342	26	,	,	PUNCT
iajs-17	342	27	ٍسخ٘ٙ	ٍسخ٘ٙ	VERB
iajs-17	342	28	اإلّس٘ىِٞ	اإلّس٘ىِٞ	ADJ
iajs-17	342	29	فٜ	فٜ	PUNCT
iajs-17	342	30	اىَصو	اىَصو	PROPN
iajs-17	342	31	بعذ	بعذ	ADJ
iajs-17	342	32	اىصٞاً	اىصٞاً	PROPN
iajs-17	342	33	)	)	PUNCT
iajs-17	342	34	ٍاٝنشٗ	ٍاٝنشٗ	PROPN
iajs-17	342	35	ٗحذة	ٗحذة	PROPN
iajs-17	342	36	دٗىٞت	دٗىٞت	NOUN
iajs-17	342	37	/	/	SYM
iajs-17	342	38	ٍو	ٍو	PROPN
iajs-17	342	39	(	(	PUNCT
iajs-17	342	40	اإلّس٘ىِٞ	اإلّس٘ىِٞ	NOUN
iajs-17	342	41	)	)	PUNCT
iajs-17	342	42	%	%	NOUN
iajs-17	342	43	(	(	PUNCT
iajs-17	342	44	ب٘ساغت	ب٘ساغت	PROPN
iajs-17	342	45	حَ٘رج	حَ٘رج	PROPN
iajs-17	342	46	,	,	PUNCT
iajs-17	342	47	ّسبت	ّسبت	PROPN
iajs-17	342	48	خالٝا	خالٝا	PROPN
iajs-17	343	1	بٞخا	بٞخا	PROPN
iajs-17	343	2	)	)	PUNCT
iajs-17	343	3	%	%	NOUN
iajs-17	343	4	(	(	PUNCT
iajs-17	343	5	)	)	PUNCT
iajs-17	343	6	ب٘ساغت	ب٘ساغت	PROPN
iajs-17	343	7	َّ٘رج	َّ٘رج	PROPN
iajs-17	343	8	ٍٕ٘٘	ٍٕ٘٘	PROPN
iajs-17	343	9	(	(	PUNCT
iajs-17	343	10	,	,	PUNCT
iajs-17	343	11	ّسبت	ّسبت	PROPN
iajs-17	343	12	حساسٞت	حساسٞت	NUM
iajs-17	343	13	بأسخعَاه	بأسخعَاه	PUNCT
iajs-17	343	14	غشٝقت	غشٝقت	NOUN
iajs-17	343	15	غٞفٞت	غٞفٞت	NUM
iajs-17	343	16	,	,	PUNCT
iajs-17	343	17	ّس٘ىِٞ	ّس٘ىِٞ	NUM
iajs-17	343	18	)	)	PUNCT
iajs-17	343	19	%	%	INTJ
iajs-17	343	20	(	(	PUNCT
iajs-17	343	21	ب٘ساغت	ب٘ساغت	PROPN
iajs-17	343	22	َّ٘رج	َّ٘رج	PROPN
iajs-17	343	23	ٍٕ٘٘	ٍٕ٘٘	NOUN
iajs-17	343	24	,	,	PUNCT
iajs-17	343	25	مَا	مَا	PROPN
iajs-17	343	26	حٌ	حٌ	NOUN
iajs-17	343	27	قٞاط	قٞاط	PROPN
iajs-17	343	28	فعاىٞت	فعاىٞت	NOUN
iajs-17	343	29	اىس٘بش	اىس٘بش	PROPN
iajs-17	343	30	أٗمسٞذ	أٗمسٞذ	PROPN
iajs-17	343	31	دٝسَٞ٘حٞض	دٝسَٞ٘حٞض	ADJ
iajs-17	343	32	اىخاسج	اىخاسج	NOUN
iajs-17	343	33	خي٘ٛ	خي٘ٛ	PROPN
iajs-17	343	34	بطشٝقت	بطشٝقت	PROPN
iajs-17	343	35	ٍٕ٘٘	ٍٕ٘٘	NOUN
iajs-17	343	36	,	,	PUNCT
iajs-17	343	37	ٍقاٍٗت	ٍقاٍٗت	ADJ
iajs-17	343	38	اإل	اإل	NOUN
iajs-17	343	39	حفاعو	حفاعو	PROPN
iajs-17	343	40	اىشاٝب٘فالفِٞ	اىشاٝب٘فالفِٞ	PROPN
iajs-17	343	41	ٗ	ٗ	PROPN
iajs-17	343	42	حاٍط	حاٍط	PROPN
iajs-17	343	43	اىْاٝخشٗ	اىْاٝخشٗ	PROPN
iajs-17	343	44	بي٘	بي٘	NUM
iajs-17	343	45	حخشاصٗىًٞ٘	حخشاصٗىًٞ٘	NOUN
iajs-17	344	1	مَا	مَا	NUM
iajs-17	344	2	حٌ	حٌ	NOUN
iajs-17	344	3	حقذٝش	حقذٝش	ADJ
iajs-17	344	4	حشمٞض	حشمٞض	NOUN
iajs-17	344	5	اىَاىّ٘ٞيذاٛ	اىَاىّ٘ٞيذاٛ	PROPN
iajs-17	344	6	أىذٖٝاٝذ	أىذٖٝاٝذ	PROPN
iajs-17	344	7	ب٘ساغت	ب٘ساغت	PROPN
iajs-17	344	8	حفاعو	حفاعو	PROPN
iajs-17	344	9	خاٍط	خاٍط	PART
iajs-17	344	10	حشاٛ	حشاٛ	NOUN
iajs-17	344	11	باٛ	باٛ	ADJ
iajs-17	344	12	بٞ٘حٞشك	بٞ٘حٞشك	PROPN
iajs-17	344	13	.	.	PUNCT
iajs-17	345	1	(	(	PUNCT
iajs-17	345	2	,	,	PUNCT
iajs-17	345	3	ٍسخ٘ٙ	ٍسخ٘ٙ	VERB
iajs-17	345	4	اىني٘م٘ص	اىني٘م٘ص	PROPN
iajs-17	345	5	فٜ	فٜ	PUNCT
iajs-17	345	6	اىَصو	اىَصو	PROPN
iajs-17	345	7	بعذ	بعذ	ADJ
iajs-17	345	8	hba1cخ٘ٙ	hba1cخ٘ٙ	NOUN
iajs-17	345	9	اىسنش	اىسنش	NOUN
iajs-17	345	10	اىخشامَٜ)أظٖشث	اىخشامَٜ)أظٖشث	PRON
iajs-17	345	11	اىذساست	اىذساست	VERB
iajs-17	345	12	صٝادة	صٝادة	PROPN
iajs-17	345	13	ٍعْ٘ٝت	ٍعْ٘ٝت	X
iajs-17	345	14	فٜ	فٜ	PUNCT
iajs-17	345	15	قٌٞ	قٌٞ	NOUN
iajs-17	345	16	ٍس	ٍس	X
iajs-17	345	17	(	(	PUNCT
iajs-17	345	18	,	,	PUNCT
iajs-17	345	19	ٗ	ٗ	VERB
iajs-17	345	20	ٍسخ٘ٙ	ٍسخ٘ٙ	PROPN
iajs-17	345	21	اىَاىّ٘ٞيذاٛ	اىَاىّ٘ٞيذاٛ	PROPN
iajs-17	345	22	ir	ir	PROPN
iajs-17	345	23	(	(	PUNCT
iajs-17	345	24	,	,	PUNCT
iajs-17	345	25	ٍقاٍٗت	ٍقاٍٗت	ADV
iajs-17	345	26	اإلّس٘ىِٞ)fpi	اإلّس٘ىِٞ)fpi	PROPN
iajs-17	345	27	,	,	PUNCT
iajs-17	345	28	ٍسخ٘ٙ	ٍسخ٘ٙ	ADJ
iajs-17	345	29	اإلّس٘ىِٞ	اإلّس٘ىِٞ	ADJ
iajs-17	345	30	فٜ	فٜ	PUNCT
iajs-17	345	31	اىَصو	اىَصو	PROPN
iajs-17	345	32	بعذ	بعذ	ADJ
iajs-17	345	33	اىصٞاً	اىصٞاً	PROPN
iajs-17	345	34	)	)	PUNCT
iajs-17	345	35	(	(	PUNCT
iajs-17	345	36	fsg)اىصٞاً	fsg)اىصٞاً	PROPN
iajs-17	345	37	ا	ا	X
iajs-17	345	38	.	.	PUNCT
iajs-17	346	1	بَْٞا	بَْٞا	PROPN
iajs-17	346	2	أظٖشث	أظٖشث	PROPN
iajs-17	346	3	اىذساست	اىذساست	PROPN
iajs-17	346	4	ّقصاّا	ّقصاّا	PROPN
iajs-17	346	5	ٍعْ٘ٝ	ٍعْ٘ٝ	NUM
iajs-17	347	1	c	c	X
iajs-17	347	2	(	(	PUNCT
iajs-17	347	3	ٍقاسّت	ٍقاسّت	ADP
iajs-17	347	4	ٍع	ٍع	PROPN
iajs-17	347	5	ٍدَ٘عت	ٍدَ٘عت	PROPN
iajs-17	347	6	اىسٞطشة	اىسٞطشة	PROPN
iajs-17	347	7	p	p	NOUN
iajs-17	347	8	(	(	PUNCT
iajs-17	347	9	فٜ	فٜ	PROPN
iajs-17	347	10	ٍشظٚ	ٍشظٚ	PROPN
iajs-17	347	11	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	347	12	)	)	PUNCT
iajs-17	347	13	ٍدَ٘عت	ٍدَ٘عت	PROPN
iajs-17	347	14	mdaأىذٖٝاٝذ	mdaأىذٖٝاٝذ	PROPN
iajs-17	347	15	)	)	PUNCT
iajs-17	347	16	(	(	PUNCT
iajs-17	347	17	ٗ	ٗ	VERB
iajs-17	347	18	اىس٘بش	اىس٘بش	NOUN
iajs-17	347	19	أٗمسٞذ	أٗمسٞذ	PROPN
iajs-17	347	20	دٝسَٞ٘حٞض	دٝسَٞ٘حٞض	PROPN
iajs-17	347	21	اىخاسج	اىخاسج	PROPN
iajs-17	347	22	cr	cr	PROPN
iajs-17	347	23	)	)	PUNCT
iajs-17	347	24	%	%	NOUN
iajs-17	347	25	(	(	PUNCT
iajs-17	347	26	,	,	PUNCT
iajs-17	347	27	ٍسخ٘ٙ	ٍسخ٘ٙ	PROPN
iajs-17	347	28	اىنشsًٗ%	اىنشsًٗ%	PROPN
iajs-17	347	29	(	(	PUNCT
iajs-17	347	30	,	,	PUNCT
iajs-17	347	31	ّسبت	ّسبت	PROPN
iajs-17	347	32	حساسٞت	حساسٞت	NUM
iajs-17	347	33	اإلّس٘ىِٞ)ß	اإلّس٘ىِٞ)ß	NOUN
iajs-17	347	34	)	)	PUNCT
iajs-17	347	35	فٜ	فٜ	VERB
iajs-17	347	36	قٌٞ	قٌٞ	PUNCT
iajs-17	347	37	ّسبت	ّسبت	PROPN
iajs-17	347	38	خالٝا	خالٝا	PROPN
iajs-17	347	39	بٞخا	بٞخا	PROPN
iajs-17	347	40	.c	.c	PROPN
iajs-17	347	41	(	(	PUNCT
iajs-17	347	42	ٍقاسّت	ٍقاسّت	ADP
iajs-17	347	43	ٍع	ٍع	PROPN
iajs-17	347	44	ٍدَ٘عت	ٍدَ٘عت	PROPN
iajs-17	347	45	اىسٞطشة	اىسٞطشة	PROPN
iajs-17	347	46	pفٜ	pفٜ	NOUN
iajs-17	347	47	ٍشظٚ	ٍشظٚ	PROPN
iajs-17	347	48	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	347	49	)	)	PUNCT
iajs-17	348	1	ٍدَ٘عت	ٍدَ٘عت	PROPN
iajs-17	348	2	ec	ec	PROPN
iajs-17	348	3	-	-	PUNCT
iajs-17	348	4	sodخي٘ٛ	sodخي٘ٛ	PROPN
iajs-17	348	5	)	)	PUNCT
iajs-17	349	1	اث	اث	NOUN
iajs-17	349	2	اىخاىٞت	اىخاىٞت	NOUN
iajs-17	349	3	أظٖشث	أظٖشث	PROPN
iajs-17	349	4	حْاسبا	حْاسبا	VERB
iajs-17	349	5	غشدٝا	غشدٝا	NOUN
iajs-17	349	6	ٍع	ٍع	ADJ
iajs-17	349	7	إرا	إرا	NOUN
iajs-17	349	8	ٍا	ٍا	NOUN
iajs-17	349	9	ق٘سّج	ق٘سّج	PUNCT
iajs-17	349	10	اىْخائح	اىْخائح	NOUN
iajs-17	349	11	ٗفقا	ٗفقا	NOUN
iajs-17	349	12	ىيخقسٌٞ	ىيخقسٌٞ	PROPN
iajs-17	349	13	اىفشعٜ	اىفشعٜ	PROPN
iajs-17	349	14	اىزٛ	اىزٛ	VERB
iajs-17	349	15	حٌ	حٌ	NOUN
iajs-17	349	16	حطبٞقٔ	حطبٞقٔ	NOUN
iajs-17	349	17	عيٚ	عيٚ	PROPN
iajs-17	349	18	اىَشظٚ	اىَشظٚ	NOUN
iajs-17	349	19	فأُ	فأُ	PROPN
iajs-17	349	20	اىَخغٞش	اىَخغٞش	NOUN
iajs-17	350	1	أٗ	أٗ	PROPN
iajs-17	350	2	ٍدَ٘عت	ٍدَ٘عت	NOUN
iajs-17	350	3	p1أٗ	p1أٗ	NOUN
iajs-17	350	4	اىََدَ٘عت	اىََدَ٘عت	PRON
iajs-17	350	5	p2ماّج	p2ماّج	NOUN
iajs-17	350	6	أعيٚ	أعيٚ	NOUN
iajs-17	350	7	ٍِ	ٍِ	PROPN
iajs-17	350	8	قَٖٞا	قَٖٞا	PROPN
iajs-17	350	9	فٜ	فٜ	PROPN
iajs-17	350	10	اىَدَ٘عت	اىَدَ٘عت	PROPN
iajs-17	350	11	p3اىسنش	p3اىسنش	PROPN
iajs-17	350	12	اىخشامَٜ	اىخشامَٜ	PROPN
iajs-17	350	13	أٛ	أٛ	PROPN
iajs-17	350	14	أُ	أُ	PROPN
iajs-17	350	15	قَٖٞا	قَٖٞا	PROPN
iajs-17	350	16	فٜ	فٜ	X
iajs-17	350	17	اىَدَ٘عت	اىَدَ٘عت	PROPN
iajs-17	350	18	(	(	PUNCT
iajs-17	350	19	,	,	PUNCT
iajs-17	350	20	ٍسخ٘ٙ	ٍسخ٘ٙ	VERB
iajs-17	350	21	اإلّس٘ىِٞ	اإلّس٘ىِٞ	ADJ
iajs-17	350	22	فٜ	فٜ	PROPN
iajs-17	350	23	اىَصو	اىَصو	PROPN
iajs-17	350	24	بعذ	بعذ	ADJ
iajs-17	350	25	اىصٞاfsgً	اىصٞاfsgً	NOUN
iajs-17	350	26	,	,	PUNCT
iajs-17	350	27	اىَخغٞشاث	اىَخغٞشاث	PROPN
iajs-17	350	28	ٕٜ	ٕٜ	PROPN
iajs-17	350	29	)	)	PUNCT
iajs-17	350	30	ٍسخ٘ٙ	ٍسخ٘ٙ	VERB
iajs-17	350	31	اىني٘م٘ص	اىني٘م٘ص	NOUN
iajs-17	350	32	فٜ	فٜ	PUNCT
iajs-17	350	33	اىَصو	اىَصو	PROPN
iajs-17	350	34	بعذ	بعذ	ADJ
iajs-17	350	35	اىصٞاً	اىصٞاً	PROPN
iajs-17	350	36	)	)	PUNCT
iajs-17	351	1	c	c	PROPN
iajs-17	352	1	اىسٞطشة	اىسٞطشة	PROPN
iajs-17	352	2	(	(	PUNCT
iajs-17	352	3	fpi	fpi	PROPN
iajs-17	352	4	ٍقاٍٗت	ٍقاٍٗت	PROPN
iajs-17	352	5	,	,	PUNCT
iajs-17	352	6	)	)	PUNCT
iajs-17	352	7	ِٞاإلّس٘ى	ِٞاإلّس٘ى	PROPN
iajs-17	352	8	(	(	PUNCT
iajs-17	352	9	ir	ir	PROPN
iajs-17	352	10	(	(	PUNCT
iajs-17	352	11	ٍٗسخ٘ٙ	ٍٗسخ٘ٙ	ADP
iajs-17	352	12	اىَاىّ٘ٞيذاٛ	اىَاىّ٘ٞيذاٛ	PROPN
iajs-17	352	13	أىذٖٝاٝذ	أىذٖٝاٝذ	PROPN
iajs-17	352	14	,	,	PUNCT
iajs-17	352	15	)	)	PUNCT
iajs-17	352	16	mda	mda	PROPN
iajs-17	352	17	فٜ	فٜ	PROPN
iajs-17	352	18	اىَقابو	اىَقابو	PROPN
iajs-17	352	19	اىَخغٞشاث	اىَخغٞشاث	PROPN
iajs-17	352	20	اىخاىٞت	اىخاىٞت	PROPN
iajs-17	352	21	أبذث	أبذث	VERB
iajs-17	352	22	حْاسبا	حْاسبا	PROPN
iajs-17	352	23	عنسٞا	عنسٞا	PROPN
iajs-17	352	24	)	)	PUNCT
iajs-17	352	25	بو	بو	PROPN
iajs-17	352	26	حخٚ	حخٚ	PROPN
iajs-17	352	27	أُ	أُ	PROPN
iajs-17	352	28	قَٖٞا	قَٖٞا	PROPN
iajs-17	352	29	فٜ	فٜ	PUNCT
iajs-17	352	30	p2	p2	PROPN
iajs-17	352	31	ٗp3أعيٚ	ٗp3أعيٚ	PROPN
iajs-17	352	32	ٍِ	ٍِ	PROPN
iajs-17	352	33	اىَدَ٘عخِٞ	اىَدَ٘عخِٞ	PROPN
iajs-17	352	34	p1	p1	PROPN
iajs-17	352	35	(	(	PUNCT
iajs-17	352	36	أٛ	أٛ	PROPN
iajs-17	352	37	أُ	أُ	PROPN
iajs-17	352	38	قَٖٞا	قَٖٞا	PROPN
iajs-17	352	39	فٜ	فٜ	NOUN
iajs-17	352	40	اىَدَ٘عت	اىَدَ٘عت	PROPN
iajs-17	352	41	hba1cٍع	hba1cٍع	PROPN
iajs-17	352	42	اىسنش	اىسنش	NOUN
iajs-17	352	43	اىخشامَٜ	اىخشامَٜ	NOUN
iajs-17	352	44	)	)	PUNCT
iajs-17	352	45	(	(	PUNCT
iajs-17	352	46	,	,	PUNCT
iajs-17	352	47	ٍسخ٘ٙ	ٍسخ٘ٙ	PROPN
iajs-17	352	48	اىنشًٗ	اىنشًٗ	VERB
iajs-17	352	49	%	%	NOUN
iajs-17	352	50	s	s	PART
iajs-17	352	51	)	)	PUNCT
iajs-17	352	52	ّسبت	ّسبت	PROPN
iajs-17	352	53	حساسٞت	حساسٞت	PROPN
iajs-17	352	54	اإلّس٘ىِٞ	اإلّس٘ىِٞ	ADJ
iajs-17	352	55	(	(	PUNCT
iajs-17	352	56	,	,	PUNCT
iajs-17	352	57	%	%	INTJ
iajs-17	352	58	ß	ß	X
iajs-17	352	59	)	)	PUNCT
iajs-17	352	60	ٕٜ	ٕٜ	NOUN
iajs-17	352	61	األعيٚ	األعيٚ	PROPN
iajs-17	352	62	,	,	PUNCT
iajs-17	352	63	ٕزٓ	ٕزٓ	PROPN
iajs-17	352	64	اىَخغٞشاث	اىَخغٞشاث	PROPN
iajs-17	352	65	ٕٜ	ٕٜ	PROPN
iajs-17	352	66	ّسبت	ّسبت	PROPN
iajs-17	352	67	خالٝا	خالٝا	PROPN
iajs-17	352	68	بٞخا	بٞخا	PROPN
iajs-17	352	69	cٍدَ٘عت	cٍدَ٘عت	NOUN
iajs-17	352	70	(	(	PUNCT
iajs-17	352	71	cr	cr	PROPN
iajs-17	352	72	.	.	PUNCT
iajs-17	352	73	)	)	PUNCT
iajs-17	353	1	(	(	PUNCT
iajs-17	353	2	عالقت	عالقت	NOUN
iajs-17	353	3	إسحباغٞت	إسحباغٞت	VERB
iajs-17	353	4	ٍ٘خبت	ٍ٘خبت	NOUN
iajs-17	353	5	ٍع	ٍع	ADJ
iajs-17	353	6	اىعَش	اىعَش	PROPN
iajs-17	353	7	.	.	PUNCT
iajs-17	354	1	بَْٞا	بَْٞا	PROPN
iajs-17	354	2	فٜ	فٜ	PROPN
iajs-17	354	3	mdaأظٖش	mdaأظٖش	PROPN
iajs-17	354	4	حشمٞض	حشمٞض	PROPN
iajs-17	354	5	اىَاىّ٘ٞيذاٛ	اىَاىّ٘ٞيذاٛ	PROPN
iajs-17	354	6	أىذٖٝاٝذ	أىذٖٝاٝذ	NOUN
iajs-17	354	7	)	)	PUNCT
iajs-17	354	8	p2ٗ	p2ٗ	PROPN
iajs-17	354	9	ٍدَ٘عت	ٍدَ٘عت	PROPN
iajs-17	354	10	p1فٜ	p1فٜ	PROPN
iajs-17	354	11	ٍدَ٘عت	ٍدَ٘عت	NOUN
iajs-17	354	12	بَْٞا	بَْٞا	PROPN
iajs-17	354	13	أظٖش	أظٖش	PRON
iajs-17	354	14	(	(	PUNCT
iajs-17	354	15	,	,	PUNCT
iajs-17	354	16	cr	cr	PROPN
iajs-17	354	17	)	)	PUNCT
iajs-17	354	18	(	(	PUNCT
iajs-17	354	19	عالقت	عالقت	NOUN
iajs-17	354	20	إسحباغٞت	إسحباغٞت	VERB
iajs-17	354	21	ساىبت	ساىبت	ADJ
iajs-17	354	22	ٍع	ٍع	ADJ
iajs-17	354	23	ٍسخ٘ٙ	ٍسخ٘ٙ	ADJ
iajs-17	354	24	اىنشmdaًٗأظٖش	اىنشmdaًٗأظٖش	PROPN
iajs-17	354	25	حشمٞض	حشمٞض	NOUN
iajs-17	354	26	اىَاىّ٘ٞيذاٛ	اىَاىّ٘ٞيذاٛ	PROPN
iajs-17	354	27	أىذٖٝاٝذ	أىذٖٝاٝذ	NOUN
iajs-17	354	28	)	)	PUNCT
iajs-17	354	29	p3ٍدَ٘عت	p3ٍدَ٘عت	NOUN
iajs-17	354	30	.(hba1c	.(hba1c	PUNCT
iajs-17	354	31	)	)	PUNCT
iajs-17	354	32	.	.	PUNCT
iajs-17	355	1	القت	القت	PROPN
iajs-17	355	2	إسحباغٞت	إسحباغٞت	NOUN
iajs-17	355	3	ٍ٘خبت	ٍ٘خبت	X
iajs-17	355	4	ٍع	ٍع	ADJ
iajs-17	355	5	اىعَش	اىعَش	PROPN
iajs-17	355	6	,	,	PUNCT
iajs-17	355	7	ٍذة	ٍذة	PROPN
iajs-17	355	8	االصابت	االصابت	PROPN
iajs-17	355	9	بَشض	بَشض	NUM
iajs-17	355	10	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	355	11	,	,	PUNCT
iajs-17	355	12	ٗ	ٗ	VERB
iajs-17	355	13	ٍسخ٘ٙ	ٍسخ٘ٙ	ADJ
iajs-17	355	14	اىسنش	اىسنش	NOUN
iajs-17	355	15	اىخشامَٜع	اىخشامَٜع	PROPN
iajs-17	355	16	ٍشظٚ	ٍشظٚ	PROPN
iajs-17	355	17	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	355	18	ٍعشظِٞ	ٍعشظِٞ	PROPN
iajs-17	355	19	ىخطش	ىخطش	VERB
iajs-17	355	20	اإلخٖاد	اإلخٖاد	PROPN
iajs-17	355	21	اىخأمسذٛ	اىخأمسذٛ	PROPN
iajs-17	355	22	,	,	PUNCT
iajs-17	355	23	ٗ	ٗ	VERB
iajs-17	355	24	رىل	رىل	NOUN
iajs-17	355	25	ىضٝادة	ىضٝادة	PROPN
iajs-17	355	26	بأُ	بأُ	ADV
iajs-17	355	27	أعخَادا	أعخَادا	PUNCT
iajs-17	355	28	عيٚ	عيٚ	PROPN
iajs-17	355	29	ّخائح	ّخائح	PROPN
iajs-17	355	30	اىذساست	اىذساست	ADJ
iajs-17	355	31	اىحاىٞت	اىحاىٞت	NOUN
iajs-17	355	32	َٝنْْا	َٝنْْا	PROPN
iajs-17	355	33	إسخْخاج	إسخْخاج	PROPN
iajs-17	355	34	(	(	PUNCT
iajs-17	355	35	.	.	PUNCT
iajs-17	356	1	مَا	مَا	NUM
iajs-17	356	2	ec	ec	PROPN
iajs-17	356	3	-	-	PUNCT
iajs-17	356	4	sodاىس٘بش	sodاىس٘بش	PROPN
iajs-17	356	5	اٗمسٞذ	اٗمسٞذ	PROPN
iajs-17	356	6	دٝسَٞ٘حٞضاىخاسج	دٝسَٞ٘حٞضاىخاسج	PROPN
iajs-17	356	7	خي٘ٛ	خي٘ٛ	PROPN
iajs-17	356	8	)	)	PUNCT
iajs-17	356	9	ُٗ	ُٗ	NOUN
iajs-17	356	10	إّخفاض	إّخفاض	NOUN
iajs-17	356	11	فعاىٞت	فعاىٞت	VERB
iajs-17	356	12	إّضٌٝ	إّضٌٝ	NUM
iajs-17	356	13	(	(	PUNCT
iajs-17	356	14	mdaحشمٞض	mdaحشمٞض	PROPN
iajs-17	356	15	اىَاىّ٘ٞيذاٛ	اىَاىّ٘ٞيذاٛ	PROPN
iajs-17	356	16	أىذٖٝاٝذ	أىذٖٝاٝذ	PROPN
iajs-17	356	17	)	)	PUNCT
iajs-17	357	1	%	%	NOUN
iajs-17	357	2	ال	ال	ADP
iajs-17	357	3	ٝعذُٗ	ٝعذُٗ	PROPN
iajs-17	357	4	شبٔ	شبٔ	PROPN
iajs-17	357	5	ٍسٞطٞشِٝ	ٍسٞطٞشِٝ	PROPN
iajs-17	357	6	8إىٚ	8إىٚ	NUM
iajs-17	357	7	7	7	NUM
iajs-17	357	8	(	(	PUNCT
iajs-17	357	9	ىذٌٖٝ	ىذٌٖٝ	NUM
iajs-17	357	10	بِٞ	بِٞ	PRON
iajs-17	357	11	hba1c	hba1c	PROPN
iajs-17	357	12	)	)	PUNCT
iajs-17	357	13	أُ	أُ	PROPN
iajs-17	357	14	ٍشظٚ	ٍشظٚ	PROPN
iajs-17	357	15	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	357	16	اىزِٝ	اىزِٝ	NOUN
iajs-17	357	17	حنُ٘	حنُ٘	PART
iajs-17	357	18	ّخٞدت	ّخٞدت	NOUN
iajs-17	357	19	ٍسخ٘ٙ	ٍسخ٘ٙ	VERB
iajs-17	357	20	اىسنش	اىسنش	NOUN
iajs-17	357	21	اىخشامَٜ	اىخشامَٜ	SYM
iajs-17	357	22	%	%	NOUN
iajs-17	357	23	ٍِ	ٍِ	PROPN
iajs-17	357	24	7عيٚ	7عيٚ	NUM
iajs-17	357	25	حذة	حذة	NOUN
iajs-17	357	26	اىَشض	اىَشض	PROPN
iajs-17	357	27	بو	بو	PRON
iajs-17	357	28	إٌّٖ	إٌّٖ	VERB
iajs-17	357	29	ٍخعشسِٝ	ٍخعشسِٝ	PROPN
iajs-17	357	30	سشٝشٝا	سشٝشٝا	PROPN
iajs-17	357	31	بشنو	بشنو	PROPN
iajs-17	357	32	مبٞش	مبٞش	PROPN
iajs-17	357	33	ٗ	ٗ	VERB
iajs-17	357	34	ٝدب	ٝدب	NOUN
iajs-17	357	35	عيٌٖٞ	عيٌٖٞ	PROPN
iajs-17	357	36	خفط	خفط	NOUN
iajs-17	357	37	قَٞت	قَٞت	NOUN
iajs-17	357	38	اىسنش	اىسنش	NOUN
iajs-17	357	39	اىخشامَٜ	اىخشامَٜ	X
iajs-17	357	40	إىٚ	إىٚ	PROPN
iajs-17	357	41	ٍا	ٍا	PROPN
iajs-17	357	42	دُٗ	دُٗ	NOUN
iajs-17	357	43	اه	اه	AUX
iajs-17	357	44	اله	اله	PROPN
iajs-17	357	45	اىعالج	اىعالج	PROPN
iajs-17	357	46	ٗ	ٗ	PROPN
iajs-17	357	47	اىْظاً	اىْظاً	NOUN
iajs-17	357	48	اىغزائٜ.خ	اىغزائٜ.خ	NOUN
iajs-17	357	49	:	:	PUNCT
iajs-17	357	50	داء	داء	ADV
iajs-17	357	51	اىسنشٛ	اىسنشٛ	PROPN
iajs-17	357	52	اىَْػ	اىَْػ	PROPN
iajs-17	357	53	اىثاّٜ	اىثاّٜ	PROPN
iajs-17	357	54	,	,	PUNCT
iajs-17	357	55	س٘بش	س٘بش	PUNCT
iajs-17	357	56	أٗمسٞذ	أٗمسٞذ	PROPN
iajs-17	357	57	دٝسَٞ٘حٞض	دٝسَٞ٘حٞض	ADJ
iajs-17	357	58	اىخاسج	اىخاسج	PROPN
iajs-17	357	59	خي٘ٛ	خي٘ٛ	PROPN
iajs-17	357	60	,	,	PUNCT
iajs-17	357	61	فشغ	فشغ	NOUN
iajs-17	357	62	اىسنشٛ.الكلمات	اىسنشٛ.الكلمات	VERB
iajs-17	357	63	المفتاحية	المفتاحية	VERB